syndrome	score	normalized_score
DRAVET SYNDROME	2.6958217	100.0
RECURRENT ACUTE PANCREATITIS	2.3763921490000004	88.15093924794805
HEREDITARY ANGIOEDEMA TYPE 1	1.9032675	70.60064469397214
AFRICAN IRON OVERLOAD	1.80182267	66.83760539504522
CHILDHOOD ABSENCE EPILEPSY	1.52074085	56.411032302321765
HEPATOCELLULAR CARCINOMA	1.4720718999999998	54.605684789910235
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	1.463977309	54.30542045863047
LYMPHEDEMA, HEREDITARY, III	1.376379554	51.05603067146465
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	1.3454136639999998	49.90736828032802
AUTOIMMUNE HEPATITIS	1.3350949799999998	49.524602461653885
+173470 INTEGRIN, BETA-3; ITGB3;;PLATELET GLYCOPROTEIN IIIA; GP3A;;GP IIIA;;PLATELET FIBRINOGEN RECEPTOR, BETA SUBUNIT;;CD61THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE, INCLUDED; NAIT, INCLUDED;;POSTTRANSFUSION PURPURA, INCLUDED; PTP, INCLUDED	1.333333	49.45924279784527
SECKEL SYNDROME 10; SCKL10	1.25934579	46.71472857422284
MYOCLONIC-ASTASTIC EPILEPSY	1.220712254	45.281639138078006
LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	1.20271637	44.614091874102805
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	1.19979725	44.50580874840499
%210500 BILIARY ATRESIA, EXTRAHEPATIC; EHBA	1.19721556	44.41004240005932
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	1.19559456	44.349912310595315
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.1936939999999998	44.27941209910135
LYMPHATIC MALFORMATION 1	1.1421568	42.36766845522461
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	1.136006394	42.13952258044365
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	1.121970679	41.61887557326212
HEPATOCELLULAR CARCINOMA	1.1145833	41.34484487605393
BILATERAL POLYMICROGYRIA	1.106565524	41.04742995428815
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	1.09331874	40.55604790183267
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	1.0849554000000001	40.24581447652862
PULMONARY ARTERIOVENOUS MALFORMATION	1.083874719	40.20572721853229
CRANIOECTODERMAL DYSPLASIA 1	1.07100188	39.72821644695567
MOSAIC TRISOMY 1	1.06276051	39.42250743066575
WILSON DISEASE	1.04164923	38.639396292418
MONOSOMY 22Q13.3	1.040767143	38.606675767911504
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	1.040758319	38.60634844656084
HEPARIN-INDUCED THROMBOCYTOPENIA	1.03125	38.25364266486911
MEVALONIC ACIDURIA; MEVA	1.028271304	38.14314960073212
TEMPI SYNDROME	1.027027	38.09699283895518
COMPLEX REGIONAL PAIN SYNDROME	1.0263158	38.07061127225142
COMBINED IMMUNODEFICIENCY-ENTEROPATHY SPECTRUM	1.0204082	37.85147215040223
LOWRY-MACLEAN SYNDROME	1.019997029	37.836219991848864
TRANSSEXUALITY	1.0172414	37.7340014734654
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	1.017013454	37.72554594393242
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	1.01497094	37.64978002810794
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.00934579	37.441118231224266
PREECLAMPSIA	1.0072002599999998	37.361530994427405
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	1.003496613	37.224146277923346
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	1.002951059	37.20390925705509
ATONIC-ASTATIC SYNDROME OF FOERSTER	1.0014771	37.14923357134487
DISTAL 16P11.2 MICRODELETION SYNDROME	1.0010869729999998	37.13476202821573
PITUITARY DERMOID AND EPIDERMOID CYSTS	1.000541419	37.114525007347474
268040 RETINOHEPATOENDOCRINOLOGIC SYNDROME;;RHE SYNDROME	1.0	37.0944413719943
AGENESIS OF CEREBRAL WHITE MATTER	1.0	37.0944413719943
PAROXYSMAL KINESIGENIC DYSKINESIA	1.0	37.0944413719943
CHONDROITIN-6-SULFATURIA, DEFECTIVE CELLULAR IMMUNITY, NEPHROTIC SYNDROME	1.0	37.0944413719943
ENTEROKINASE DEFICIENCY	1.0	37.0944413719943
CARDIAC-UROGENITAL SYNDROME; CUGS	1.0	37.0944413719943
CONGENITAL MACROGLOSSIA	1.0	37.0944413719943
AUTOIMMUNE INTERSTITIAL LUNG, JOINT, AND KIDNEY DISEASE; AILJK	1.0	37.0944413719943
TETRAGAMETIC CHIMERISM	1.0	37.0944413719943
PRIMARY SCLEROSING CHOLANGITIS	0.99823066	37.02880869309717
HYPERCHOLESTEROLEMIA DUE TO CHOLESTEROL 7ALPHA-HYDROXYLASE DEFICIENCY	0.9759633999999999	36.202817122512215
MYOCLONIC EPILEPSY OF LAFORA	0.93444076	34.662557987421785
ISOLATED BILIARY ATRESIA	0.8841608190000002	32.797451663809966
JUVENILE POLYPOSIS SYNDROME	0.875	32.45763620049501
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.843344419	31.28339010699409
MARTINEZ-FRIAS SYNDROME	0.833333	30.91202211184812
ANGIOEDEMA, HEREDITARY, TYPE I; HAE1	0.8047616	29.85218198963232
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.77802685	28.8604713731624
LAFORA DISEASE	0.7730060599999999	28.6742279728663
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.7706171	28.585610836206264
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.7504837239999997	27.838774500553935
IMMUNODEFICIENCY BY DEFECTIVE EXPRESSION OF MHC CLASS II	0.73637821	27.315538338459106
EARLY MYOCLONIC ENCEPHALOPATHY	0.7087289139999999	26.289903149010186
SOMATOSTATINOMA	0.7064654800000001	26.20594232919781
AGEL AMYLOIDOSIS	0.7014771	26.02090115974658
LYSINURIC PROTEIN INTOLERANCE	0.6844092899999998	25.387780282353233
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.684326394	25.384705301541267
ANGIOEDEMA, HEREDITARY, TYPE III	0.6635850999999999	24.61531858727897
MEIGE DISEASE	0.6604669	24.499650700192817
PRIMARY HEPATIC NEUROENDOCRINE CARCINOMA	0.65825675	24.417666420594504
SLC35A2-CDG	0.639975264	23.73952490997457
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.6317565639999999	23.434656824670558
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.622449579	23.08941941523803
RING CHROMOSOME 13 SYNDROME	0.61504801	22.814862347906757
DUPLICATION/INVERSION 15Q11	0.611652419	22.68890479663399
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.60795866	22.55188686996621
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.59421851	22.042203681348806
GRAFT VERSUS HOST DISEASE	0.5926615300000001	21.984448378021444
ALAGILLE SYNDROME 1; ALGS1	0.59108942	21.926131835796113
ROLANDIC EPILEPSY	0.5906213	21.908767185901056
SICKLE CELL ANEMIA	0.5870825999999999	21.777501086217974
GALLBLADDER NEUROENDOCRINE TUMOR	0.5839289000000001	21.660516346463123
METACHROMATIC LEUKODYSTROPHY	0.582375619	21.602898255474386
MECKEL SYNDROME	0.5787148999999999	21.46710592914954
AICARDI-GOUTIÈRES SYNDROME	0.577799383	21.433145337467977
MECKEL SYNDROME, TYPE 6; MKS6	0.5692983	21.11780241252602
LATHOSTEROLOSIS	0.5665111890000001	21.014416086939285
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.565363104	20.971828515216714
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.56068381	20.79825271827139
DIAPHANOSPONDYLODYSOSTOSIS	0.559369054	20.749482578910914
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.5591847300000001	20.742645183099466
PETERS-PLUS SYNDROME; PTRPLS	0.5576555830000001	20.6859223293588
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.5552631600000001	20.59717673464829
PULMONARY FIBROSIS-HEPATIC HYPERPLASIA-BONE MARROW HYPOPLASIA SYNDROME	0.5425042600000001	20.12389246662715
MOWAT-WILSON SYNDROME; MOWS	0.537411569	19.934981938901966
GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME; GIDID	0.5357143	19.87202269348896
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.5348101000000001	19.838481899600406
THROMBOCYTOPENIA 1	0.5333330000000001	19.783689700249834
HEREDITARY ANGIOEDEMA	0.5302521	19.669405435826857
ACQUIRED ANGIOEDEMA	0.5302521	19.669405435826857
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.527027	19.549772152958038
SPLENOPORTAL VASCULAR ANOMALIES	0.52536235	19.488022891128146
ALAGILLE SYNDROME	0.52392578	19.43473412948638
AICARDI-GOUTIERES SYNDROME 5	0.523055044	19.402434663983897
MEDULLOBLASTOMA	0.522950874	19.398570536026174
PAROXYSMAL HEMICRANIA	0.5227273	19.390277183390875
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.520228924	19.297601321333673
INHERITED CREUTZFELDT-JAKOB DISEASE	0.517574429	19.199134312183922
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.516674554	19.1657539517543
MOSAIC TRISOMY 9	0.515470954	19.121107082118968
NUCHAL BLEB, FAMILIAL	0.5149254	19.10087006125071
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.51301586	19.030036741673232
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.51128216	18.96572610866661
CREST SYNDROME	0.50862069	18.867000365788282
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.507316609	18.818626209589453
EPILEPSY, BENIGN NEONATAL, 2	0.50704225	18.808449015749076
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.503496613	18.676925591926203
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.502018519	18.622096520700907
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.501086973	18.58754134221859
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.500541419	18.567304321350335
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	18.54722068599715
PSEUDOXANTHOMA ELASTICUM; PXE	0.5	18.54722068599715
PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE	0.5	18.54722068599715
NPHP3-RELATED MECKEL-LIKE SYNDROME	0.5	18.54722068599715
BRANCHIOOTORENAL SYNDROME 1	0.5	18.54722068599715
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.5	18.54722068599715
PORTAL VEIN, CAVERNOUS TRANSFORMATION OF	0.5	18.54722068599715
MATTHEW-WOOD SYNDROME	0.5	18.54722068599715
INHALATIONAL ANTHRAX	0.5	18.54722068599715
PRIMARY BILIARY CHOLANGITIS	0.4944281099999999	18.340534539060943
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.48500134399999995	17.990853920346435
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.47924894399999995	17.777471855798176
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.456215183	16.92304735880715
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.45617241300000005	16.92146082954967
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.45	16.692498617397433
SPINOCEREBELLAR ATAXIA TYPE 10	0.44863226	16.641763066155303
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.44279431	16.425207572147666
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.434976719	16.135218401127936
CHOLESTASIS-LYMPHEDEMA SYNDROME	0.42766089	15.863841811199903
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.426260619	15.811899540685499
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT MENTAL RETARDATION; MLC2B	0.4242421	15.737023705981743
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.422833569	15.684775035381604
SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	0.41931105	15.554109160854368
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.414724933	15.383989712672763
SARCOIDOSIS	0.41207636999999997	15.285742747749229
KLATSKIN TUMOR	0.41172833999999997	15.272832769318532
PMM2-CDG	0.41116820299999995	15.252054800211749
IMMUNE DEFICIENCY DISEASE	0.4047616	15.014405440834604
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.40430155	14.99734014308142
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.398794304	14.793051929213268
PERIODIC FEVER, FAMILIAL, AUTOSOMAL DOMINANT	0.39458529	14.636920906156368
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 1; CBAS1	0.39458395999999996	14.63687157054934
SPINOCEREBELLAR ATAXIA TYPE 42	0.39401681	14.615833458125216
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.39154326	14.524078502669518
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.38960110400000003	14.452035310792253
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.37616221299999997	13.95352715648813
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.375541419	13.930499149851045
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.372626199	13.822360692474579
COG4-CDG	0.369205904	13.695486760122153
PERIORAL MYOCLONIA WITH ABSENCES	0.36455991	13.523146208074516
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.36356845899999995	13.48636888708181
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.360355234	13.367176100704286
CONGENITAL ENTEROVIRUS INFECTION	0.35816579	13.28595989860902
EPILEPSY, JUVENILE ABSENCE	0.35751765999999996	13.261917878322588
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.35751765999999996	13.261917878322588
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.35683145299999997	13.236463412992036
CENTRALOPATHIC EPILEPSY	0.3547009	13.15743173964361
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.35022597	12.991436711114831
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.35002877299999996	12.984121798559597
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.34964553	12.969905613564872
DANDY-WALKER SYNDROME	0.3474175	12.887258085354828
DANDY-WALKER MALFORMATION WITH MENTAL RETARDATION, MACROCEPHALY, MYOPIA, AND BRACHYTELEPHALANGY	0.3474175	12.887258085354828
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.3474175	12.887258085354828
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.34713229900000003	12.876678713581095
CHYLOMICRON RETENTION DISEASE	0.34660036	12.856946733532116
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.343344419	12.736169420996946
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.34323261400000005	12.73202207697935
OVARIAN HYPERSTIMULATION SYNDROME	0.3418371	12.68025626472255
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.34037525	12.626029755602902
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.339499569	12.593546858087832
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.33859616	12.560035405902397
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1; XLP1	0.33831526999999995	12.54961594826542
EPIDERMAL NEVUS SYNDROME	0.335783314	12.455694454866952
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.335779179	12.455541069351877
CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC 1	0.33503688	12.428005902615888
DUODENAL NEUROENDOCRINE TUMOR	0.33397086	12.388462486224514
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.333878554	12.38503844671923
CODAS SYNDROME	0.333878554	12.38503844671923
MITCHELL-RILEY SYNDROME; MTCHRS	0.3333333	12.364812554183386
IMMUNODEFICIENCY 46; IMD46	0.333333	12.364801425850974
LMNA-RELATED CARDIOCUTANEOUS PROGERIA SYNDROME	0.333333	12.364801425850974
ROLANDIC EPILEPSY-PAROXYSMAL EXERCISE-INDUCED DYSTONIA-WRITER'S CRAMP SYNDROME	0.333333	12.364801425850974
NEUROMYELITIS OPTICA	0.333333	12.364801425850974
16P12.1P12.3 TRIPLICATION SYNDROME	0.333333	12.364801425850974
PSEUDO-VON WILLEBRAND DISEASE	0.333333	12.364801425850974
APOLIPOPROTEIN A-I; APOA1	0.333333	12.364801425850974
ACITRETIN/ETRETINATE EMBRYOPATHY	0.333333	12.364801425850974
CHOLANGIOCARCINOMA	0.333333	12.364801425850974
PLACENTAL INSUFFICIENCY	0.333333	12.364801425850974
OROFACIODIGITAL SYNDROME TYPE 3	0.333333	12.364801425850974
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	0.333333	12.364801425850974
TRISOMY 8P	0.33140152900000003	12.29315458807977
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 3	0.33018661000000005	12.248087846462546
TUBULAR RENAL DISEASE-CARDIOMYOPATHY SYNDROME	0.32847085	12.184442687734132
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.32412051000000003	12.02306925565589
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.321413119	11.922640098935327
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.32001585000000005	11.870809185933922
ARGININOSUCCINIC ACIDURIA	0.316388853	11.736267758361024
SHORT-RIB THORACIC DYSPLASIA 1 WITH OR WITHOUT POLYDACTYLY; SRTD1	0.31622816	11.73030694129363
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.31332961400000003	11.622786996632604
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.308510794	11.444035560660408
ALSTROM SYNDROME; ALMS	0.30718319400000005	11.394788980294951
IMMUNE DYSREGULATION-POLYENDOCRINOPATHY-ENTEROPATHY-X-LINKED SYNDROME	0.30557977	11.3353108627325
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.3055556	11.33441429008454
WILSON DISEASE	0.30493573999999996	11.311420929655695
LEPTOSPIROSIS	0.30106183	11.167720402280313
SCLEROSING CHOLANGITIS, NEONATAL	0.29839536	11.068809187195132
%265300 LYMPHANGIECTASIA, PULMONARY, CONGENITAL; CPL;;LYMPHANGIOMATOSIS, PULMONARY;;PULMONARY CYSTIC LYMPHANGIECTASIS	0.2982093	11.061907395433458
HEMOCHROMATOSIS, NEONATAL	0.29807505000000006	11.05692746667927
CHOLANGIOCARCINOMA	0.29693016	11.014458411696886
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.294067164	10.90825717442663
PALLISTER-HALL SYNDROME	0.29402385400000003	10.906650614170811
PEUTZ-JEGHERS SYNDROME	0.291667	10.81922443164546
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.28975221900000003	10.748196700100753
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 3; PFIC3	0.28888256	10.715937185311624
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE III; ALPS3	0.28295358	10.496004984305896
POTOCKI-LUPSKI SYNDROME	0.28177951300000004	10.452453624807607
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.28132551000000006	10.435612637141396
MENTAL RETARDATION, BUENOS AIRES TYPE	0.28125	10.432811635873396
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.281158884	10.429431738753344
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.281158884	10.429431738753344
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 4	0.28062515000000005	10.409633174182106
EISENMENGER SYNDROME	0.27801968000000005	10.312984720020618
IGG4-RELATED RETROPERITONEAL FIBROSIS	0.2763158	10.249780243255701
VIPOMA	0.27313218	10.131685637814993
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.272763619	10.118014073408489
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 1	0.27221555999999997	10.097684130964595
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 2	0.27221555999999997	10.097684130964595
BARE LYMPHOCYTE SYNDROME, TYPE II	0.2714286	10.06849228938249
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I	0.2712766	10.062853934293948
GCGR-RELATED HYPERGLUCAGONEMIA	0.2712766	10.062853934293948
POEMS SYNDROME	0.2704082	10.030641121406507
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.26882296	9.971837529165969
BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS	0.26683557999999996	9.898116778272092
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 1	0.26566238999999997	9.854597950598883
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.264915569	9.82689504279901
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.26490139	9.826369080714796
8P INVERTED DUPLICATION/DELETION SYNDROME	0.263790599	9.785164909088758
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.261508394	9.700507789517383
GLUTAMINE DEFICIENCY, CONGENITAL	0.260358469	9.657851964022694
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.259667204	9.632209875007682
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.259237069	9.616254257468139
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.259237069	9.616254257468139
118900 CIRRHOSIS, FAMILIAL	0.25869565	9.596170622114956
PEHO SYNDROME; PEHO	0.25746461299999995	9.550505992291699
LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP	0.2570327	9.534484420835398
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.256467864	9.513532144948606
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.256166569	9.502355775235431
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.256101154	9.499929242353081
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.25562995400000005	9.4824503415786
GLYCOGEN STORAGE DISEASE VI	0.25562514999999997	9.482272139882246
CHILDHOOD APRAXIA OF SPEECH	0.2555556	9.479692221484825
CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND MENTAL RETARDATION	0.2555556	9.479692221484825
LAMBERT SYNDROME	0.25526316	9.46884432305
LAMBERT SYNDROME	0.25526316	9.46884432305
KETOADIPICACIDURIA	0.25505497299999996	9.461121742584085
IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 1	0.25498226999999996	9.458424865413019
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.254042054	9.423548078124009
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.25396799999999997	9.420801086362646
ACRAL SELF-HEALING COLLODION BABY	0.25396799999999997	9.420801086362646
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.25390908900000003	9.418615815726984
RAPIDLY INVOLUTING CONGENITAL HEMANGIOMA	0.25327869	9.395231516980516
NON-INVOLUTING CONGENITAL HEMANGIOMA	0.25327869	9.395231516980516
AMEGAKARYOCYTIC THROMBOCYTOPENIA, CONGENITAL	0.25327869	9.395231516980516
KASABACH-MERRITT SYNDROME	0.25327869	9.395231516980516
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.252564073	9.368723198570587
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.252450614	9.364514500346962
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.25205413000000004	9.34980714785403
DISTAL TRISOMY 5Q	0.25190476	9.344266351146294
GLYCOGEN STORAGE DISEASE IXB	0.25170358	9.336803691431076
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.2506428	9.297454649912492
LOWE OCULOCEREBRORENAL SYNDROME	0.250541419	9.293693978351756
GM2 GANGLIOSIDOSIS, AB VARIANT	0.250541419	9.293693978351756
HYPEREKPLEXIA 1; HKPX1	0.25	9.273610342998575
MEDULLARY THYROID CARCINOMA	0.25	9.273610342998575
601165 CLEFT LIP/PALATE WITH CHARACTERISTIC FACIES, INTESTINAL MALROTATION,AND LETHAL CONGENITAL HEART DISEASE	0.25	9.273610342998575
MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME	0.25	9.273610342998575
KETAMINE-INDUCED BILIARY DILATATION	0.25	9.273610342998575
NEUROFIBROMA	0.25	9.273610342998575
JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME; JPHT	0.25	9.273610342998575
RADIO-ULNAR SYNOSTOSIS-AMEGAKARYOCYTIC THROMBOCYTOPENIA SYNDROME	0.25	9.273610342998575
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25	9.273610342998575
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.248612884	9.22215604986042
PEHO SYNDROME	0.24851375400000003	9.218478877887213
NAVAJO NEUROHEPATOPATHY	0.24767835400000002	9.187490181565048
MYH9-RELATED DISEASE	0.24558827000000003	9.109959683164506
POLYCYSTIC KIDNEY DISEASE 4 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD4	0.24425798	9.060613318751756
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.243045154	9.015624215800324
GAUCHER DISEASE TYPE 1	0.23999372000000002	8.902432976186816
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.2399687	8.901504873263688
BENIGN SCHWANNOMA	0.237037	8.792755099493412
FIBROSCLEROSIS, MULTIFOCAL	0.237037	8.792755099493412
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.234614804	8.702905091979932
LENNOX-GASTAUT SYNDROME	0.23257131	8.627102823602911
CHOLESTASIS-LYMPHEDEMA SYNDROME	0.23069506000000004	8.557504377978708
ATAXIA-PANCYTOPENIA SYNDROME	0.22919184	8.501743271819496
ADNP SYNDROME	0.22904502899999996	8.496297399787231
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.228885754	8.490389182637708
NEUTROPENIA-MONOCYTOPENIA-DEAFNESS SYNDROME	0.2285714	8.478728396614658
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.228208819	8.465278656967557
CHOLESTASIS WITH GALLSTONE, ATAXIA, AND VISUAL DISTURBANCE	0.22801686000000002	8.458158045096232
GRFOMA	0.22774208	8.447965234496035
PPOMA	0.22774208	8.447965234496035
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.22751569000000002	8.439567423913829
POLYARTERITIS NODOSA	0.227027	8.421439741359748
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.22592915	8.380715608899504
HALOTHANE HEPATITIS	0.22567136	8.371153032858219
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME	0.22472750000000002	8.33614107342485
BETA-THALASSEMIA INTERMEDIA	0.22309418999999997	8.275554351387555
PYKNOACHONDROGENESIS	0.22272730000000002	8.261944771792585
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.22066354	8.185390747466718
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.2192308	8.132244057535406
PEDIATRIC HEPATOCELLULAR CARCINOMA	0.21837028	8.100323548845978
TETRASOMY 9P	0.216588193	8.034218027104686
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.21554631300000002	7.995570070528032
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.21548435400000004	7.993271736035067
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.212555703	7.884635063216533
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.212214454	7.871976622192781
FRONTORHINY	0.21204820000000002	7.865809522936922
ADENYLOSUCCINATE LYASE DEFICIENCY	0.21144532900000002	7.843446359972546
%211890 CAMPOMELIA, CUMMING TYPE;;CERVICAL LYMPHOCELE WITH BOWED LONG BONES;;CUMMING SYNDROME	0.21111110000000002	7.831048321927225
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.20940109400000004	7.767616604614467
LEISHMANIASIS	0.20890384000000004	7.749171245264478
PANCREATITIS, SCLEROSING CHOLANGITIS, AND SICCA COMPLEX	0.20696674	7.6773156028827865
NON-DISTAL MONOSOMY 20Q	0.206873529	7.6738579929080615
CEREBELLAR VERMIS APLASIA WITH ASSOCIATED FEATURES SUGGESTING SMITH-LEMLI-OPITZSYNDROME AND MECKEL SYNDROME	0.20666700000000002	7.666196915025945
GLUCAGONOMA	0.20646548000000003	7.658721643200662
AICARDI SYNDROME; AIC	0.20636530000000003	7.655005522064015
FRONTONASAL DYSPLASIA-SEVERE MICROPHTHALMIA-SEVERE FACIAL CLEFTING SYNDROME	0.20393701	7.564929461024815
FRONTONASAL DYSPLASIA 1; FND1	0.20393701	7.564929461024815
CARCINOID SYNDROME	0.20392157000000002	7.5643567228500315
MALARIA	0.20327869	7.540509448380803
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 2	0.20327869	7.540509448380803
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.202781293	7.522058784525696
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.202018519	7.4937641091026155
ISOLATED POLYCYSTIC LIVER DISEASE	0.20170358000000002	7.482081622831362
CRYOGLOBULINEMIC VASCULITIS	0.20170358000000002	7.482081622831362
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.20147710000000002	7.473680473749432
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.201086973	7.459208930620299
TETRASOMY 5P	0.201086973	7.459208930620299
TUBEROUS SCLEROSIS COMPLEX	0.2010849	7.459132033843336
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.200541419	7.438971909752043
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.200541419	7.438971909752043
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.200541419	7.438971909752043
BRANCHIOSKELETOGENITAL SYNDROME	0.200541419	7.438971909752043
LYMPHATIC MALFORMATION 7; LMPHM7	0.2001867	7.42581380660301
MODY	0.2	7.418888274398859
BLEPHAROCHALASIS, SUPERIOR	0.2	7.418888274398859
SCARF SYNDROME	0.2	7.418888274398859
HEPATIC ADENOMAS, FAMILIAL	0.2	7.418888274398859
BLEPHAROCHALASIS AND DOUBLE LIP	0.2	7.418888274398859
SOLITARY BONE CYST	0.2	7.418888274398859
EOSINOPHILIC FASCIITIS	0.2	7.418888274398859
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.2	7.418888274398859
GAMMA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R5	0.2	7.418888274398859
DYSFERLIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R2	0.2	7.418888274398859
MYOTONIA FLUCTUANS	0.2	7.418888274398859
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.2	7.418888274398859
CLEFT VELUM	0.2	7.418888274398859
CARNEY COMPLEX	0.2	7.418888274398859
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.2	7.418888274398859
AXIAL OSTEOMALACIA	0.2	7.418888274398859
OCULOAURICULOFRONTONASAL SYNDROME	0.2	7.418888274398859
SMITH-LEMLI-OPITZ SYNDROME	0.196958673	7.306071948304297
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.19667374	7.29550251784085
CARCINOMA OF GALLBLADDER AND EXTRAHEPATIC BILIARY TRACT	0.19320676	7.166896831492972
PERIPARTUM CARDIOMYOPATHY	0.1929828	7.1585891604033005
NON-HISTAMINIC ANGIOEDEMA	0.19190030000000002	7.1184344276181175
NEPHRONOPHTHISIS 18; NPHP18	0.1888892	7.006739355202905
LIVER FAILURE, INFANTILE, TRANSIENT	0.18781141	6.966759337236583
AICARDI SYNDROME	0.18401081000000002	6.825778203358182
GRACILE SYNDROME	0.18312063999999997	6.792757844482073
JUVENILE MYOCLONIC EPILEPSY	0.18297529999999998	6.7873665383730675
HELLP SYNDROME	0.18237036	6.764926627009493
MICROSPORIDIOSIS	0.181663919	6.7387215927522215
MYOCLONIC EPILEPSY OF INFANCY	0.181285814	6.724695998997262
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.181285814	6.724695998997262
SCHINZEL-GIEDION SYNDROME	0.18098114	6.713394287166692
CAROLI DISEASE, ISOLATED	0.17972128000000004	6.666660484259772
H SYNDROME	0.17871520000000002	6.629340508684235
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.17783460999999998	6.59667551455647
YELLOW NAIL SYNDROME	0.17777810000000002	6.5945793076745405
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.177738004	6.593091968953288
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.17771637	6.592289467808646
UNILATERAL POLYMICROGYRIA	0.17731386999999998	6.577358955156417
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.177059543	6.567924837165603
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.17699127	6.5653922883698135
MONOSOMY X	0.17672501000000002	6.555515522410106
MOSAIC MONOSOMY X	0.17672501000000002	6.555515522410106
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.17672501000000002	6.555515522410106
TURNER SYNDROME	0.17672501000000002	6.555515522410106
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.17625588399999997	6.538113555507026
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.176237683	6.537438399579616
MUCOLIPIDOSIS TYPE II	0.17577799	6.520386344542
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 2	0.17498253000000002	6.4908792002082345
ANEMIA, SIDEROBLASTIC, 3, PYRIDOXINE-REFRACTORY; SIDBA3	0.17448916	6.472577915668533
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.174231054	6.463003617783772
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.173245433	6.426442557384266
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.17201311900000002	6.380730557959378
AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE	0.1719299	6.377643595642842
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.171867193	6.375317514507728
COMBINED SAPOSIN DEFICIENCY	0.17022601999999998	6.314439118877928
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.16988399999999998	6.301752078039878
LEIGH SYNDROME; LS	0.169231073	6.277532115718188
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.16911731400000002	6.27331228916215
DISTAL MONOSOMY 12Q	0.169117014	6.273301160829739
13Q12.3 MICRODELETION SYNDROME	0.16857176000000001	6.253075268293894
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.168248754	6.241093541164091
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.167571403	6.2159675842063296
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.167571403	6.2159675842063296
LIGNEOUS CONJUNCTIVITIS	0.167212254	6.2026451526820185
MÉNÉTRIER DISEASE	0.166667	6.182419260146173
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 2; ADMIO2	0.166667	6.182419260146173
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.166667	6.182419260146173
RIN2 SYNDROME	0.166667	6.182419260146173
FAMILIAL IDIOPATHIC STEROID-RESISTANT NEPHROTIC SYNDROME	0.166667	6.182419260146173
DERMATOLEUKODYSTROPHY	0.166667	6.182419260146173
NEOVASCULAR GLAUCOMA	0.166667	6.182419260146173
HYPERPLASTIC POLYPOSIS SYNDROME	0.166667	6.182419260146173
NEPHROTIC SYNDROME, TYPE 15; NPHS15	0.166667	6.182419260146173
ASCHER SYNDROME	0.166667	6.182419260146173
CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 1	0.166667	6.182419260146173
HERPES SIMPLEX VIRUS STROMAL KERATITIS	0.166667	6.182419260146173
NEUROTROPHIC KERATOPATHY	0.166667	6.182419260146173
AMOEBIC KERATITIS	0.166667	6.182419260146173
CHRONIC INTESTINAL PSEUDOOBSTRUCTION	0.166667	6.182419260146173
CEREBROOCULONASAL SYNDROME	0.166667	6.182419260146173
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.16564161000000002	6.144382990907745
SCALP-EAR-NIPPLE SYNDROME	0.1655843	6.142257108472714
SCALP-EAR-NIPPLE SYNDROME; SENS	0.1655843	6.142257108472714
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA SYNDROME; HLTS	0.1648841	6.116283580624045
RARE HEREDITARY HEMOCHROMATOSIS	0.16475635	6.111544765738772
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.161068889	5.974760459862757
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.160983554	5.971595005708278
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.16025640000000002	5.944621634286867
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.1595057	5.91677483714891
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.1595057	5.91677483714891
%123550 CRYOGLOBULINEMIA, FAMILIAL MIXED;;MELTZER SYNDROME	0.1594828	5.915925374441492
FAMILIAL PANCREATIC CARCINOMA	0.15932823000000002	5.9101916866386235
SEVERE CONGENITAL HYPOCHROMIC ANEMIA WITH RINGED SIDEROBLASTS	0.15882677	5.891590308068222
WOLF-HIRSCHHORN SYNDROME	0.15852808300000001	5.880510680658146
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.158288294	5.871615841655997
ADAMS-OLIVER SYNDROME	0.15799385900000001	5.860693939810633
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.15663521900000002	5.810295947984987
JOUBERT SYNDROME 2	0.156611954	5.809432945806467
DISTAL TRISOMY 14Q	0.1549052	5.74612185961705
PGM3-CDG	0.15479621899999998	5.742079270301889
WOLFRAM-LIKE SYNDROME	0.15476179999999998	5.740802516724306
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.15420466000000002	5.720135719658314
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.15400113999999998	5.712586258950285
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.15271019900000002	5.664699523711082
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.15266181399999998	5.662904709165297
ENHANCED S-CONE SYNDROME	0.15147769	5.618980290870127
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.15077670999999998	5.592977829357185
BECKWITH-WIEDEMANN SYNDROME	0.15005528	5.566216786518188
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.14970512	5.55322779692737
PYRUVATE KINASE DEFICIENCY OF RED CELLS	0.14786326000000002	5.4849050291419505
CIRRHOSIS-DYSTONIA-POLYCYTHEMIA-HYPERMANGANESEMIA SYNDROME	0.14769091	5.478511802171486
HSD10 DISEASE	0.147325833	5.464969474798722
JOHANSON-BLIZZARD SYNDROME; JBS	0.1472222	5.461125266556018
XANTHINURIA, TYPE I	0.14664487999999998	5.439709903663138
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	0.1464647	5.4330262272167325
ACERULOPLASMINEMIA	0.14623886	5.424648818577282
NIEMANN-PICK DISEASE TYPE B	0.14599503	5.415604080937548
COFFIN-SIRIS SYNDROME 1; CSS1	0.145857613	5.410506674087532
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.14549495399999998	5.397054041074006
THYROCEREBRORENAL SYNDROME	0.145486809	5.3967519068490315
DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR10	0.1454082	5.393835949907221
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 55	0.14526663999999997	5.3885848607866
NEUROFIBROMATOSIS TYPE 1	0.14487551899999998	5.374076445782745
IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION	0.14285699999999998	5.299200611078988
RETINITIS PIGMENTOSA 27; RP27	0.14285699999999998	5.299200611078988
TORTICOLLIS, KELOIDS, CRYPTORCHIDISM, AND RENAL DYSPLASIA; TKCR	0.14285699999999998	5.299200611078988
RETINITIS PIGMENTOSA 11	0.14285699999999998	5.299200611078988
POSTERIOR URETHRAL VALVE	0.14285699999999998	5.299200611078988
CRANIOSYNOSTOSIS, HERRMANN-OPITZ TYPE	0.14285699999999998	5.299200611078988
STEINERT MYOTONIC DYSTROPHY	0.14285699999999998	5.299200611078988
POSTAXIAL POLYDACTYLY-DENTAL AND VERTEBRAL ANOMALIES SYNDROME	0.14285699999999998	5.299200611078988
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.14285699999999998	5.299200611078988
HAND-FOOT-GENITAL SYNDROME; HFG	0.14285699999999998	5.299200611078988
IRVAN SYNDROME	0.14285699999999998	5.299200611078988
IDIOPATHIC ANTERIOR UVEITIS	0.14285699999999998	5.299200611078988
FOCAL FACIAL DERMAL DYSPLASIA TYPE III	0.14285699999999998	5.299200611078988
LYMPHEDEMA, HEREDITARY, II	0.14215680000000003	5.27322708323032
SECONDARY INTESTINAL LYMPHANGIECTASIA	0.14116840000000003	5.23656293737824
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.14110335400000001	5.234150092344757
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.14079355999999998	5.222658456974361
AL AMYLOIDOSIS	0.14026438000000002	5.20302882048913
MICROGASTRIA-LIMB REDUCTION DEFECTS ASSOCIATION; MLRD	0.13990191	5.189583198325022
WILLIAMS SYNDROME	0.13931065	5.167650738919417
LEUKOCYTE ADHESION DEFICIENCY, TYPE III	0.13875178000000002	5.146919768469852
TRIPLOIDY	0.13875178	5.14691976846985
TRICHOHEPATOENTERIC SYNDROME 1	0.13866399	5.143663247461803
HENNEKAM SYNDROME	0.137688919	5.107493533418771
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.136799653	5.074506707917664
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.1367931	5.0742636280433535
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.136616454	5.067711043352755
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.136382004	5.059014251573092
CINCA SYNDROME	0.135869824	5.040015220591183
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.134711683	4.99705462716618
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.13431519400000003	4.982347089201041
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.134261954	4.980372181142394
16P13.2 MICRODELETION SYNDROME	0.13397731300000004	4.9698135822558305
CASTLEMAN DISEASE	0.13354185	4.953660325532656
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.132602744	4.918824713073568
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.132178984	4.903105572597772
PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS	0.13196674	4.895232499983215
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.13098643299999999	4.858868559445159
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.130842763	4.853539201053245
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.13070636400000002	4.848479556344546
T-CELL LYMPHOMA, SUBCUTANEOUS PANNICULITIS-LIKE; SPTCL	0.1302521	4.831628887029138
INTESTINAL LYMPHANGIECTASIA	0.13005730000000001	4.824402889849874
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.12957786000000002	4.806618330878485
TRICHOTHIODYSTROPHY	0.129516364	4.804337171111872
BERNARD-SOULIER SYNDROME	0.128820109	4.778509980834414
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.128496613	4.76651007742834
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.12835239999999998	4.76116057675476
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.12797200300000003	4.74704996254018
FUCOSIDOSIS	0.127790553	4.74031917615323
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.12771037300000002	4.737344943844024
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.127446179	4.727544815000191
3Q27.3 MICRODELETION SYNDROME	0.12690476	4.707461179647007
ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	0.12649583	4.692292149736757
PITT-HOPKINS-LIKE SYNDROME	0.126477899	4.691627009308516
GIANT CELL ARTERITIS	0.1264771	4.69159737084986
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.126086973	4.677125827720728
TRANSALDOLASE DEFICIENCY	0.12572612000000002	4.663740187268321
COHEN SYNDROME	0.125541419	4.6568888068524705
HERMANSKY-PUDLAK SYNDROME	0.125	4.6368051714992875
PRIMARY ERYTHROMELALGIA	0.125	4.6368051714992875
VACTERL/VATER ASSOCIATION	0.125	4.6368051714992875
STORMORKEN-SJAASTAD-LANGSLET SYNDROME	0.125	4.6368051714992875
PANCREATIC INSUFFICIENCY, COMBINED EXOCRINE	0.125	4.6368051714992875
GENITOPALATOCARDIAC SYNDROME	0.125	4.6368051714992875
BLEEDING DISORDER, PLATELET-TYPE, 19; BDPLT19	0.125	4.6368051714992875
HETEROTAXY, VISCERAL, 1, X-LINKED; HTX1	0.125	4.6368051714992875
THROMBOCYTOPENIA WITH CONGENITAL DYSERYTHROPOIETIC ANEMIA	0.125	4.6368051714992875
BLEEDING DISORDER, PLATELET-TYPE, 16; BDPLT16	0.125	4.6368051714992875
PSEUDOXANTHOMA ELASTICUM	0.125	4.6368051714992875
FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ	0.125	4.6368051714992875
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.124672414	4.6246535518280005
SOLAR URTICARIA	0.12406020000000001	4.601943815497887
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.12388457300000001	4.595429030043048
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.12332545399999999	4.574688823077579
WHITE MATTER HYPOPLASIA-CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY SYNDROME	0.1231592	4.5685217238217195
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.12293675	4.5602700653385195
LYMPHANGIOLEIOMYOMATOSIS	0.12276351899999999	4.553844158165207
GREENBERG DYSPLASIA	0.12222209999999999	4.533760522812023
SPINOCEREBELLAR ATAXIA TYPE 37	0.1211226	4.492975184523516
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.12061402899999998	4.47411002738052
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.12005800999999999	4.453484813183304
SPINOCEREBELLAR ATAXIA 13	0.11999031	4.450973519502421
WILD TYPE ATTR AMYLOIDOSIS	0.11985618	4.445998042081195
CEREBELLAR ATAXIA, CAYMAN TYPE	0.119758264	4.442365902759815
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.11869880399999999	4.403065825903842
SYSTEMIC CAPILLARY LEAK SYNDROME	0.11815260000000001	4.382804693648693
CONGENITAL ANALBUMINEMIA	0.1173974	4.3547909715245625
HOYERAAL-HREIDARSSON SYNDROME	0.11641234399999999	4.318250869484432
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.11626946899999999	4.312951001173407
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.116204229	4.3105309598182995
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.11597095399999999	4.301877754007247
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.11597095399999999	4.301877754007247
FRYNS SYNDROME; FRNS	0.115589429	4.287725297262797
LYSOSOMAL ACID LIPASE DEFICIENCY	0.115368284	4.279522047025588
ISOLATED SEDOHEPTULOKINASE DEFICIENCY	0.1150926	4.269295703050391
MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS, X-LINKED	0.11489887999999998	4.262109767867807
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.11484286400000002	4.260031885639915
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.11460761299999998	4.251305381212711
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.11458330000000001	4.250403504059634
GOOD SYNDROME	0.11438968999999999	4.243221649265601
CORTICOSTEROID-SENSITIVE ASEPTIC ABSCESS SYNDROME	0.11428187000000001	4.239222126596874
X-LINKED NON PROGRESSIVE CEREBELLAR ATAXIA	0.1140845	4.231900796703283
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.11352063999999999	4.21098472499127
DEHYDRATED HEREDITARY STOMATOCYTOSIS	0.11323059000000002	4.200225482271324
IMMUNODEFICIENCY 23; IMD23	0.11313365399999999	4.196629695502487
ICHTHYOSIS, LEUKOCYTE VACUOLES, ALOPECIA, AND SCLEROSING CHOLANGITIS; ILVASC	0.11287814000000002	4.187151546409765
MULTIPLE SCLEROSIS-ICHTHYOSIS-FACTOR VIII DEFICIENCY SYNDROME	0.11258809999999998	4.17639267463423
REFSUM DISEASE	0.11258809999999998	4.17639267463423
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.11219797299999999	4.161921131505099
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.11195644999999999	4.15296197074161
DOWN SYNDROME	0.11190470000000001	4.151042333400611
MICROVILLUS INCLUSION DISEASE	0.11165655399999999	4.141837496151915
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.11165241899999999	4.141684110636842
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.11165241899999999	4.141684110636842
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.111617	4.140370262617887
WELL-DIFFERENTIATED LIPOSARCOMA	0.11111099999999999	4.121600475283658
RADIO-RENAL SYNDROME	0.11111099999999999	4.121600475283658
ALBERS-SCHÖNBERG OSTEOPETROSIS	0.11111099999999999	4.121600475283658
AUTOIMMUNE HEMOLYTIC ANEMIA, COLD TYPE	0.11111099999999999	4.121600475283658
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.11111099999999999	4.121600475283658
NEUTROPHIL CHEMOTACTIC RESPONSE	0.11111099999999999	4.121600475283658
COMPLEMENT COMPONENT 3 DEFICIENCY, AUTOSOMAL RECESSIVE; C3D	0.11111099999999999	4.121600475283658
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA	0.11111099999999999	4.121600475283658
SEVERE CONGENITAL NEMALINE MYOPATHY	0.11111099999999999	4.121600475283658
LIPODYSTROPHY, PARTIAL, ACQUIRED, WITH LOW COMPLEMENT COMPONENT C3, WITH OR WITHOUT GLOMERULONEPHRITIS; APLDC3	0.11111099999999999	4.121600475283658
AUTOIMMUNE HEMOLYTIC ANEMIA	0.11111099999999999	4.121600475283658
SECONDARY POLYCYTHEMIA	0.11111099999999999	4.121600475283658
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.11102279000000001	4.118328374610234
MILROY DISEASE	0.10964910000000001	4.06737211144194
CITRULLINEMIA TYPE II	0.109429113	4.059211816567839
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.108607764	4.028744334241392
3P25.3 MICRODELETION SYNDROME	0.10762911000000001	3.9924417108149255
BETA-THALASSEMIA MAJOR	0.10752726	3.9886636419611867
HEMOCHROMATOSIS TYPE 4	0.10743544	3.9852576303544107
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 4	0.1072138	3.9770360183687217
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 3	0.1072138	3.9770360183687217
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	0.1070381	3.9705185250196626
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.10677287	3.960679966334569
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.10675886400000001	3.9601604215887125
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.106166569	3.9381895694362874
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.1058999	3.928297631850059
COG5-CDG	0.105632629	3.9183833634101246
HARDIKAR SYNDROME	0.10557271000000001	3.916160701577556
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.105527824	3.914495680482133
BUDD-CHIARI SYNDROME	0.10533976	3.9075195514599503
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 4	0.10450580000000001	3.876584271133362
GLYCOGEN STORAGE DISEASE IC; GSD1C	0.10438218000000002	3.8719986562909563
NOCARDIOSIS	0.10428291900000002	3.8683166249459306
MELIOIDOSIS	0.10374150000000001	3.8482329895927467
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.103496613	3.839149043128483
19P13.13 MICRODELETION SYNDROME	0.103388773	3.8351487785709266
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 8	0.1029573	3.8191435286688282
%600223 SPINOCEREBELLAR ATAXIA 4; SCA4;;SPINOCEREBELLAR ATAXIA, AUTOSOMAL DOMINANT, WITH SENSORY AXONAL NEUROPATHY	0.1028139	3.8138241857760846
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA-DEAFNESS-NARCOLEPSY SYNDROME	0.10266750000000001	3.808393559559225
WALDENSTRÖM MACROGLOBULINEMIA	0.10253628000000001	3.8035260269623916
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.10233086400000001	3.795906235193522
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.102249134	3.7928745065001888
ACROCEPHALOSYNDACTYLY	0.10195418	3.7819333526397534
CONGENITAL ISOLATED ACTH DEFICIENCY	0.10096379999999999	3.7451957597937575
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.100530073	3.7291068990208065
INSULIN-RESISTANCE SYNDROME TYPE B	0.10050099	3.728028081382385
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.10032689400000001	3.721570087517287
BARDET-BIEDL SYNDROME 1; BBS1	0.10025271399999999	3.718818421856311
SYNDROMIC DIARRHEA	0.099040084	3.6738365894153904
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.09895310400000001	3.670610114904855
FAMILIAL ADENOMATOUS POLYPOSIS DUE TO 5Q22.2 MICRODELETION	0.0984556	3.6521554819445217
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.098393854	3.6498650485675666
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.098393854	3.6498650485675666
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.09812185	3.639775212136618
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.09812185	3.639775212136618
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.09812185	3.639775212136618
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.09812185	3.639775212136618
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.09812185	3.639775212136618
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.097763719	3.626490542753625
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.09744489	3.6146637591054334
KAWASAKI DISEASE	0.09679205	3.5904470240001407
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.09593308300000002	3.558584122978163
KAPOSI SARCOMA	0.0957671	3.5524270763159143
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS	0.09575837000000001	3.5521032418427376
SIALURIA	0.09559252300000001	3.545951240024517
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.095558899	3.544703976527824
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 26	0.0955556	3.5445816019657386
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.09531049	3.5354893834410483
KAGAMI-OGATA SYNDROME	0.095242873	3.5329811685987984
MITOCHONDRIAL DNA DEPLETION SYNDROME 15 (HEPATOCEREBRAL TYPE); MTDPS15	0.09480348000000001	3.5166821307210343
ENTERIC ANENDOCRINOSIS	0.0946844	3.512264924642457
%153300 YELLOW NAIL SYNDROME;;YNS;;LYMPHEDEMA AND YELLOW NAILS	0.09444440000000001	3.503362258713178
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.09444440000000001	3.503362258713178
BLAU SYNDROME	0.09415590000000001	3.492660512377358
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2; XLP2	0.09354038	3.469828141824068
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.093473173	3.46733513570278
AUTOIMMUNE HEMOLYTIC ANEMIA-AUTOIMMUNE THROMBOCYTOPENIA-PRIMARY IMMUNODEFICIENCY SYNDROME	0.09332489999999999	3.4618350315972295
NEPHRONOPHTHISIS 19; NPHP19	0.09322408	3.458095170018106
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.093025213	3.4507183097457816
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.092867544	3.4448696662691005
ERYTHROCYTOSIS, FAMILIAL, 8; ECYT8	0.09282763999999999	3.443389449680592
MECKEL SYNDROME, TYPE 5	0.09263160000000001	3.436117455394027
COACH SYNDROME	0.092521673	3.4320397747373277
MUCOLIPIDOSIS IV; ML4	0.092387954	3.427079543131505
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.09207311	3.4154005808321815
MONOSOMY 18Q	0.09199607300000001	3.412542936352208
NEONATAL HEMOCHROMATOSIS	0.09166669999999999	3.400325028914189
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.09145051900000001	3.3923059154839508
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.09137259400000002	3.389415331140038
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.0909091	3.372222280130767
SPINOCEREBELLAR ATAXIA TYPE 12	0.0909091	3.372222280130767
DDOST-CDG	0.09073187900000002	3.365648366136381
AUTOSOMAL RECESSIVE SPASTIC ATAXIA WITH LEUKOENCEPHALOPATHY	0.09046176	3.355628452727419
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.09017040400000001	3.3448207646670407
LISSENCEPHALY TYPE 3-METACARPAL BONE DYSPLASIA SYNDROME	0.0900735	3.341226164920328
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.089585314	3.3231171779646997
GLIOBLASTOMA	0.08947421900000001	3.318996171000478
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.089369319	3.3151049641005557
CIRRHOSIS, FAMILIAL	0.08859646000000002	3.286436191236238
SPINOCEREBELLAR ATAXIA TYPE 2	0.08846161000000001	3.281434005817225
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.08835728300000002	3.277564054032209
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.0881577	3.2701606341398617
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.08792732	3.2616148167365813
CHROMOSOME 1P36 DELETION SYNDROME	0.087854283	3.2589055500220954
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.0878137	3.2574001463078956
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.08662845999999999	3.213434330616152
X-LINKED INTELLECTUAL DISABILITY-CRANIOFACIOSKELETAL SYNDROME	0.08661199000000001	3.212823385166757
THANATOPHORIC DYSPLASIA TYPE 1	0.086391919	3.2046599743595796
THANATOPHORIC DYSPLASIA	0.086391919	3.2046599743595796
THANATOPHORIC DYSPLASIA TYPE 2	0.086391919	3.2046599743595796
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.08636610999999998	3.2037026039222094
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.085794449	3.1824971584730544
SHORT RIB-POLYDACTYLY SYNDROME, VERMA-NAUMOFF TYPE	0.08552910999999999	3.1726545564938506
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME B-NEGATIVE	0.08503688000000001	3.1543955596173143
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME B-POSITIVE, TYPE I; CDG1	0.08503688000000001	3.1543955596173143
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME B-POSITIVE, TYPE II; CDG2	0.08503688000000001	3.1543955596173143
CHRONIC GRANULOMATOUS DISEASE	0.08503688000000001	3.1543955596173143
COMPLEMENT HYPERACTIVATION, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY; CHAPLE	0.08503688000000001	3.1543955596173143
GRANULOMATOUS DISEASE, CHRONIC, X-LINKED; CDGX	0.08503688000000001	3.1543955596173143
VON HIPPEL-LINDAU DISEASE	0.08481040000000001	3.145994410535385
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.084802034	3.1456840784388667
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.084692319	3.141614261803739
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.08465600000000001	3.1402670287875494
BURKITT LYMPHOMA	0.08465600000000001	3.1402670287875494
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.08456676900000001	3.1369570546894847
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.084087519	3.1191795436619563
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 5A	0.0839898	3.1155547119455265
ILEAL NEUROENDOCRINE TUMOR	0.08397086000000001	3.1148521432259413
JEJUNAL NEUROENDOCRINE TUMOR	0.08397086000000001	3.1148521432259413
%300712 CRANIOFACIOSKELETAL SYNDROME	0.08387885400000002	3.1114392320530695
SUBCUTANEOUS PANNICULITIS-LIKE T-CELL LYMPHOMA	0.08347680000000002	3.096525263521694
BULLOUS IMPETIGO	0.08333330000000001	3.0912022111848128
MYCETOMA	0.08333330000000001	3.0912022111848128
APLASIA CUTIS CONGENITA WITH INTESTINAL LYMPHANGIECTASIA	0.08333330000000001	3.0912022111848128
LYMPHEDEMA-DISTICHIASIS SYNDROME	0.08333330000000001	3.0912022111848128
NEUROFIBROMATOSIS-NOONAN SYNDROME	0.08333330000000001	3.0912022111848128
SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY; SRTD20	0.08333330000000001	3.0912022111848128
PENTALOGY OF CANTRELL	0.08333330000000001	3.0912022111848128
SPINAL MUSCULAR ATROPHY, TYPE I, WITH CONGENITAL BONE FRACTURES	0.08333330000000001	3.0912022111848128
OVERHYDRATED HEREDITARY STOMATOCYTOSIS	0.08333330000000001	3.0912022111848128
184705 STEINFELD SYNDROME	0.08333330000000001	3.0912022111848128
PAPILLON-LEFÈVRE SYNDROME	0.08333330000000001	3.0912022111848128
HEMIHYPERPLASIA-MULTIPLE LIPOMATOSIS SYNDROME	0.08333330000000001	3.0912022111848128
FAMILIAL MELANOMA	0.08333330000000001	3.0912022111848128
CONGENITAL ALVEOLAR CAPILLARY DYSPLASIA	0.08333330000000001	3.0912022111848128
RED CELL PHOSPHOLIPID DEFECT WITH HEMOLYSIS	0.08333330000000001	3.0912022111848128
HOLOPROSENCEPHALY-RADIAL HEART RENAL ANOMALIES SYNDROME	0.08333330000000001	3.0912022111848128
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.08312401900000001	3.08343904940004
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.082986899	3.078352659599112
DILATED CARDIOMYOPATHY WITH ATAXIA	0.082863189	3.0737637062569827
NEURAMINIDASE DEFICIENCY	0.082572849	3.062993706149038
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.08254825	3.062081219985728
ALPORT SYNDROME	0.08222609	3.0501308747533264
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.08145056399999999	3.021363171013869
RHEUMATOID ARTHRITIS	0.081136	3.009694595158129
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.08020179000000001	2.9750405970839986
CRIGLER-NAJJAR SYNDROME TYPE 1	0.080077779	2.970440478315016
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.080055859	2.9696273681601415
%153880 MACULAR EDEMA, CYSTOID;;CYSTOID MACULAR DYSTROPHY; CYMD;;MACULAR DYSTROPHY, DOMINANT CYSTOID; MDDC;;DCMD	0.08004929000000001	2.9693836947747694
SALT-AND-PEPPER SYNDROME	0.07961130400000001	2.953136848776015
CHRISTIANSON SYNDROME	0.07920181999999999	2.937947268545245
ETHYLMALONIC ENCEPHALOPATHY	0.078941619	2.928295257805811
GRISCELLI SYNDROME TYPE 2	0.07893675900000001	2.9281149788207435
DISORDER OF BILE ACID SYNTHESIS	0.07877537	2.922128344022158
CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC, 2; BRIC2	0.07824334	2.902392988379016
YUNIS-VARON SYNDROME	0.078231464	2.9019524547932822
SIMPSON-GOLABI-BEHMEL SYNDROME	0.07815616300000001	2.8991592062635303
ALG11-CDG	0.07791424300000001	2.890185319006817
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.07777780000000001	2.885124042142698
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.07777780000000001	2.885124042142698
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.07777780000000001	2.885124042142698
MPI-CDG	0.0777778	2.8851240421426976
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.077728814	2.883306933837649
TRISOMY 1Q	0.07768591	2.881715433925025
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.0776216	2.8793298904003923
HISTIOCYTOID CARDIOMYOPATHY	0.07761060900000001	2.878922185395273
RETINITIS PIGMENTOSA 59; RP59	0.077595169	2.878349447220489
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.07749784300000001	2.8747391936195186
NEUTRAL LIPID STORAGE MYOPATHY	0.07747093999999999	2.873741241863287
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.07746865400000001	2.8736564439703116
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.07736239	2.869714640252358
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.07715875999999999	2.862161099155778
FETAL PARVOVIRUS SYNDROME	0.07702759	2.857295421281014
X-LINKED PROGRESSIVE CEREBELLAR ATAXIA	0.07696395	2.8549347310321003
ISOLATED OPTIC NERVE HYPOPLASIA/APLASIA	0.07692310000000001	2.8534194231020544
IMMUNODEFICIENCY 36; IMD36	0.07692310000000001	2.8534194231020544
ZOLLINGER-ELLISON SYNDROME	0.07669176000000001	2.8448379950350575
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.07643714300000001	2.8353931196562447
LYSINURIC PROTEIN INTOLERANCE; LPI	0.07641087	2.834418537398078
GAUCHER DISEASE, PERINATAL LETHAL	0.07639538900000001	2.833844278351198
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.076140499	2.82438927618989
17Q23.1Q23.2 MICRODELETION SYNDROME	0.07582955999999999	2.8128551676841234
AMISH INFANTILE EPILEPSY SYNDROME	0.07560445	2.804504837986874
NEPHROPATHY, PROGRESSIVE TUBULOINTERSTITIAL, WITH CHOLESTATIC LIVERDISEASE	0.07535017000000001	2.7950724634348036
CRYPTOCOCCOSIS	0.075099769	2.7857839782208145
AMYLOIDOSIS	0.0748664	2.7771272855322735
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IIA	0.07462028	2.7679976016217984
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.07437965900000001	2.7590719000444284
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.07437965900000001	2.7590719000444284
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.07421915300000001	2.753118019637575
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 74	0.07383824000000001	2.7389882646912445
OROFACIODIGITAL SYNDROME I; OFD1	0.073776729	2.7367065485080113
SLC39A8-CDG	0.073292719	2.7187524679395527
SYMPTOMATIC FORM OF HEMOCHROMATOSIS TYPE 1	0.07321722	2.715951874710408
BECKWITH-WIEDEMANN SYNDROME	0.07313218	2.7127973634161338
MASTOCYTOSIS	0.07313218	2.7127973634161338
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4; CMH4	0.07313218	2.7127973634161338
LYMPHOPROLIFERATIVE SYNDROME 2; LPFS2	0.07313218	2.7127973634161338
TURCOT SYNDROME WITH POLYPOSIS	0.0729057	2.7043962143342046
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.07289361	2.7039477425380167
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.07251557300000001	2.689924671205073
SMITH-MAGENIS SYNDROME; SMS	0.07240353299999999	2.685768609993754
DK1-CDG	0.07229184999999999	2.6816257914980053
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.072194524	2.6780155378970347
CEREBROFACIOARTICULAR SYNDROME	0.07211200400000001	2.6749545045950183
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.07197415400000001	2.669841035851889
NETHERTON SYNDROME; NETH	0.07197415400000001	2.669841035851889
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.07197415400000001	2.669841035851889
IMMUNOGLOBULIN A VASCULITIS	0.07197001900000001	2.6696876503368157
GRISCELLI SYNDROME, TYPE 2; GS2	0.07197001900000001	2.6696876503368157
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.07197001900000001	2.6696876503368157
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.071470033	2.6511409489729973
CRYPTOSPORIDIOSIS	0.07142860000000001	2.6496040149836317
ADULT ACUTE RESPIRATORY DISTRESS SYNDROME	0.07142860000000001	2.6496040149836317
RETINITIS PIGMENTOSA 83; RP83	0.07142860000000001	2.6496040149836317
RETINITIS PIGMENTOSA 76; RP76	0.07142860000000001	2.6496040149836317
CARBOXYPEPTIDASE N DEFICIENCY	0.07142860000000001	2.6496040149836317
PULMONARY EDEMA OF MOUNTAINEERS	0.07142860000000001	2.6496040149836317
IDIOPATHIC PANUVEITIS	0.07142860000000001	2.6496040149836317
RETINITIS PIGMENTOSA 13; RP13	0.07142860000000001	2.6496040149836317
RETINITIS PIGMENTOSA 77; RP77	0.07142860000000001	2.6496040149836317
FAMILIAL ADENOMATOUS POLYPOSIS 1; FAP1	0.07142860000000001	2.6496040149836317
RETINITIS PIGMENTOSA 78; RP78	0.07142860000000001	2.6496040149836317
ACQUIRED ANGIOEDEMA	0.07142860000000001	2.6496040149836317
GARDNER SYNDROME	0.07142860000000001	2.6496040149836317
RETINITIS PUNCTATA ALBESCENS	0.07142860000000001	2.6496040149836317
BIRDSHOT CHORIORETINOPATHY	0.07142860000000001	2.6496040149836317
MULTIPLE ENDOCRINE NEOPLASIA TYPE 1	0.07142860000000001	2.6496040149836317
INTERMEDIATE UVEITIS	0.07142860000000001	2.6496040149836317
ALAGILLE SYNDROME 2	0.07142860000000001	2.6496040149836317
PSORIASIS 14, PUSTULAR	0.07142860000000001	2.6496040149836317
MICROPHTHALMIA, ISOLATED 5	0.07142860000000001	2.6496040149836317
MULTIPLE ENDOCRINE NEOPLASIA TYPE 4	0.07142860000000001	2.6496040149836317
JOUBERT SYNDROME 6	0.071320954	2.645610946747702
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.071002219	2.6337876499769997
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.07087537299999999	2.6290823684667273
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.070697973	2.6225018145673356
HEMOCHROMATOSIS TYPE 2	0.07058827	2.6184324430655033
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.070336344	2.6090873888284225
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.07016619	2.6027756212512125
ALPHA-THALASSEMIA	0.07003656	2.597967068816161
RHABDOID TUMOR	0.06994539	2.594585168596276
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 3; HKLLS3	0.0699346	2.5941849195738724
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.069617759	2.582431879675128
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.069298173	2.570577015534818
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.069184414	2.566357188978781
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.069181969	2.5662664930696266
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.06913730900000001	2.564609855317954
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.068952953	2.557771272484378
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.06878306000000001	2.5514691865563663
HYPEREKPLEXIA-EPILEPSY SYNDROME	0.0686937	2.5481544272753642
SENIOR-LOKEN SYNDROME	0.068689354	2.5479932148331614
AUTOSOMAL RECESSIVE ATAXIA DUE TO PEX10 DEFICIENCY	0.0683405	2.535052670582776
SPINOCEREBELLAR ATAXIA TYPE 26	0.0683405	2.535052670582776
LAURENCE-MOON SYNDROME	0.06814379999999999	2.5277561939649043
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 78	0.06787324	2.517719921907298
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.06770741300000001	2.5115686619779045
MYELOPEROXIDASE DEFICIENCY	0.06768247999999999	2.510643786271176
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.067676923	2.5104376524604723
GLYCOGEN STORAGE DISEASE IV	0.06754573999999999	2.5055714923579697
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	0.06745836	2.5023301800708846
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.067208119	2.4930476299675157
EPENDYMOMA	0.067208119	2.4930476299675157
SUBEPENDYMOMA	0.067208119	2.4930476299675157
GLYCOGEN STORAGE DISEASE IXC	0.0669524	2.4835618765143104
GAUCHER DISEASE	0.06679013	2.4775425615128777
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.066703819	2.474340903183619
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.0666667	2.472963994614332
ADENOCARCINOMA OF THE ANAL CANAL	0.0666667	2.472963994614332
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.0666667	2.472963994614332
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.0666667	2.472963994614332
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.0666667	2.472963994614332
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.0666667	2.472963994614332
AUTOIMMUNE HYPOPARATHYROIDISM	0.0666667	2.472963994614332
SQUAMOUS CELL CARCINOMA OF THE ANAL CANAL	0.0666667	2.472963994614332
FAMILIAL ISOLATED HYPOPARATHYROIDISM DUE TO AGENESIS OF PARATHYROID GLAND	0.0666667	2.472963994614332
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.0666667	2.472963994614332
NEPHROBLASTOMA	0.0666667	2.472963994614332
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.0666667	2.472963994614332
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.0666667	2.472963994614332
SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA	0.0666667	2.472963994614332
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.0666667	2.472963994614332
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.0666667	2.472963994614332
MUIR-TORRE SYNDROME	0.0666667	2.472963994614332
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.0666667	2.472963994614332
TRANSALDOLASE DEFICIENCY	0.066520494	2.467540564719098
REYNOLDS SYNDROME	0.06644391000000001	2.4646997240210657
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.0662919	2.4590609979881086
HEMOCHROMATOSIS, TYPE 1	0.065979	2.4474541472828117
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.06589500899999999	2.4443385480575364
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.06555502900000001	2.431727179879886
1P36 DELETION SYNDROME	0.065485273	2.4291396200275406
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.06548385000000001	2.4290868346374688
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.065330119	2.423384269070911
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.065089744	2.4144676927261175
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.0648148	2.404268798637536
%108650 SPASTIC ATAXIA 7, AUTOSOMAL DOMINANT; SPAX7;;SPASTIC ATAXIA WITH CONGENITAL MIOSIS;;MIOSIS, CONGENITAL, WITH SPASTIC ATAXIA	0.063748	2.3646964485818924
AUTOIMMUNE ENTEROPATHY AND ENDOCRINOPATHY-SUSCEPTIBILITY TO CHRONIC INFECTIONS SYNDROME	0.0637064	2.363153319820817
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.062842929	2.3311233454349005
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.06279881	2.329486775776009
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.0627413	2.3273534744527056
COCAINE EMBRYOFETOPATHY	0.0627273	2.3268341522734977
CONGENITAL ERYTHROPOIETIC PORPHYRIA	0.06210219	2.3036460460274504
ACYL-COA DEHYDROGENASE 9 DEFICIENCY	0.06200055	2.2998757670064007
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.06190225	2.2962293834195338
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.061614053	2.2855388766994493
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3	0.061535440000000004	2.282622771379873
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.061512412999999995	2.2817685976783997
49,XXXYY SYNDROME	0.06142855999999999	2.2786581174860334
49,XYYYY SYNDROME	0.06142855999999999	2.2786581174860334
HEREDITARY ELLIPTOCYTOSIS	0.061202	2.270254000848795
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2	0.06088831	2.258617845534814
CHILDHOOD-ONSET AUTOSOMAL RECESSIVE SLOWLY PROGRESSIVE SPINOCEREBELLAR ATAXIA	0.06083495	2.256638486143204
AUTOSOMAL RECESSIVE ATAXIA, BEAUCE TYPE	0.06083495	2.256638486143204
HOLOPROSENCEPHALY	0.060754173	2.2536421084524987
YUNIS-VARON SYNDROME	0.06075261999999999	2.253584500785048
SPINOCEREBELLAR ATAXIA 1	0.06074545	2.2533185336404107
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.060529313	2.2453010523655923
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.060529313	2.2453010523655923
NOONAN SYNDROME	0.060433680000000004	2.241753599653864
PHELAN-MCDERMID SYNDROME	0.060085932999999994	2.228854118950077
RFT1-CDG	0.05982325300000001	2.219110151090482
BLAU SYNDROME	0.0597643	2.2169233224882787
AUTOSOMAL DOMINANT SPASTIC ATAXIA TYPE 1	0.059667200000000004	2.213321452231058
DUBIN-JOHNSON SYNDROME	0.05959834	2.2107671289981825
GRISCELLI SYNDROME	0.059533503	2.2083620367029466
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 48	0.05944234	2.204980396144151
FOUNTAIN SYNDROME	0.059364919	2.20210850739869
CORNELIA DE LANGE SYNDROME	0.059364919	2.20210850739869
FOUNTAIN SYNDROME	0.059364919	2.20210850739869
ADAMS-OLIVER SYNDROME 1; AOS1	0.059052213000000006	2.1905088530150194
8Q24.3 MICRODELETION SYNDROME	0.059052213	2.1905088530150194
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.059014789	2.1891206306411135
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.058964519	2.1872558930733437
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.058900014	2.184863116132643
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.0588235	2.182024872045506
HYDROPS FETALIS, NONIMMUNE, WITH GRACILE BONES AND DYSMORPHIC FEATURES	0.0588235	2.182024872045506
JUVENILE NASOPHARYNGEAL ANGIOFIBROMA	0.0588235	2.182024872045506
HYDROPS FETALIS, NONIMMUNE	0.0588235	2.182024872045506
MELKERSSON-ROSENTHAL SYNDROME	0.0588235	2.182024872045506
AUTOSOMAL RECESSIVE OMODYSPLASIA	0.0588235	2.182024872045506
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	0.0588235	2.182024872045506
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.058547333	2.1717806114551266
WHITE-SUTTON SYNDROME; WHSUS	0.058510794000000005	2.1704252176618355
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.058510794000000005	2.1704252176618355
17P11.2 MICRODUPLICATION SYNDROME	0.058510794000000005	2.1704252176618355
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.0584691	2.1688786020232715
CITRULLINEMIA, CLASSIC	0.058417803000000004	2.1669757684642126
PYRUVATE CARBOXYLASE DEFICIENCY	0.058346153	2.164317951739909
WITTEVEEN-KOLK SYNDROME	0.058032973	2.152700714591028
COFFIN-SIRIS SYNDROME 6; CSS6	0.058005914000000006	2.151696976101943
PORPHYRIA CUTANEA TARDA	0.05791213	2.1482181110123117
DUBIN-JOHNSON SYNDROME	0.05789476	2.1475737805656805
DE BARSY SYNDROME	0.057833414	2.145298184965274
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.05777791	2.1432392950913632
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 46	0.057562800000000004	2.1352599098078335
CYSTIC FIBROSIS	0.05725918000000001	2.1239972955184685
PANNER DISEASE	0.0572101	2.1221767003359306
EVEN-PLUS SYNDROME	0.057114163999999995	2.118618008008467
SPORADIC CREUTZFELDT-JAKOB DISEASE	0.057032700000000006	2.115596146436539
COG2-CDG	0.05667009399999999	2.1021454794284056
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.056642573	2.101124603307407
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.056642573	2.101124603307407
DYSPLASTIC CORTICAL HYPEROSTOSIS	0.056628979999999995	2.1006203785658375
MECKEL SYNDROME, TYPE 1; MKS1	0.05656861	2.09838098714021
RENAL CYSTS AND DIABETES SYNDROME; RCAD	0.05655317	2.0978082489654266
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.05651325000000001	2.0963274388658566
EPISODIC ATAXIA, TYPE 6	0.056292618999999995	2.088143255171512
219400 CYANOSIS AND HEPATIC DISEASE	0.056122500000000006	2.08183278589975
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.056101154	2.081040967954223
FLOATING-HARBOR SYNDROME	0.056101154	2.081040967954223
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.056097019000000005	2.08088758243915
LATHOSTEROLOSIS	0.056069243000000005	2.079857247235602
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2; PRAAS2	0.05591029	2.073960974496199
THROMBOCYTOPENIA WITH ELEVATED SERUM IGA AND RENAL DISEASE	0.05591029	2.073960974496199
IMMUNODEFICIENCY, COMMON VARIABLE, 6; CVID6	0.05591029	2.073960974496199
NEPHROTIC SYNDROME, TYPE 7; NPHS7	0.05591029	2.073960974496199
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.055555600000000004	2.0608039470859665
FAMILIAL DEVELOPMENTAL DYSPHASIA	0.055555600000000004	2.0608039470859665
FLOATING-HARBOR SYNDROME	0.055555600000000004	2.0608039470859665
BILIARY CIRRHOSIS, PRIMARY	0.055555600000000004	2.0608039470859665
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.055555600000000004	2.0608039470859665
GITELMAN SYNDROME	0.055555600000000004	2.0608039470859665
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.055555600000000004	2.0608039470859665
MICROANGIOPATHY AND LEUKOENCEPHALOPATHY, PONTINE, AUTOSOMAL DOMINANT	0.055555600000000004	2.0608039470859665
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.055555600000000004	2.0608039470859665
DYSPHASIA, FAMILIAL DEVELOPMENTAL	0.055555600000000004	2.0608039470859665
SPECIFIC LANGUAGE IMPAIRMENT 2; SLI2	0.055555600000000004	2.0608039470859665
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.055555600000000004	2.0608039470859665
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.055555600000000004	2.0608039470859665
CYSTIC FIBROSIS	0.055555600000000004	2.0608039470859665
XQ12-Q13.3 DUPLICATION SYNDROME	0.05524035999999999	2.0491102953878584
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.055081914	2.0432328295302318
MECKEL SYNDROME, TYPE 4; MKS4	0.05504124	2.0417240502218674
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.054777714	2.031948700464871
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.054743504	2.030679699625535
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.054654254	2.027369020733085
SILVER-RUSSELL SYNDROME; SRS	0.054522853999999996	2.022494811136805
300270 ADRENOMYODYSTROPHY	0.05433575399999999	2.0155544411561044
POLYCYSTIC LIVER DISEASE 2	0.054335180000000004	2.015533148946757
AMERICAN TRYPANOSOMIASIS	0.054335180000000004	2.015533148946757
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.053718573	1.9926604567356958
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.0536499	1.9901130701633567
EPISODIC ATAXIA, TYPE 2	0.053571499999999994	1.987204865959792
KIKUCHI-FUJIMOTO DISEASE	0.05351644	1.9851624460178505
MICROGASTRIA-LIMB REDUCTION DEFECT SYNDROME	0.05325959	1.975634738751454
JOUBERT SYNDROME 23; JBTS23	0.053177154	1.972576821382512
GRANULOMATOSIS WITH POLYANGIITIS	0.053173019	1.9724234358674388
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.053173019	1.9724234358674388
LEUKOCYTE ADHESION DEFICIENCY	0.053173019	1.9724234358674388
SPINOCEREBELLAR ATAXIA 18	0.053010949999999994	1.9664115768487207
9Q33.3Q34.11 MICRODELETION SYNDROME	0.052728979	1.9559520201206184
GOODPASTURE SYNDROME	0.0526316	1.9523398005142552
NEPHRONOPHTHISIS 13	0.0526316	1.9523398005142552
SENIOR-LOKEN SYNDROME 8; SLSN8	0.0526316	1.9523398005142552
ACUTE MONOBLASTIC LEUKEMIA	0.0526316	1.9523398005142552
MICROCEPHALY-GLOMERULONEPHRITIS-MARFANOID HABITUS SYNDROME	0.0526316	1.9523398005142552
MELKERSSON-ROSENTHAL SYNDROME	0.0526316	1.9523398005142552
DERMATOMYOSITIS	0.0526316	1.9523398005142552
NAIL-PATELLA SYNDROME	0.0526316	1.9523398005142552
TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS; TINU	0.0526316	1.9523398005142552
KAPUR-TORIELLO SYNDROME	0.0526316	1.9523398005142552
SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5	0.0526316	1.9523398005142552
LACRIMAL DUCT DEFECT	0.0526316	1.9523398005142552
POLYCYSTIC KIDNEY DISEASE 6 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD6	0.0526316	1.9523398005142552
%247800 LYMPHOPENIC HYPERGAMMAGLOBULINEMIA, ANTIBODY DEFICIENCY, AUTOIMMUNEHEMOLYTIC ANEMIA, AND GLOMERULONEPHRITIS	0.0526316	1.9523398005142552
ROBERTS SYNDROME; RBS	0.0526316	1.9523398005142552
%263630 POLYSYNDACTYLY WITH CARDIAC MALFORMATION;;BONNEAU SYNDROME	0.0526316	1.9523398005142552
CONGENITAL MEMBRANOUS NEPHROPATHY DUE TO FETOMATERNAL ANTI-NEUTRAL ENDOPEPTIDASE ALLOIMMUNIZATION	0.0526316	1.9523398005142552
POLYCYSTIC LIVER DISEASE 3 WITH OR WITHOUT KIDNEY CYSTS; PCLD3	0.0526316	1.9523398005142552
POLYCYSTIC KIDNEYS	0.0526316	1.9523398005142552
248760 MARFANOID HABITUS WITH MICROCEPHALY AND GLOMERULONEPHRITIS	0.0526316	1.9523398005142552
POLYCYSTIC LIVER DISEASE 4 WITH OR WITHOUT KIDNEY CYSTS; PCLD4	0.0526316	1.9523398005142552
POLYCYSTIC KIDNEY DISEASE 2	0.0526316	1.9523398005142552
SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY; SRTD4	0.0526316	1.9523398005142552
%174770 ACTINIC PRURIGOPOLYMORPHIC LIGHT ERUPTION, HEREDITARY; HPLE;;JUVENILE SPRING ERUPTION OF EARS, INCLUDED	0.0526316	1.9523398005142552
POLYCYSTIC KIDNEY DISEASE 3	0.0526316	1.9523398005142552
PEUTZ-JEGHERS SYNDROME	0.0526316	1.9523398005142552
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.0526316	1.9523398005142552
SUBAORTIC STENOSIS-SHORT STATURE SYNDROME	0.0526316	1.9523398005142552
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.0526316	1.9523398005142552
601016 MIDLINE MALFORMATIONS, MULTIPLE, WITH LIMB ABNORMALITIES AND HYPOPITUITARISM;;DINCSOY SYNDROME	0.0526316	1.9523398005142552
VISCERAL STEATOSIS, CONGENITAL	0.052187369000000004	1.9358612997291327
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.051972683000000006	1.9278976424887448
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.05144192400000001	1.9082094338805866
CEPHALIN LIPIDOSIS	0.05140688	1.9069094962771462
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.051237064	1.9006102666211193
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.051144223	1.8971663815897024
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.051115613000000004	1.8961051096220496
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.05074541	1.882372636142813
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.050602804	1.8770827462365185
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.050602804	1.8770827462365185
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.050570059	1.8758680887537924
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.050436504	1.8709139406363557
RETINAL VENOUS BEADING	0.050287389999999994	1.8653826401056122
12Q14 MICRODELETION SYNDROME	0.050069314000000004	1.8572932327089735
MEDNIK SYNDROME	0.05	1.8547220685997148
IRIDA SYNDROME	0.05	1.8547220685997148
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.049569269000000006	1.8387443427731145
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.04955366900000001	1.8381656694877113
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.049538873000000004	1.8376168201331713
SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4	0.04952376	1.8370562118407163
IMMUNODEFICIENCY 47	0.049208009	1.8253436048830673
MCLEOD SYNDROME; MCLDS	0.0490852	1.8207880736326145
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.049076853999999996	1.8204784834249235
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.04907410999999999	1.8203766962777985
MICROHYDRANENCEPHALY; MHAC	0.04891057	1.8143102713358232
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.048879673	1.8131641643807526
NEONATAL ADRENOLEUKODYSTROPHY	0.048773709000000005	1.8092334889952106
ADULT-ONSET STILL DISEASE	0.048760649999999996	1.8087490726853335
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.048708949999999994	1.8068312900664012
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.048705973	1.806720859914437
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.048700272999999995	1.8065094215986166
LISSENCEPHALY 2; LIS2	0.048693653999999996	1.8062638934911754
DEHYDRATED HEREDITARY STOMATOCYTOSIS 1 WITH OR WITHOUT PSEUDOHYPERKALEMIA AND/OR PERINATAL EDEMA; DHS1	0.04865153999999999	1.804701698187235
SUSAC SYNDROME	0.048606510000000006	1.8030313354922545
LYSOSOMAL ACID LIPASE DEFICIENCY	0.04845992	1.7975936613315338
CONGENITAL HYPOTHYROIDISM	0.048272854000000004	1.7906545525618407
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.048272854000000004	1.7906545525618407
DEXTROCARDIA	0.048164554	1.7866372245612532
SPASTIC ATAXIA WITH CONGENITAL MIOSIS	0.048160419	1.7864838390461804
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.048130104	1.785359321055988
ATYPICAL MYCOBACTERIOSIS, FAMILIAL	0.047762500000000006	1.771723256029878
FEINGOLD SYNDROME	0.047619	1.7664002036929964
SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1	0.047619	1.7664002036929964
LOWER LIMB MALFORMATION-HYPOSPADIAS SYNDROME	0.047619	1.7664002036929964
MEACHAM SYNDROME	0.047619	1.7664002036929964
CEROID STORAGE DISEASE	0.047619	1.7664002036929964
LARYNGOTRACHEOESOPHAGEAL CLEFT TYPE 4	0.047619	1.7664002036929964
PAGOD SYNDROME	0.047619	1.7664002036929964
TUFTSIN DEFICIENCY	0.047619	1.7664002036929964
SPINOCEREBELLAR DEGENERATION WITH MACULAR CORNEAL DYSTROPHY, CONGENITALCATARACTS, AND MYOPIA	0.047619	1.7664002036929964
SPINOCEREBELLAR ATAXIA 42	0.047619	1.7664002036929964
SPASTIC ATAXIA-CORNEAL DYSTROPHY SYNDROME	0.047619	1.7664002036929964
LISSENCEPHALY, X-LINKED, 2	0.047600139	1.7657005654342792
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.04747941	1.7612221906218795
MAPLE SYRUP URINE DISEASE; MSUD	0.047473019000000005	1.7609851200470716
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.0474338	1.7595303131509028
SIALIDOSIS TYPE 2	0.047413613	1.7587814876629266
CHANARIN-DORFMAN SYNDROME	0.047009270000000006	1.7437826099552505
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.046974800000000004	1.7425039645611577
THYROCEREBRORETINAL SYNDROME	0.046963909	1.742099969000175
LASSA FEVER	0.046955608999999995	1.7417920851367876
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.046854049999999994	1.738024810765489
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.046720953999999995	1.7330876889966422
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.04669068299999999	1.7319648031618704
BETA-THALASSEMIA	0.04666707	1.7310888921177536
SPINOCEREBELLAR ATAXIA 2; SCA2	0.04666095	1.7308618741365571
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.046550919	1.7267803356579552
COFFIN-SIRIS SYNDROME 2; CSS2	0.04647003300000001	1.7237799146731403
MUCOPOLYSACCHARIDOSIS TYPE 7	0.0464447	1.7228402011898636
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.046293464	1.7172301862545285
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.046135319	1.7113638858237543
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.046115803	1.7106399507059384
CEDNIK SYNDROME	0.046042373000000004	1.7079161058759933
CEREBROTENDINOUS XANTHOMATOSIS	0.046019419000000006	1.7070646400687406
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.045995919	1.7061929206964987
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.045995919	1.7061929206964987
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.045928614	1.7036962793199564
WIEDEMANN-STEINER SYNDROME	0.045924479000000004	1.7035428938048836
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.045924479000000004	1.7035428938048836
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0458128	1.6994002236869001
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.045775053999999996	1.6980000569028728
EDEMA, FAMILIAL IDIOPATHIC, PREPUBERTAL	0.04565769	1.6936465048856904
TYROSINEMIA, TYPE I; TYRSN1	0.0455708	1.6904233688748778
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.045500954	1.6878324705228094
JOUBERT SYNDROME 7	0.045500954	1.6878324705228094
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.045486808999999996	1.6873077696496024
SOMATOMAMMOTROPINOMA	0.0454546	1.6861129947874518
ACROMEGALY	0.0454546	1.6861129947874518
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.045454579999999994	1.6861122528986243
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.0454439	1.6857160842647716
KOOLEN-DE VRIES SYNDROME; KDVS	0.045401373	1.6841385689565447
LISSENCEPHALY 5; LIS5	0.045036729	1.6706123034768952
ALPORT SYNDROME, X-LINKED; ATS	0.044945389999999995	1.6672241342964185
FECHTNER SYNDROME	0.044945389999999995	1.6672241342964185
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.044925509999999995	1.6664866968019432
SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS	0.044839079999999996	1.663280624234162
MALAN OVERGROWTH SYNDROME	0.04461775899999999	1.6550708453752707
ERDHEIM-CHESTER DISEASE	0.044612599999999995	1.6548794751522327
TARP SYNDROME	0.044565273	1.6531239065254204
COFFIN-SIRIS SYNDROME 4; CSS4	0.044565273	1.6531239065254204
COFFIN-SIRIS SYNDROME 3; CSS3	0.044565273	1.6531239065254204
ADRENOLEUKODYSTROPHY	0.044531219000000004	1.6518606924189387
COG1-CDG	0.0443063	1.6435174477599908
CONGENITAL TRACHEAL STENOSIS	0.0442684	1.6421115684319925
MACHADO-JOSEPH DISEASE TYPE 3	0.044112559999999995	1.6363307706885803
MACHADO-JOSEPH DISEASE TYPE 2	0.044112559999999995	1.6363307706885803
MACHADO-JOSEPH DISEASE TYPE 1	0.044112559999999995	1.6363307706885803
ALSTRÖM SYNDROME	0.044087793	1.6354120526591205
TARP SYNDROME; TARPS	0.044023854	1.6330402711722365
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.044019719000000006	1.6328868856571637
3Q13 MICRODELETION SYNDROME	0.04393701	1.629818841505727
ALPHA-1-ANTITRYPSIN DEFICIENCY; A1ATD	0.04386722	1.6272300204423755
ALKAPTONURIA	0.04378788	1.6242869474639217
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.043663129	1.619659378808324
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.043614749999999994	1.617864786829188
RING CHROMOSOME 22 SYNDROME	0.043576252999999995	1.6164367621196902
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.04357145999999999	1.6162589684621944
HYPERBILIVERDINEMIA; HBLVD	0.043498800000000004	1.6135636863521055
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.043478300000000004	1.6128032503039798
SEVERE MOTOR AND INTELLECTUAL DISABILITIES-SENSORINEURAL DEAFNESS-DYSTONIA SYNDROME	0.043478300000000004	1.6128032503039798
ENCEPHALOPATHY, AXONAL, WITH NECROTIZING MYOPATHY, CARDIOMYOPATHY, AND CATARACTS	0.043478300000000004	1.6128032503039798
16P13.11 MICRODELETION SYNDROME	0.04342432399999999	1.6108010407364846
COMBINED IMMUNODEFICIENCY DUE TO ZAP70 DEFICIENCY	0.0432982	1.6061225414128835
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO IL-7RALPHA DEFICIENCY	0.0432982	1.6061225414128835
ZELLWEGER SYNDROME	0.043222459000000005	1.6033129713289276
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-SACCADIC INTRUSION SYNDROME	0.043165709999999996	1.6012078988755076
EPISODIC ATAXIA, TYPE 8	0.043143799999999996	1.6003951596650474
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.04312171000000001	1.5995757434551405
HARTNUP DISORDER	0.04275367299999999	1.5859236165359152
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.042466213999999995	1.5752604855135632
XP22.13P22.2 DUPLICATION SYNDROME	0.042208118999999995	1.5656865956676584
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.042208118999999995	1.5656865956676584
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.042208118999999995	1.5656865956676584
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.042208118999999995	1.5656865956676584
EPISODIC ATAXIA TYPE 3	0.042208118999999995	1.5656865956676584
EARLY-ONSET CEREBELLAR ATAXIA WITH RETAINED TENDON REFLEXES	0.0422078	1.5656747625408605
AUTOSOMAL RECESSIVE SPASTIC ATAXIA-OPTIC ATROPHY-DYSARTHRIA SYNDROME	0.0422078	1.5656747625408605
MYOCLONUS-CEREBELLAR ATAXIA-DEAFNESS SYNDROME	0.0422078	1.5656747625408605
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.042069579999999995	1.5605475688544237
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.042021954	1.5587809089896412
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.042019270000000004	1.558681347508999
PELIZAEUS-MERZBACHER DISEASE	0.042018519000000004	1.5586534895835285
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.041825633	1.5514984911650498
MENTAL RETARDATION, X-LINKED 98; MRX98	0.041739532999999995	1.548304659762921
SOTOS SYNDROME	0.041706573000000004	1.5470820269753005
ALPORT SYNDROME, AUTOSOMAL RECESSIVE	0.041666699999999994	1.5456029603144743
EPISODIC ATAXIA, TYPE 7; EA7	0.041666699999999994	1.5456029603144743
EPISODIC ATAXIA, TYPE 4	0.041666699999999994	1.5456029603144743
EPISODIC ATAXIA, TYPE 3	0.041666699999999994	1.5456029603144743
%613944 IGA NEPHROPATHY, SUSCEPTIBILITY TO, 2; IGAN2	0.041666699999999994	1.5456029603144743
HAMAMY SYNDROME; HMMS	0.041666699999999994	1.5456029603144743
EPISODIC ATAXIA, TYPE 5	0.041666699999999994	1.5456029603144743
PAROXYSMAL TONIC UPGAZE, BENIGN CHILDHOOD, WITH ATAXIA	0.041666699999999994	1.5456029603144743
COMPLEMENT COMPONENT C1R DEFICIENCY	0.041666699999999994	1.5456029603144743
EPISODIC ATAXIA TYPE 7	0.041666699999999994	1.5456029603144743
BENIGN PAROXYSMAL TONIC UPGAZE OF CHILDHOOD WITH ATAXIA	0.041666699999999994	1.5456029603144743
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.041666699999999994	1.5456029603144743
%161900 RENAL FAILURE, PROGRESSIVE, WITH HYPERTENSION; RFH1;;NEPHROPATHY, FAMILIAL;;NEPHRITIS, FAMILIAL, WITHOUT DEAFNESS OR OCULAR DEFECT;;RENAL FAILURE, ADULT-ONSET; AORF	0.041666699999999994	1.5456029603144743
IGA NEPHROPATHY, SUSCEPTIBILITY TO, 1; IGAN1	0.041666699999999994	1.5456029603144743
HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 1; HNFJ1	0.041666699999999994	1.5456029603144743
DISTAL 17P13.1 MICRODELETION SYNDROME	0.041666699999999994	1.5456029603144743
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.041666699999999994	1.5456029603144743
HISTIDINEMIA	0.041666699999999994	1.5456029603144743
DYSCHONDROSTEOSIS AND NEPHRITIS	0.041666699999999994	1.5456029603144743
PAPILLARY TUMOR OF THE PINEAL REGION	0.041666699999999994	1.5456029603144743
PINEOCYTOMA	0.041666699999999994	1.5456029603144743
EPISODIC ATAXIA, TYPE 1; EA1	0.041666699999999994	1.5456029603144743
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.041661114	1.5453957507649707
CEREBELLAR ATAXIA WITH NEUROPATHY AND BILATERAL VESTIBULAR AREFLEXIA SYNDROME	0.04164572	1.5448247189344901
YOU-HOOVER-FONG SYNDROME; YHFS	0.041233454	1.5295319419678237
C SYNDROME	0.041161019	1.5268450061070433
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.04097401	1.519908011720508
FANCONI ANEMIA	0.040861244	1.5157250199447536
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1; AHMIO1	0.04082488	1.5143761176787025
RENAL-HEPATIC-PANCREATIC DYSPLASIA 2; RHPD2	0.04059248	1.5057553695038508
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.04059248	1.5057553695038508
TRISOMY 12P	0.040545554	1.5040146757480288
KAPUR-TORIELLO SYNDROME	0.040541419	1.5038612902329556
SPINOCEREBELLAR ATAXIA 5; SCA5	0.040429914	1.4997250745477713
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.04034055	1.4964101668890046
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.04031569	1.4954879990764967
DK PHOCOMELIA SYNDROME	0.04031569	1.4954879990764967
PRIMARY MYELOFIBROSIS	0.04028627	1.4943966806113325
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.040192729	1.490926829470955
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.040079963	1.4867438376952007
BLACKFAN-DIAMOND ANEMIA	0.04	1.4837776548797719
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASEDEFICIENCY	0.04	1.4837776548797719
DISLOCATION OF THE HIP-DYSMORPHISM SYNDROME	0.04	1.4837776548797719
HYDROCEPHALY-LOW INSERTION UMBILICUS SYNDROME	0.04	1.4837776548797719
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IV; MEN4	0.04	1.4837776548797719
SPLIT HAND/FOOT MALFORMATION 1 (SHFM1)	0.04	1.4837776548797719
GLUCOCORTICOID-REMEDIABLE ALDOSTERONISM	0.04	1.4837776548797719
NON-DISTAL TRISOMY 10Q	0.04	1.4837776548797719
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.039981953	1.4831082114963314
BUDD-CHIARI SYNDROMEMEMBRANOUS OBSTRUCTION OF INFERIOR VENA CAVA, INCLUDED	0.03994565	1.4817615719912038
PORPHYRIA CUTANEA TARDA	0.03994565	1.4817615719912038
HEMOLYTIC ANEMIA DUE TO RED CELL PYRUVATE KINASE DEFICIENCY	0.0399254	1.481010409553421
ADAMS-OLIVER SYNDROME 6; AOS6	0.0399225	1.4809028356734422
LICHTENSTEIN-KNORR SYNDROME; LIKNS	0.03988436	1.4794880536795145
NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	0.03988436	1.4794880536795145
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.039752219000000005	1.4745863571021778
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.039708304	1.4729573547093266
MISMATCH REPAIR CANCER SYNDROME; MMRCS	0.03965131	1.470843194117771
LINEAR VERRUCOUS NEVUS SYNDROME	0.039616619000000006	1.4695563508521354
MACHADO-JOSEPH DISEASE; MJD	0.0395146	1.4657720130378056
ASPLENIA, ISOLATED CONGENITAL; ICAS	0.039502180000000005	1.4653113000759659
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.039502180000000005	1.4653113000759659
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.039502180000000005	1.4653113000759659
PELVIC LIPOMATOSIS WITH CROSSED RENAL ECTOPIA	0.039502180000000005	1.4653113000759659
HYPERLYSINEMIA, TYPE I	0.039483179	1.4646064685954563
SENIOR-LOKEN SYNDROME 9	0.039434454	1.462799041939606
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.039272100000000004	1.4567766110050973
CONO-SPONDYLAR DYSPLASIA	0.039198829000000004	1.45405866419133
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.039093649999999994	1.4501571079422646
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.039068579	1.4492271132026275
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.039009459999999996	1.4470341269231564
LEPRECHAUNISM	0.038888900000000004	1.442562021071349
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.03870979399999999	1.4359181840549762
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.038665359	1.434269892552612
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.038665359	1.434269892552612
AUTOSOMAL ERYTHROPOIETIC PROTOPORPHYRIA	0.03859294	1.4315835502028935
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.038521299999999994	1.4289261044230035
MYOCLONUS AND ATAXIA	0.0385141	1.4286590244451256
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.038455619999999996	1.4264897415136912
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.03827229	1.4196892175769635
FLOOD FACTOR DEFICIENCY	0.03827068	1.4196294955263546
PHAGOCYTOSIS, PLASMA-RELATED DEFECT IN	0.03827068	1.4196294955263546
MACROCYTOSIS, FAMILIAL	0.03827068	1.4196294955263546
THIOPURINE S-METHYLTRANSFERASE DEFICIENCY	0.03827068	1.4196294955263546
COUMARIN RESISTANCE	0.03827068	1.4196294955263546
FUMARASE DEFICIENCY; FMRD	0.038199064	1.416972940013058
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.037987104	1.40911040221985
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.037883259999999995	1.4052583670500165
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.037551279	1.3929437173089005
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.037221679	1.3807173894326912
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.0370879	1.3757549321603872
CONGENITAL PULMONARY LYMPHANGIECTASIA	0.037037179999999996	1.3738735020939994
PEYRONIE DISEASE	0.037037	1.3738668250945527
%193250 VOLVULUS OF MIDGUT;;INTESTINAL MALROTATION, FAMILIAL	0.037037	1.3738668250945527
POLAND SYNDROME	0.037037	1.3738668250945527
RCAD (RENAL CYSTS AND DIABETES)	0.037037	1.3738668250945527
CANAVAN DISEASE	0.037037	1.3738668250945527
TESTICULAR TORSION	0.037037	1.3738668250945527
138790 GOITER, MULTINODULAR, CYSTIC RENAL DISEASE, AND DIGITAL ANOMALIES;;MULTINODULAR GOITER/CYSTIC RENAL DISEASE/DIGITAL ANOMALIES;;MNG/CRD/DA	0.037037	1.3738668250945527
SCIMITAR SYNDROME	0.037037	1.3738668250945527
OVARIAN HYPERSTIMULATION SYNDROME	0.037037	1.3738668250945527
FAMILIAL SUPERNUMERARY NIPPLES	0.037037	1.3738668250945527
APOLIPOPROTEIN A-I DEFICIENCY	0.037037	1.3738668250945527
HYPERVITAMINOSIS A, SUSCEPTIBILITY TO	0.037037	1.3738668250945527
SITOSTEROLEMIA	0.037037	1.3738668250945527
GENITOURINARY TRACT ANOMALIES	0.037037	1.3738668250945527
ATRANSFERRINEMIA	0.037037	1.3738668250945527
JEUNE SYNDROME	0.037037	1.3738668250945527
RHYNS SYNDROME	0.037037	1.3738668250945527
LABIA MINORA, INCOMPLETE ADHESION OF	0.037037	1.3738668250945527
GALACTORRHEA	0.037037	1.3738668250945527
GASTROINTESTINAL STROMAL TUMOR	0.037037	1.3738668250945527
HYDATIDIFORM MOLE, RECURRENT, 1; HYDM1	0.037037	1.3738668250945527
ADENOMYOSIS	0.037037	1.3738668250945527
CONGENITAL RESPIRATORY-BILIARY FISTULA	0.037037	1.3738668250945527
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.037037	1.3738668250945527
URINARY BLADDER, ATONY OF	0.037037	1.3738668250945527
BUTYRYLCHOLINESTERASE DEFICIENCY	0.037037	1.3738668250945527
207620 APHALANGY WITH HEMIVERTEBRAE	0.037037	1.3738668250945527
LEUKEMIA, ACUTE MYELOCYTIC, WITH POLYPOSIS COLI AND COLON CANCER	0.037037	1.3738668250945527
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.037037	1.3738668250945527
FRYNS MICROPHTHALMIA SYNDROME	0.037037	1.3738668250945527
NATHALIE SYNDROME	0.037037	1.3738668250945527
SPLENOGONADAL FUSION WITH LIMB DEFECTS AND MICROGNATHIA	0.037037	1.3738668250945527
HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY	0.037037	1.3738668250945527
SYSTEMIC MASTOCYTOSIS	0.03693372	1.3700357111896533
GLYCOGEN STORAGE DISEASE IA	0.03687515	1.3678630897584956
GLYCOGEN STORAGE DISEASE IB	0.03687515	1.3678630897584956
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.036859092999999996	1.367267464313385
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.036856813999999995	1.3671829260814985
ALPERS-HUTTENLOCHER SYNDROME	0.036842704000000004	1.3666595235137398
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.036587399	1.3571891271592627
COFS SYNDROME	0.036520229	1.354697493532306
EVANS SYNDROME	0.03651316	1.3544352729262472
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.03629715	1.3464225026454828
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.036178853999999996	1.3420343786089413
GALACTOSEMIA	0.035846613	1.3297100843130685
KAPOSIFORM LYMPHANGIOMATOSIS	0.03573509	1.3255732009279395
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.035714300000000004	1.3248020074918159
PARANA HARD-SKIN SYNDROME	0.035714300000000004	1.3248020074918159
SCLERODERMA, FAMILIAL PROGRESSIVE	0.035714300000000004	1.3248020074918159
GASTRIC SNEEZING	0.035714300000000004	1.3248020074918159
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.035714300000000004	1.3248020074918159
METHANE PRODUCTION	0.035714300000000004	1.3248020074918159
GALLBLADDER, AGENESIS OF	0.035714300000000004	1.3248020074918159
%243600 JEJUNAL ATRESIA;;APPLE PEEL SYNDROME;;APPLE PEEL SMALL BOWEL SYNDROME; APSB	0.035714300000000004	1.3248020074918159
BLUE DIAPER SYNDROME	0.035714300000000004	1.3248020074918159
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.035714300000000004	1.3248020074918159
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.035714300000000004	1.3248020074918159
PANCREATIC BETA CELL AGENESIS WITH NEONATAL DIABETES MELLITUS	0.035714300000000004	1.3248020074918159
AMYLOIDOSIS, FINNISH TYPE	0.035714300000000004	1.3248020074918159
MESOMELIA-SYNOSTOSES SYNDROME	0.035714300000000004	1.3248020074918159
POLYPOSIS SYNDROME, HEREDITARY MIXED, 1	0.035714300000000004	1.3248020074918159
TERATOMA, PINEAL	0.035714300000000004	1.3248020074918159
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.035714300000000004	1.3248020074918159
AURAL ATRESIA, MULTIPLE CONGENITAL ANOMALIES, AND MENTAL RETARDATION	0.035714300000000004	1.3248020074918159
JUVENILE ABSENCE EPILEPSY	0.03566625	1.3230196195838915
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.03566625	1.3230196195838915
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.03566625	1.3230196195838915
SPINOCEREBELLAR ATAXIA TYPE 35	0.035660159999999996	1.322793714435936
SPINOCEREBELLAR ATAXIA TYPE 23	0.035660159999999996	1.322793714435936
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.035470254	1.3157492574527463
JUVENILE HUNTINGTON DISEASE	0.035431528999999996	1.3143127752106154
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.03533359999999999	1.3106801536614974
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.035220514	1.3064852916645042
COMMON VARIABLE IMMUNODEFICIENCY	0.03517157	1.3046697413259933
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.035024219	1.2992038382953885
%152800 LYMPHANGIECTASIA, INTESTINAL	0.03493649	1.295949580048265
ANGELMAN SYNDROME	0.034886472999999994	1.2940942273741616
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.034820050000000005	1.2916303032949101
MONOSOMY 22	0.0347755	1.2899777459317876
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 26; SCAR26	0.03475615	1.2892599684912396
COFFIN-SIRIS SYNDROME	0.034746613	1.2889061988038748
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.034746612999999996	1.2889061988038746
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.034670004	1.2860644307448077
DOORS SYNDROME	0.034614804	1.2840168175810736
SPINOCEREBELLAR ATAXIA 12	0.03461275	1.2839406255984955
SPINOCEREBELLAR ATAXIA TYPE 1	0.03461275	1.2839406255984955
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.034540009999999996	1.2812423759330964
EOSINOPHILOPENIA	0.0344828	1.279120202942205
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.0344828	1.279120202942205
FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 3	0.0344828	1.279120202942205
SULFHEMOGLOBINEMIA, CONGENITAL	0.0344828	1.279120202942205
CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL RECESSIVE	0.0344828	1.279120202942205
MYELOMA, MULTIPLE	0.0344828	1.279120202942205
HEMOPOIETIC PROLIFERATION	0.0344828	1.279120202942205
HEMOGLOBIN, HIGH OXYGEN SATURATION OF	0.0344828	1.279120202942205
260570 PELGER-HUET-LIKE ANOMALY AND EPISODIC FEVER WITH ABDOMINAL PAIN	0.0344828	1.279120202942205
BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY; BCD	0.0344828	1.279120202942205
GIANT NEUTROPHIL LEUKOCYTES	0.0344828	1.279120202942205
LEUKOCYTE NUCLEAR APPENDAGES, HEREDITARY PREVALENCE OF	0.0344828	1.279120202942205
FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 2	0.0344828	1.279120202942205
ACETOPHENETIDIN SENSITIVITY	0.0344828	1.279120202942205
OCULODENTODIGITAL DYSPLASIA	0.034276618999999994	1.2714720339256855
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.034276618999999994	1.2714720339256855
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.034241732999999996	1.2701779572439822
OROFACIODIGITAL SYNDROME TYPE 14	0.034205194	1.268822563450691
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.034162859999999996	1.2672522073696488
MILD CANAVAN DISEASE	0.034162859999999996	1.2672522073696488
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.034162859999999996	1.2672522073696488
ALG13-CDG	0.034162859999999996	1.2672522073696488
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.034147369	1.2666775773783552
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.034069249999999995	1.2637797967128166
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.034069249999999995	1.2637797967128166
EPILEPSY, PYRIDOXINE-DEPENDENT	0.03403400399999999	1.262472366032219
PIGMENTED VILLONODULAR SYNOVITIS	0.0338384	1.2552165449220916
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.033814073	1.2543141484468352
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.033700313999999995	1.2500943218907985
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.033700313999999995	1.2500943218907985
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.033696179	1.2499409363757252
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.03365964	1.248585542582434
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.033606343999999996	1.246608557235072
CONGENITAL DISORDER OF GLYCOSYLATION	0.033579943	1.2456292268884104
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.033496859999999996	1.2425473094159005
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.033410189	1.2393322970877485
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.033328053999999996	1.2362855451456598
SPINOCEREBELLAR ATAXIA 34; SCA34	0.03330541	1.2354455786152325
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.033272654	1.2342305130936515
INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	0.033199679999999995	1.2315235833289715
BLOOD GROUP, DUFFY SYSTEM; FY	0.033199679999999995	1.2315235833289715
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.033038423	1.2255418449966478
GAMMA-HEAVY CHAIN DISEASE	0.03295358	1.222394641307324
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE V; ALPS5	0.03295358	1.222394641307324
RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER; RALD	0.03295358	1.222394641307324
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.03295358	1.222394641307324
TYROSINEMIA TYPE 1	0.03295358	1.222394641307324
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.03295358	1.222394641307324
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.03293314	1.2216364309256802
CHROMOSOME 17Q12 DELETION SYNDROME	0.03285333	1.2186759235597815
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.032803653999999995	1.216833220090186
TUBEROUS SCLEROSIS-1	0.032799519	1.2166798345751129
DEND SYNDROME	0.032799519	1.2166798345751129
TUBEROUS SCLEROSIS 2; TSC2	0.032799519	1.2166798345751129
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.032789944	1.2163246552989762
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.032785809	1.2161712697839029
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.03273801	1.2143981925807628
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.0327271	1.2139934922253945
SPINOCEREBELLAR ATAXIA TYPE 36	0.03271165	1.2134203831061972
AMYLOIDOSIS, FAMILIAL VISCERAL	0.03254647	1.2072931232803712
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.03250841	1.2058813088417533
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO CD3DELTA/CD3EPSILON/CD3ZETA	0.032456399999999996	1.2039520269459953
KABUKI SYNDROME 1	0.032336973	1.1995219490962625
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.032336973	1.1995219490962625
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.032297983	1.1980756368271683
NEONATAL INTRAHEPATIC CHOLESTASIS DUE TO CITRIN DEFICIENCY	0.0322823	1.1974938847031313
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.0322581	1.196596199221929
9P13 MICRODELETION SYNDROME	0.0322581	1.196596199221929
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.0322581	1.196596199221929
SECKEL SYNDROME 2; SCKL2	0.0322581	1.196596199221929
SECKEL SYNDROME	0.0322581	1.196596199221929
ANIRIDIA-RENAL AGENESIS-PSYCHOMOTOR RETARDATION SYNDROME	0.0322581	1.196596199221929
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.0322581	1.196596199221929
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.0322581	1.196596199221929
WEST SYNDROME	0.0322581	1.196596199221929
DYSTONIA, JUVENILE-ONSET	0.0322581	1.196596199221929
9Q31.1Q31.3 MICRODELETION SYNDROME	0.0322581	1.196596199221929
DENT DISEASE	0.0322581	1.196596199221929
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.0322581	1.196596199221929
ISOTRETINOIN-LIKE SYNDROME	0.0322581	1.196596199221929
MEIER-GORLIN SYNDROME 5; MGORS5	0.0322581	1.196596199221929
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.03214847	1.1925295356143173
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.031795554	1.1794383137430786
ACUTE INTERMITTENT PORPHYRIA	0.031791419	1.1792849282280056
LYNCH SYNDROME	0.031791419	1.1792849282280056
FAMILIAL COLORECTAL CANCER TYPE X	0.031791419	1.1792849282280056
KRABBE DISEASE	0.031791419	1.1792849282280056
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.031791419	1.1792849282280056
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.031791419	1.1792849282280056
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.03161573299999999	1.172767954201125
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.0315921	1.1718913012681809
FAMILIAL ATRIAL MYXOMA	0.03157896	1.171403880308553
22Q11.2 MICRODUPLICATION SYNDROME	0.031563133	1.1708167865849584
FOLLICULAR LYMPHOMA	0.0315193	1.1691908259362997
NARP SYNDROME	0.031389972999999995	1.1643935131169836
SHORT SYNDROME	0.03131656	1.1616702988925416
SPINOCEREBELLAR ATAXIA 27; SCA27	0.03126091	1.1596059932301903
SPINOCEREBELLAR ATAXIA 26	0.03126091	1.1596059932301903
SPINOCEREBELLAR ATAXIA TYPE 27	0.03126091	1.1596059932301903
SPINOCEREBELLAR ATAXIA 15	0.03126091	1.1596059932301903
SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI	0.03125	1.1592012928748219
IMMUNODEFICIENCY 62; IMD62	0.03125	1.1592012928748219
IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 4	0.03125	1.1592012928748219
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1	0.03125	1.1592012928748219
SPASTIC PARAPLEGIA AND EVANS SYNDROME	0.03125	1.1592012928748219
RUIJS-AALFS SYNDROME; RJALS	0.03125	1.1592012928748219
ANTIPHOSPHOLIPID SYNDROME, FAMILIAL	0.03125	1.1592012928748219
CERVICAL RIBS, SPRENGEL ANOMALY, ANAL ATRESIA, AND URETHRAL OBSTRUCTION	0.03125	1.1592012928748219
EPILEPSY, IDIOPATHIC GENERALIZED	0.031226909999999997	1.1583447822235422
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.031204629	1.157518280975333
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.031135473	1.1549529777878114
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.031135473	1.1549529777878114
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA WITH LATE-ONSET SPASTICITY	0.03111751	1.1542866503374463
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 3; SCAN3	0.03093796	1.1476263433891047
HUNTINGTON DISEASE-LIKE 3	0.030844418999999998	1.1441564922487268
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.030844418999999998	1.1441564922487268
PROPIONIC ACIDEMIA	0.030820534	1.1432704915165568
TRICHOHEPATOENTERIC SYNDROME 2	0.030807429999999997	1.1427844059568182
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.030802549	1.1426033479884814
14Q12 MICRODELETION SYNDROME	0.030702229	1.1388820336300431
GAUCHER DISEASE TYPE 3	0.03064403	1.1367231742366342
BOHRING-OPITZ SYNDROME	0.030523613	1.1322563728899429
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.030498773	1.1313349469662626
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.030393222999999997	1.1274196286794484
POLYARTERITIS NODOSA, CHILDHOOD-ONSET	0.03035805	1.1261149058930715
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.030315104	1.1245218480139096
NORMAL PRESSURE HYDROCEPHALUS	0.030302999999999997	1.124072856895543
AXONAL POLYNEUROPATHY ASSOCIATED WITH IGG/IGM/IGA MONOCLONAL GAMMOPATHY	0.030302999999999997	1.124072856895543
CARIBBEAN PARKINSONISM	0.030302999999999997	1.124072856895543
POLYRADICULONEUROPATHY ASSOCIATED WITH IGG/IGA/IGM MONOCLONAL GAMMOPATHY WITHOUT KNOWN ANTIBODIES	0.030302999999999997	1.124072856895543
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9B	0.030302999999999997	1.124072856895543
SPINOCEREBELLAR ATAXIA TYPE 29	0.030286473999999997	1.1234598341574296
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.030286473999999997	1.1234598341574296
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.030282339	1.1233064486423563
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.03026316	1.1225950143512828
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.030248913000000002	1.122066529845056
NEONATAL ICHTHYOSIS-SCLEROSING CHOLANGITIS SYNDROME	0.03022254	1.1210882381427523
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.030187440000000003	1.1197862232505955
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.030057663	1.114972217932662
WHIPPLE DISEASE	0.030037899	1.114239083393386
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.030018733	1.1135281313300505
PROTOPORPHYRIA, ERYTHROPOIETIC	0.02989729	1.1090232710865113
OPTIC ATROPHY 11; OPA11	0.029851804	1.1073359933262648
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.029756883	1.1038149518567937
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.029740919999999997	1.1032228132891726
SPINOCEREBELLAR ATAXIA 44; SCA44	0.029740919999999997	1.1032228132891726
ARIMA SYNDROME	0.029738723999999998	1.1031413538959196
HEREDITARY SPHEROCYTOSIS	0.029720439999999997	1.1024631191298742
GALLOWAY-MOWAT SYNDROME	0.029658373000000002	1.1001607784372387
ALG1-CDG	0.029658373000000002	1.1001607784372387
REFRACTORY ANEMIA WITH EXCESS BLASTS	0.02959449	1.0977910742390715
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.029478429000000004	1.0934858562789966
7P22.1 MICRODUPLICATION SYNDROME	0.029477313999999998	1.0934444959768665
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.029470983000000003	1.0932096510685405
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.0294118	1.0910142907448217
MONOMELIC AMYOTROPHY	0.0294118	1.0910142907448217
IMMUNOGLOBULIN D LEVEL IN PLASMA, LOW	0.0294118	1.0910142907448217
IMMUNE SUPPRESSION	0.0294118	1.0910142907448217
RAGWEED SENSITIVITY	0.0294118	1.0910142907448217
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.0294118	1.0910142907448217
SUSCEPTIBILITY TO LYSIS BY ALLOREACTIVE NATURAL KILLER CELLS	0.0294118	1.0910142907448217
SCHISTOSOMA MANSONI INFECTION, SUSCEPTIBILITY/RESISTANCE TO	0.0294118	1.0910142907448217
RADIATION SENSITIVITY OF NATURAL KILLER ACTIVITY	0.0294118	1.0910142907448217
DEFECTIVE INTERFERING PARTICLE INDUCTION, CONTROL OF	0.0294118	1.0910142907448217
GLOBULIN ANOMALY INVOLVING BETA (2A)-GLOBULIN	0.0294118	1.0910142907448217
MYASTHENIA GRAVIS; MG	0.0294118	1.0910142907448217
RHEUMATIC FEVER-RELATED ANTIGENRHEUMATIC FEVER, ACUTE, SUSCEPTIBILITY TO, INCLUDED	0.0294118	1.0910142907448217
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.0294118	1.0910142907448217
ECHO VIRUS 11 SENSITIVITY	0.0294118	1.0910142907448217
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.0294118	1.0910142907448217
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	0.0294118	1.0910142907448217
NIEMANN-PICK DISEASE, TYPE C2	0.029267653	1.085667238304373
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.029267653	1.085667238304373
MENINGIOMA	0.0292549	1.085194172893556
PENTASOMY X	0.029116954	1.0800771430840548
TETRASOMY X	0.029116954	1.0800771430840548
CHARGE SYNDROME	0.029116954	1.0800771430840548
FETAL ALCOHOL SYNDROME	0.029116954	1.0800771430840548
NORRIE DISEASE	0.029112819	1.0799237575689817
DISTAL MONOSOMY 7Q36	0.029112819	1.0799237575689817
SPINOCEREBELLAR ATAXIA TYPE 43	0.02908121	1.078751239371654
MULTIPLE SYSTEM ATROPHY, CEREBELLAR TYPE	0.02908121	1.078751239371654
SPINOCEREBELLAR ATAXIA TYPE 14	0.02908121	1.078751239371654
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.029065510000000003	1.078168856642114
CRI-DU-CHAT SYNDROME	0.028931759999999997	1.0732074751086096
PRADER-WILLI SYNDROME	0.028923969	1.0729184723158804
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.028900869000000003	1.0720615907201876
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.028774954	1.0673908441348328
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.028760809	1.0668661432616258
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.028657173	1.063021823735598
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.028623999999999997	1.0617912898319646
FEBRILE CONVULSIONS, FAMILIAL, 9	0.028623999999999997	1.0617912898319646
ACRODYSOSTOSIS	0.0285714	1.0598401222157978
SCHWARTZ-JAMPEL SYNDROME	0.0285714	1.0598401222157978
HAIR DEFECT-PHOTOSENSITIVITY-INTELLECTUAL DISABILITY SYNDROME	0.0285714	1.0598401222157978
COG7-CDG	0.0285714	1.0598401222157978
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.0285714	1.0598401222157978
GHOSAL HEMATODIAPHYSEAL DYSPLASIA	0.0285714	1.0598401222157978
INTELLECTUAL DISABILITY-POLYDACTYLY-UNCOMBABLE HAIR SYNDROME	0.0285714	1.0598401222157978
SHORT STATURE-DEAFNESS-NEUTROPHIL DYSFUNCTION-DYSMORPHISM SYNDROME	0.0285714	1.0598401222157978
MENDELIAN SUSCEPTIBILITY TO MYCOBACTERIAL DISEASES DUE TO PARTIAL IRF8 DEFICIENCY	0.0285714	1.0598401222157978
ALG12-CDG	0.0285714	1.0598401222157978
CONGENITAL LOBAR EMPHYSEMA	0.0285714	1.0598401222157978
TRIOSE PHOSPHATE-ISOMERASE DEFICIENCY	0.0285714	1.0598401222157978
CHEILITIS GLANDULARIS	0.0285714	1.0598401222157978
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.028454273	1.0554953615812201
SICKLE CELL ANEMIA	0.02824334	1.0476709197793013
RECOMBINANT 8 SYNDROME	0.028113973	1.0428721231823306
CHROMOSOME 16P13.3 DELETION SYNDROME	0.028113973	1.0428721231823306
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.028053713999999997	1.0406368492396953
SPINOCEREBELLAR ATAXIA TYPE 34	0.028033799999999998	1.0398981505342135
PULMONARY ARTERIAL HYPERTENSION	0.02801938	1.0393632486896296
IDIOPATHIC/HERITABLE PULMONARY ARTERIAL HYPERTENSION	0.02801938	1.0393632486896296
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.027847913000000002	1.0330027761108977
SPINOCEREBELLAR ATAXIA TYPE 40	0.02783616	1.0325668051414527
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.02783616	1.0325668051414527
GANGLIOCYTOMA	0.027777800000000002	1.0304019735429832
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.027777800000000002	1.0304019735429832
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.027777800000000002	1.0304019735429832
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.027777800000000002	1.0304019735429832
PERIVENTRICULAR NODULAR HETEROTOPIA	0.027777800000000002	1.0304019735429832
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.027751283	1.029418340241122
CAMPOMELIA, CUMMING TYPE	0.02774008	1.0290027712144316
SPINOCEREBELLAR ATAXIA 23; SCA23	0.02769237	1.0272329954165735
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.027688094	1.027074379585267
HEMORRHAGIC FEVER-RENAL SYNDROME	0.027608459999999998	1.0241204008410494
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.027572554	1.0227884878291467
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.027572554	1.0227884878291467
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.02752642	1.0210771728708912
ALPHA-1-ANTITRYPSIN DEFICIENCY	0.027374939999999997	1.0154581068918613
NIEMANN-PICK DISEASE, TYPE A	0.027249134	1.0107914036006165
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.02720447	1.0091346174711777
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.027193483999999997	1.0087270979382648
MILLER-DIEKER SYNDROME	0.027155459	1.0073165818050949
LEGIONELLOSIS	0.027148459999999996	1.0070569578099322
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IB; CDG1B	0.02706593	1.0039955535635015
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.027039	1.0029966002573538
APNEA, OBSTRUCTIVE SLEEP	0.027027	1.0025514669608897
SPINAL ARTERIOVENOUS METAMERIC SYNDROME	0.027027	1.0025514669608897
LIPOSARCOMA	0.027027	1.0025514669608897
INFANTILE MYOFIBROMATOSIS	0.027027	1.0025514669608897
BARDET-BIEDL SYNDROME 11; BBS11	0.027027	1.0025514669608897
BARDET-BIEDL SYNDROME 12; BBS12	0.027027	1.0025514669608897
WAARDENBURG SYNDROME TYPE 2	0.027027	1.0025514669608897
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.027027	1.0025514669608897
NIPPLES, SUPERNUMERARY	0.027027	1.0025514669608897
BENIGN OCCIPITAL EPILEPSY	0.027027	1.0025514669608897
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.02690476	0.9980170424475773
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.026896723	0.9977189144222706
FAMILIAL MEDITERRANEAN FEVER	0.026857219	0.9962535356103114
NEONATAL LUPUS ERYTHEMATOSUS	0.02676094	0.992682119889457
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.026752413000000003	0.9923658155878781
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.026752413000000003	0.9923658155878781
SSR4-CDG	0.026752413000000003	0.9923658155878781
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.0267523	0.992361623916003
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.026678254000000002	0.9896149289101723
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.026678254000000002	0.9896149289101723
FAMILIAL CHYLOMICRONEMIA SYNDROME	0.02665715	0.9888320878194576
PEHO-LIKE SYNDROME; PEHOL	0.026566684	0.9854763020862989
OCULOCEREBRORENAL SYNDROME OF LOWE	0.026547409	0.9847613067288538
SPHEROCYTOSIS, TYPE 1; SPH1	0.02653976	0.9844775713467993
HEMOGLOBIN--BETA LOCUS	0.02653976	0.9844775713467993
GLYCOGEN STORAGE DISEASE VII	0.02653976	0.9844775713467993
ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE II	0.02653976	0.9844775713467993
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 5	0.026501069999999998	0.9830423874101167
FIBRONECTIN GLOMERULOPATHY	0.0263158	0.9761699002571276
LIPEDEMA	0.0263158	0.9761699002571276
MALIGNANT PERITONEAL MESOTHELIOMA	0.0263158	0.9761699002571276
DISTICHIASIS WITH CONGENITAL ANOMALIES OF THE HEART AND PERIPHERAL	0.0263158	0.9761699002571276
HUGHES-STOVIN SYNDROME	0.0263158	0.9761699002571276
OSTEOSCLEROSIS-ICHTHYOSIS-PREMATURE OVARIAN FAILURE SYNDROME	0.0263158	0.9761699002571276
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.0263158	0.9761699002571276
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.026285143	0.9750326959679861
OCCIPITAL HORN SYNDROME	0.026216913999999997	0.9725017793276164
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.026212779	0.9723483938125431
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.026210994	0.9722821802346944
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.026205674	0.9720848378065953
SPINOCEREBELLAR ATAXIA TYPE 19/22	0.026132700000000002	0.9693779080419154
SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY; SPAX8	0.026132700000000002	0.9693779080419154
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO GRID2 DEFICIENCY	0.026132700000000002	0.9693779080419154
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 16; SCAR16	0.026132700000000002	0.9693779080419154
AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY	0.026021600000000002	0.9652567156054868
PLIN1-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.02601249	0.9649187852445877
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.02586209	0.95933978126224
WRINKLY SKIN SYNDROME	0.025849413999999998	0.9588695721234084
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.0257534	0.9553079864295178
20Q11.2 MICRODUPLICATION SYNDROME	0.025719033	0.9540331617628866
SPASTIC PARAPLEGIA 63, AUTOSOMAL RECESSIVE; SPG63	0.02566544	0.9520451593664374
22Q11.2 DELETION SYNDROME	0.025642263000000002	0.9511854214987587
PEROXISOME BIOGENESIS DISORDER 10B	0.025545554	0.9475980551681144
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.025545554	0.9475980551681144
ACUTE BILIRUBIN ENCEPHALOPATHY	0.025541419000000003	0.9474446696530412
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.025541419000000003	0.9474446696530412
MENKES DISEASE	0.025541419000000003	0.9474446696530412
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.025484009999999998	0.9453151148683163
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.025252363	0.936722298807818
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.025173479	0.9337961408946296
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.02516056	0.9333169178065447
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.025158263999999996	0.9332317489691546
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.025117589999999995	0.9317229696607899
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.025029288999999996	0.9284474933932017
CRIGLER-NAJJAR SYNDROME TYPE 2	0.025	0.9273610342998574
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY	0.025	0.9273610342998574
GALACTOKINASE DEFICIENCY	0.025	0.9273610342998574
FARBER DISEASE	0.024976434	0.9264868666944849
MIXED CONNECTIVE TISSUE DISEASE	0.024972299	0.9263334811794118
POLYCYTHEMIA VERA	0.02495938	0.9258542580913268
PORTAL HYPERTENSION, NONCIRRHOTIC	0.02495938	0.9258542580913268
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.024900429	0.9236675036780067
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.02489935	0.9236274787757662
CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS 2	0.0247329	0.9174531090093977
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.024730214	0.9173534733398726
PORPHYRIA, CONGENITAL ERYTHROPOIETIC; CEP	0.02455529	0.9108647652773179
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.02446241	0.907419433562687
PACHYDERMOPERIOSTOSIS	0.02443088	0.9062498458262279
OSTEOMYELITIS, STERILE MULTIFOCAL, WITH PERIOSTITIS AND PUSTULOSIS; OMPP	0.02443088	0.9062498458262279
CRANIOFACIOFRONTODIGITAL SYNDROME	0.02443088	0.9062498458262279
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.02443088	0.9062498458262279
JUVENILE IDIOPATHIC ARTHRITIS	0.02443088	0.9062498458262279
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.024417963999999997	0.9057707340214672
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.024417963999999997	0.9057707340214672
CHRONIC GRAFT VERSUS HOST DISEASE	0.024329769999999997	0.9024992268591054
DIGEORGE SYNDROME; DGS	0.024268333	0.9002202556645343
RHOMBENCEPHALOSYNAPSIS	0.024204399999999997	0.8978486967442986
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN BRANCHING ENZYME DEFICIENCY	0.02419608	0.8975400709920837
AA AMYLOIDOSIS	0.02392578	0.8875134434892338
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.023814273	0.8833771536151667
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.023814273	0.8833771536151667
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.023814273	0.8833771536151667
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.023801354	0.882897930527082
HEMIDYSTONIA-HEMIATROPHY SYNDROME	0.023797219	0.8827445450120087
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.023797219	0.8827445450120087
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.023794922999999996	0.8826593761746184
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.023794922999999996	0.8826593761746184
SPINOCEREBELLAR ATAXIA 46; SCA46	0.023755360000000003	0.8811918087906184
FRIEDREICH ATAXIA	0.023755360000000003	0.8811918087906184
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	0.023755360000000003	0.8811918087906184
X-LINKED AGAMMAGLOBULINEMIA	0.02368689	0.8786519523898778
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2	0.023666589999999998	0.8778989352300265
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.023666589999999998	0.8778989352300265
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1	0.023666589999999998	0.8778989352300265
INTERSTITIAL LUNG AND LIVER DISEASE; ILLD	0.023666589999999998	0.8778989352300265
LARYNGEAL ABDUCTOR PARALYSIS WITH CEREBELLAR ATAXIA AND MOTOR NEUROPATHY	0.023611959999999998	0.8758724658978744
SPINOCEREBELLAR ATAXIA 14	0.023611959999999998	0.8758724658978744
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.02354609	0.8734290550447011
CARDIAC VALVULAR DEFECT, DEVELOPMENTAL; CVDD	0.02354609	0.8734290550447011
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21	0.02349849	0.8716633596353942
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.023459443000000003	0.870214932983142
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.023444749999999997	0.8696699043560632
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.023272854	0.8632935182619829
FETAL HYDANTOIN SYNDROME	0.023272854	0.8632935182619829
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.023272854	0.8632935182619829
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.023268719	0.8631401327469097
HYPOADRENOCORTICISM, FAMILIAL	0.023268719	0.8631401327469097
FAMILIAL CALCIUM PYROPHOSPHATE DEPOSITION	0.023268719	0.8631401327469097
COWDEN SYNDROME 6; CWS6	0.023268719	0.8631401327469097
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.023268719	0.8631401327469097
COWDEN SYNDROME 5; CWS5	0.023268719	0.8631401327469097
FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW	0.0232558	0.862660909658825
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 63	0.0232558	0.862660909658825
NODULAR REGENERATIVE HYPERPLASIA OF THE LIVER	0.0232558	0.862660909658825
DELAYED ENCEPHALOPATHY DUE TO CARBON MONOXIDE POISONING	0.0232558	0.862660909658825
CYSTINOSIS	0.0232558	0.862660909658825
WILLIAMS-BEUREN SYNDROME; WBS	0.0232558	0.862660909658825
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.023253503999999998	0.8625757408214347
SPINOCEREBELLAR ATAXIA TYPE 7	0.023253503999999998	0.8625757408214347
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3; CGL3	0.02309757	0.8567914562005343
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 22	0.023073089999999997	0.8558833842757476
ISOLATED COMPLEX I DEFICIENCY	0.022957033999999998	0.8515783517878797
TRISOMY 13	0.022874228999999996	0.8485067465700715
%113950 BUNDLE BRANCH BLOCK, FAMILIAL ISOLATED COMPLETE RIGHT	0.0227273	0.8430564973937259
OSTEOSARCOMA	0.0227273	0.8430564973937259
PARIS-TROUSSEAU THROMBOCYTOPENIA	0.0227273	0.8430564973937259
FACIOSCAPULOHUMERAL DYSTROPHY	0.0227273	0.8430564973937259
CRANIO-OSTEOARTHROPATHY	0.0227273	0.8430564973937259
REACTIVE ARTHRITIS	0.0227273	0.8430564973937259
LARSEN SYNDROME	0.0227273	0.8430564973937259
ACRORENAL-MANDIBULAR SYNDROME	0.0227273	0.8430564973937259
SIRENOMELIA	0.0227273	0.8430564973937259
FAMILIAL AFIBRINOGENEMIA	0.0227273	0.8430564973937259
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.0227273	0.8430564973937259
127820 DYSPLASIA EPIPHYSEALIS HEMIMELICA WITH CHONDROMAS AND OSTEOCHONDROMAS;;OSTEOCHONDROMATOSIS, DOMINANT CARPOTARSAL	0.0227273	0.8430564973937259
HEMOPHILIA A	0.0227273	0.8430564973937259
PREPAPILLARY VASCULAR LOOPS	0.0227273	0.8430564973937259
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.0227273	0.8430564973937259
AUTOINFLAMMATION, PANNICULITIS, AND DERMATOSIS SYNDROME; AIPDS	0.0227273	0.8430564973937259
MUSCULAR HYPERTONIA, LETHAL	0.0227273	0.8430564973937259
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	0.0227273	0.8430564973937259
ATROPHODERMA VERMICULATA; AVA	0.0227273	0.8430564973937259
RHEUMATOID FACTOR-NEGATIVE JUVENILE IDIOPATHIC ARTHRITIS	0.0227273	0.8430564973937259
THYMIC TUMOR	0.0227273	0.8430564973937259
CONGENITAL ATRANSFERRINEMIA	0.0227273	0.8430564973937259
OLIGOARTICULAR JUVENILE IDIOPATHIC ARTHRITIS	0.0227273	0.8430564973937259
OSTEOCHONDRITIS DISSECANS	0.0227273	0.8430564973937259
BLEPHAROPTOSIS-MYOPIA-ECTOPIA LENTIS SYNDROME	0.0227273	0.8430564973937259
GLYCOGEN STORAGE DISEASE DUE TO MUSCLE GLYCOGEN PHOSPHORYLASE DEFICIENCY	0.0227273	0.8430564973937259
GAPO SYNDROME	0.0227273	0.8430564973937259
SINDING-LARSEN-JOHANSSON DISEASE	0.0227273	0.8430564973937259
ENTHESITIS-RELATED JUVENILE IDIOPATHIC ARTHRITIS	0.0227273	0.8430564973937259
RHEUMATOID FACTOR-POSITIVE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS	0.0227273	0.8430564973937259
LYME DISEASE	0.0227273	0.8430564973937259
FATCO SYNDROME	0.0227273	0.8430564973937259
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.0227273	0.8430564973937259
ACUTE RESPIRATORY CORONAVIRUS INFECTION	0.0227273	0.8430564973937259
BETHLEM MYOPATHY 1	0.0227273	0.8430564973937259
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.0227273	0.8430564973937259
SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	0.0227273	0.8430564973937259
ARTERIES, ANOMALIES OF	0.0227273	0.8430564973937259
POPLITEAL CYST	0.0227273	0.8430564973937259
MACS SYNDROME	0.0227273	0.8430564973937259
HEMANGIOPERICYTOMA, MALIGNANT	0.0227273	0.8430564973937259
JUVENILE DERMATOMYOSITIS	0.0227273	0.8430564973937259
HYPERTRICHOSIS-ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0227273	0.8430564973937259
THYMIC CARCINOMA	0.0227273	0.8430564973937259
SILVER-RUSSELL SYNDROME	0.0227273	0.8430564973937259
VENULAR INSUFFICIENCY, SYSTEMIC	0.0227273	0.8430564973937259
NAIL-PATELLA SYNDROME	0.0227273	0.8430564973937259
WATSON SYNDROME	0.0227273	0.8430564973937259
THUMB DEFORMITY	0.0227273	0.8430564973937259
ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD	0.0227273	0.8430564973937259
ALKAPTONURIA	0.0227273	0.8430564973937259
SEVERE HEMOPHILIA A	0.0227273	0.8430564973937259
ATAXIA WITH VITAMIN E DEFICIENCY	0.022707949999999998	0.8423387199531778
SPINOCEREBELLAR ATAXIA 40; SCA40	0.022707949999999998	0.8423387199531778
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.022578604	0.8375407023394758
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.022513204	0.8351147258737474
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.022513204	0.8351147258737474
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.022440573000000002	0.8324205195024583
BEHÇET DISEASE	0.022426718999999998	0.8319066131116903
XQ21 MICRODELETION SYNDROME	0.022344183	0.8288449862986116
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.022325933	0.8281680127435727
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.022324224	0.8281046183432679
HYPOHIDROSIS-ENAMEL HYPOPLASIA-PALMOPLANTAR KERATODERMA-INTELLECTUAL DISABILITY SYNDROME	0.022312959999999996	0.8276867865556536
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.022289904000000003	0.8268315371153813
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.022245459	0.8251828746686029
SECONDARY SHORT BOWEL SYNDROME	0.0222222	0.8243200950567316
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.022181858999999998	0.822823668197344
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.022163769	0.8221526297529246
PLEURAL MESOTHELIOMA	0.022111779999999998	0.8202241268404359
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.021899154	0.8123368841492744
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.021895019	0.8121834986342013
CRIMEAN-CONGO HEMORRHAGIC FEVER	0.02180921	0.8090004617145116
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.021794873	0.8084686387085614
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.021794873	0.8084686387085614
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.021794873	0.8084686387085614
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.021794873	0.8084686387085614
PITT-HOPKINS SYNDROME	0.021759883	0.8071707042049554
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.021750423	0.8068197907895763
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.021681113999999998	0.8042488121525246
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.02164498	0.8029084416079891
LEUKOENCEPHALOPATHY-SPONDYLOMETAPHYSEAL DYSPLASIA SYNDROME	0.02164044	0.8027400328441603
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.02151033	0.7979136750772501
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.021399183999999998	0.7937907762965183
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.021299114	0.790078735548423
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.021286404	0.7896072651985848
MYOTONIC DYSTROPHY 1	0.0212766	0.7892435912953738
PANCREATIC COLIPASE DEFICIENCY	0.0212766	0.7892435912953738
SPORADIC ADULT-ONSET ATAXIA OF UNKNOWN ETIOLOGY	0.02125721	0.7885243300771708
EARLY-ONSET X-LINKED OPTIC ATROPHY	0.02125721	0.7885243300771708
ATAXIA-TELANGIECTASIA-LIKE DISORDER 1; ATLD1	0.02125721	0.7885243300771708
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.021249319	0.7882316178403045
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.021209004	0.7867361554363924
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.021209004	0.7867361554363924
INTELLECTUAL DISABILITY-MUSCLE WEAKNESS-SHORT STATURE-FACIAL DYSMORPHISM SYNDROME	0.021135559999999998	0.7840117912842677
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.02102928	0.7800693940552522
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.02102928	0.7800693940552522
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.02102928	0.7800693940552522
GRANULOMAS, CONGENITAL CEREBRAL	0.02102928	0.7800693940552522
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.02102928	0.7800693940552522
SEVERE COMBINED IMMUNODEFICIENCY DUE TO COMPLETE RAG1/2 DEFICIENCY	0.02095204	0.7772042194036795
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.020949619	0.7771144137611178
MALIGNANT ATROPHIC PAPULOSIS	0.020949619	0.7771144137611178
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.020949619	0.7771144137611178
MYASTHENIA GRAVIS	0.020949619	0.7771144137611178
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.020848833	0.773375813393
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.020740849999999998	0.7693702443303277
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.020740849999999998	0.7693702443303277
LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	0.020707899999999998	0.7681479824871206
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.020647653000000002	0.7659131536777822
LETTERER-SIWE DISEASE	0.020590050000000002	0.7637764025714312
FETAL GAUCHER DISEASE	0.020449089	0.7585475330211935
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.020421173	0.7575120045958529
ADENOCARCINOMA OF OVARY	0.020408199999999998	0.7570307784079339
HEPATITIS B VACCINE, RESPONSE TO	0.020408199999999998	0.7570307784079339
PANCREATITIS, HEREDITARY	0.020408199999999998	0.7570307784079339
%602248 MALIGNANT ATROPHIC PAPULOSIS;;DEGOS DISEASE;;PAPULOSIS, MALIGNANT ATROPHIC	0.020408199999999998	0.7570307784079339
LICHEN PLANOPILARIS	0.020408199999999998	0.7570307784079339
OVARIAN FIBROTHECOMA	0.020408199999999998	0.7570307784079339
MULTIPLE MYELOMA	0.020408199999999998	0.7570307784079339
OVARIAN FIBROMA	0.020408199999999998	0.7570307784079339
PRIMARY EFFUSION LYMPHOMA	0.020408199999999998	0.7570307784079339
RELAPSING POLYCHONDRITIS	0.020408199999999998	0.7570307784079339
NOONAN SYNDROME 8; NS8	0.020408199999999998	0.7570307784079339
AUTOSOMAL AGAMMAGLOBULINEMIA	0.020408199999999998	0.7570307784079339
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.020317773	0.7536764393579887
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.020307414	0.7532921780398162
GABRIELE-DE VRIES SYNDROME; GADEVS	0.020307414	0.7532921780398162
HEMOGLOBIN--ALPHA LOCUS 1; HBA1	0.020188559999999998	0.7488833553049891
AMISH LETHAL MICROCEPHALY	0.02009025	0.7452366007737083
COFFIN-LOWRY SYNDROME	0.019997029	0.7417786198545697
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.019997029	0.7417786198545697
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.01999064	0.741541623468644
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1	0.01994539	0.7398630999965613
DIFFUSE NEONATAL HEMANGIOMATOSIS	0.01990767	0.7384638976680096
RIDDLE SYNDROME	0.019879754	0.7374283692426691
PEROXISOME BIOGENESIS DISORDER 6B	0.019879754	0.7374283692426691
MEGALENCEPHALY WITH DYSMYELINATION	0.019875619	0.7372749837275959
OCULODENTODIGITAL DYSPLASIA; ODDD	0.019875619	0.7372749837275959
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.019776354	0.7335928040048049
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.019772219	0.7334394184897317
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.019772219	0.7334394184897317
RETT SYNDROME; RTT	0.019754129	0.7327683800453123
PPARG-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.01974502	0.7324304867788547
ACQUIRED GENERALIZED LIPODYSTROPHY	0.01974502	0.7324304867788547
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.019622589000000003	0.7278889772272402
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.019425544000000003	0.7205797030270956
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.019392523999999998	0.7193548445729921
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.0193342	0.717191348374412
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.019334014	0.7171844488083169
LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY	0.0192308	0.7133557831365479
ANGIOPATHY, HEREDITARY, WITH NEPHROPATHY, ANEURYSMS, AND MUSCLE CRAMPS	0.0192308	0.7133557831365479
UROCANIC ACIDURIA	0.01921271	0.7126847446921285
MARINESCO-SJOGREN SYNDROME; MSS	0.019199064000000002	0.7121785539451664
FREE SIALIC ACID STORAGE DISEASE	0.019193052999999998	0.7119555792580792
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.019120732999999997	0.7092729092580564
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO WWOX DEFICIENCY	0.01908117	0.7078053418740565
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.019076074	0.7076163086008247
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.01894498	0.7027534499036044
LISSENCEPHALY 1; LIS1	0.018944073000000002	0.7027198052452802
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.018927923	0.7021207300171224
MYCOPHENOLATE MOFETIL EMBRYOPATHY	0.01886241	0.699690561879519
HAREL-YOON SYNDROME; HAYOS	0.018852814	0.6993346036201132
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.01882681	0.6983699997666759
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.018823390000000002	0.6982431367771837
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.018700273	0.6936761804387879
JOUBERT SYNDROME 1	0.018689354	0.693271146233447
21Q22.11Q22.12 MICRODELETION SYNDROME	0.018661029000000003	0.6922204461815854
SPINOCEREBELLAR ATAXIA 31	0.01865351	0.6919415330769093
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.018567064	0.688734866998066
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.018558553999999998	0.6884191933019901
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.018558553999999998	0.6884191933019901
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.01853655	0.6876029672140408
SPINOCEREBELLAR ATAXIA 7 OPCA III OPCA WITH RETINAL DEGENERATION OPCA WITH MACULAR DEGENERATION AND EXTERNAL OPHTHALMOPLEGIA AUTOSOMAL DOMINANT CEREBELLAR ATAXIA, TYPE II ADCA, TYPE II	0.01848375	0.6856443807095995
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.018402654	0.6826361698920963
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.018402654	0.6826361698920963
MERCURY POISONING	0.018398519000000002	0.6824827843770231
CHROMOSOME 18Q DELETION SYNDROME	0.018398519000000002	0.6824827843770231
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.01837028	0.6814352744471193
PERMANENT NEONATAL DIABETES MELLITUS	0.018324164	0.6797246271888084
SPINOCEREBELLAR ATAXIA TYPE 13	0.018263383	0.6774699899477773
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.018108773	0.6717348183672532
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.018042483	0.6692758278487038
PRIMARY LIPODYSTROPHY	0.01804144	0.6692371383463527
MOEBIUS SYNDROME; MBS	0.018033759999999996	0.6689522530366157
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.018032034	0.6688882280308077
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.01800509	0.6678887554024808
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.01794616	0.6657027799724291
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.017945994	0.6656966222951614
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.017945994	0.6656966222951614
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.017945994	0.6656966222951614
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5	0.0178571	0.6623991490238393
NEPHROPATHIC INFANTILE CYSTINOSIS	0.0178571	0.6623991490238393
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 64	0.0178571	0.6623991490238393
SPASTIC PARAPLEGIA TYPE 7	0.0178571	0.6623991490238393
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.0178571	0.6623991490238393
PROGRESSIVE NON-FLUENT APHASIA	0.0178571	0.6623991490238393
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.0178571	0.6623991490238393
19P13.3 MICRODUPLICATION SYNDROME	0.017740653999999998	0.658079649703836
INFANTILE SIALIC ACID STORAGE DISEASE	0.017715953	0.6571633799075064
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.017535013	0.6504515116856577
PYRIDOXINE-DEPENDENT EPILEPSY	0.017531314	0.6503142993470228
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.017449573000000003	0.6472821626148347
RETICULOENDOTHELIOSIS, X-LINKED	0.01731136	0.6421552285894871
HYPERLIPOPROTEINEMIA, TYPE I	0.01731136	0.6421552285894871
ADRENOMYODYSTROPHY	0.017294618999999997	0.6415342305464785
GABRIELE-DE VRIES SYNDROME	0.017250559999999998	0.6398998865540698
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.6395601014711025
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.6395601014711025
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	0.6395601014711025
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.6395601014711025
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.6395601014711025
PALMOMENTAL REFLEX	0.0172414	0.6395601014711025
CERVICAL RIB	0.0172414	0.6395601014711025
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.6395601014711025
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.6395601014711025
JUMPING FRENCHMAN OF MAINE	0.0172414	0.6395601014711025
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.6395601014711025
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.6395601014711025
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.6395601014711025
ERYTHERMALGIA, PRIMARY	0.0172414	0.6395601014711025
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.6395601014711025
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.6395601014711025
MOSAIC TRISOMY 15	0.0172414	0.6395601014711025
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	0.6395601014711025
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.6395601014711025
THUMBS, CONGENITAL CLASPED	0.0172414	0.6395601014711025
CARDIAC ARRHYTHMIA	0.0172414	0.6395601014711025
269800 SENILE PLAQUE FORMATION	0.0172414	0.6395601014711025
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.6395601014711025
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.6395601014711025
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.6395601014711025
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.6395601014711025
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.6395601014711025
DIASTEMATOMYELIA	0.0172414	0.6395601014711025
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	0.6395601014711025
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.6395601014711025
MOTION SICKNESS	0.0172414	0.6395601014711025
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.6395601014711025
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.6395601014711025
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.6395601014711025
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	0.6395601014711025
MYOPATHY, CONGENITAL	0.0172414	0.6395601014711025
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.6395601014711025
ALCOHOL DEPENDENCE	0.0172414	0.6395601014711025
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	0.6395601014711025
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.6395601014711025
NEPHRONOPHTHISIS 11; NPHP11	0.017212254	0.6384789468828742
FADD-RELATED IMMUNODEFICIENCY	0.017208119	0.6383255613678012
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.017195099999999998	0.637842628835579
SPINOCEREBELLAR ATAXIA 20	0.017176410000000003	0.6371493337263366
SPINOCEREBELLAR ATAXIA TYPE 28	0.017176410000000003	0.6371493337263366
SPINOCEREBELLAR ATAXIA 38; SCA38	0.017176410000000003	0.6371493337263366
SPINOCEREBELLAR ATAXIA 43; SCA43	0.017176410000000003	0.6371493337263366
SPINOCEREBELLAR ATAXIA 45; SCA45	0.017176410000000003	0.6371493337263366
CEREBELLAR ATAXIA, NEUROPATHY, AND VESTIBULAR AREFLEXIA SYNDROME; CANVAS	0.017176410000000003	0.6371493337263366
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 76	0.017176410000000003	0.6371493337263366
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 24; SCAR24	0.017176410000000003	0.6371493337263366
SPINOCEREBELLAR ATAXIA TYPE 8	0.017176410000000003	0.6371493337263366
SPINOCEREBELLAR ATAXIA TYPE 30	0.017176410000000003	0.6371493337263366
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.017168064	0.6368397435186458
6Q TERMINAL DELETION SYNDROME	0.017108533	0.6346314743293296
JOUBERT SYNDROME 31; JBTS31	0.017039694	0.632077930079723
SPINOCEREBELLAR ATAXIA TYPE 21	0.017033009999999998	0.6318299908335925
SPINOCEREBELLAR ATAXIA TYPE 6	0.017033009999999998	0.6318299908335925
SPINOCEREBELLAR ATAXIA TYPE 25	0.017033009999999998	0.6318299908335925
MULTIPLE SYSTEM ATROPHY, PARKINSONIAN TYPE	0.017033009999999998	0.6318299908335925
AUTOSOMAL RECESSIVE SPINOCEREBELLAR ATAXIA-BLINDNESS-DEAFNESS SYNDROME	0.017033009999999998	0.6318299908335925
MULTIPLE SYSTEM ATROPHY	0.017033009999999998	0.6318299908335925
ARNOLD-CHIARI MALFORMATION TYPE I	0.017033009999999998	0.6318299908335925
OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4; OPTB4	0.017030470000000002	0.6317357709525078
TRANSIENT NEONATAL DIABETES MELLITUS	0.016847064000000002	0.6249324278382358
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.016837784	0.6245881914223037
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.016745793	0.6211758366660525
JABERI-ELAHI SYNDROME; JABELS	0.016731143	0.6206324030999527
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.016710309	0.6198595775084086
BARDET-BIEDL SYNDROME	0.0166667	0.6182419260146172
PORPHYRIA CUTANEA TARDA, TYPE I	0.0166667	0.6182419260146172
AYMÉ-GRIPP SYNDROME	0.016653794	0.6177631851542704
HB BART'S HYDROPS FETALIS	0.016628979999999998	0.6168427236860656
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.016628979999999998	0.6168427236860656
KLIPPEL-TRÉNAUNAY SYNDROME	0.016628979999999998	0.6168427236860656
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.016600113	0.6157719184469803
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.016562979	0.6143944534610727
ACROCALLOSAL SYNDROME; ACLS	0.016526629	0.6130460705172007
RAYNAUD-CLAES SYNDROME; MRXSRC	0.016488272999999998	0.6116232761239364
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.01647927	0.6112893148682644
MYOCLONIC-ATONIC EPILEPSY	0.016402499999999997	0.6084415746041363
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.016402499999999997	0.6084415746041363
PREECLAMPSIA/ECLAMPSIA 1	0.016362369	0.606952937577437
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.016302693	0.6047392896941218
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.016301509999999998	0.6046954069699786
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.016301509999999998	0.6046954069699786
CHÉDIAK-HIGASHI SYNDROME	0.016167033	0.599707057777597
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.016148913999999997	0.5990349435943777
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.016148913999999997	0.5990349435943777
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.016135082999999998	0.5985218903757618
AUTOSOMAL DOMINANT STRIATAL NEURODEGENERATION	0.016128999999999998	0.5982962448888959
CEREBRAL PALSY, ATAXIC, AUTOSOMAL RECESSIVE	0.016128999999999998	0.5982962448888959
OPTIC ATROPHY 2	0.016128999999999998	0.5982962448888959
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 27	0.016128999999999998	0.5982962448888959
PRIMARY DYSTONIA, DYT4 TYPE	0.016128999999999998	0.5982962448888959
DEAFNESS-LYMPHEDEMA-LEUKEMIA SYNDROME	0.01609337	0.5969745699428118
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.016090254000000002	0.5968589836634968
INFANTILE LIVER FAILURE SYNDROME 1	0.016057913	0.595659312335085
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.015976864	0.5926528449563263
HYPERPROLINEMIA, TYPE I	0.015963132999999997	0.5921435011818473
DUBOWITZ SYNDROME	0.015868309	0.5886260578731894
THANATOPHORIC DYSPLASIA, GLASGOW VARIANT	0.015836080000000002	0.5874305411222115
REYNOLDS SYNDROME	0.015662389999999998	0.5809876076003097
CHOLESTERYL ESTER STORAGE DISEASE	0.015662389999999998	0.5809876076003097
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.015603359999999998	0.5787979227261209
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.015603359999999998	0.5787979227261209
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.015593664	0.5784382550225781
HEART AND BRAIN MALFORMATION SYNDROME	0.015544813000000001	0.5766261544671147
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.015536353999999999	0.576312372587549
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.015536353999999999	0.576312372587549
ADENYLOSUCCINASE DEFICIENCY	0.015527353	0.5759784855207598
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.015512359	0.575422291466828
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.015512359	0.575422291466828
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.015470953999999999	0.5738863961218206
MENTAL RETARDATION, X-LINKED 41	0.015470953999999999	0.5738863961218206
DESMOSTEROLOSIS	0.01543131	0.5724158240880693
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.015421714	0.5720598658286636
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.015332068999999999	0.5687345346318712
TANGIER DISEASE	0.015326890000000003	0.5685424225200058
CONGENITAL TOXOPLASMOSIS	0.015253973	0.565837607138484
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.015218924	0.5645374840628369
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.015203773	0.5639754661816098
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.015203773	0.5639754661816098
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.015175699999999999	0.5629341139289737
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.015171473	0.5627773157252944
N-ACETYLASPARTATE DEFICIENCY; NACED	0.015171473	0.5627773157252944
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.015110353	0.560510103468638
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.01508902	0.5597187677508494
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.015051078999999998	0.5583113675507545
AL-GAZALI-BAKALINOVA SYNDROME; AGBK	0.01504811	0.558201234154321
SMITH-MAGENIS SYNDROME	0.015039933000000002	0.5578979129072223
FG SYNDROME TYPE 1	0.015039933000000002	0.5578979129072223
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.015039933000000002	0.5578979129072223
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.014990799999999999	0.556075351719292
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.014970939999999999	0.5553386561136442
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.014970939999999999	0.5553386561136442
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.014970939999999999	0.5553386561136442
PHOCOMELIA, SCHINZEL TYPE	0.014925399999999998	0.5536493752535636
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.014925399999999998	0.5536493752535636
ACHONDROGENESIS TYPE 1A	0.014925399999999998	0.5536493752535636
ACHONDROGENESIS TYPE 1B	0.014925399999999998	0.5536493752535636
BOOMERANG DYSPLASIA	0.014925399999999998	0.5536493752535636
ACHONDROGENESIS TYPE 2	0.014925399999999998	0.5536493752535636
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC 27; CMH27	0.014925399999999998	0.5536493752535636
FRASER SYNDROME 3; FRASRS3	0.014925399999999998	0.5536493752535636
PLATYSPONDYLIC DYSPLASIA, TORRANCE TYPE	0.014925399999999998	0.5536493752535636
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.014925399999999998	0.5536493752535636
ULNAR AGENESIS AND ENDOCARDIAL FIBROELASTOSIS	0.014925399999999998	0.5536493752535636
FIBROCHONDROGENESIS 1; FBCG1	0.014925399999999998	0.5536493752535636
BLOMSTRAND LETHAL CHONDRODYSPLASIA	0.014925399999999998	0.5536493752535636
INDOMETHACIN EMBRYOFETOPATHY	0.014925399999999998	0.5536493752535636
ACHONDROGENESIS	0.014925399999999998	0.5536493752535636
UMBILICAL CORD ULCERATION-INTESTINAL ATRESIA SYNDROME	0.014925399999999998	0.5536493752535636
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.014925399999999998	0.5536493752535636
LETHAL CONGENITAL CONTRACTURE SYNDROME 10; LCCS10	0.014925399999999998	0.5536493752535636
19P13.12 MICRODELETION SYNDROME	0.014747163	0.5470377733067435
PEDIATRIC-ONSET GRAVES DISEASE	0.014712554	0.5457539717853
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.014698893000000001	0.5452472246217174
ANGELMAN SYNDROME (TYPE 1)	0.014625919	0.5425402948570375
ANGELMAN SYNDROME (TYPE 2)	0.014625919	0.5425402948570375
JOUBERT SYNDROME	0.014612273000000002	0.5420341041100752
PYRUVATE DEHYDROGENASE DEFICIENCY	0.014612273000000002	0.5420341041100752
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.014612273000000002	0.5420341041100752
OROFACIODIGITAL SYNDROME TYPE 6	0.014612273000000002	0.5420341041100752
9Q21.13 MICRODELETION SYNDROME	0.014494379000000002	0.5376608920389654
ROIFMAN SYNDROME	0.014457840000000001	0.5363054982456741
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.01444966	0.536002065715251
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.01444966	0.536002065715251
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.014449493999999998	0.5359959080379834
RETINITIS PIGMENTOSA 71; RP71	0.014447020000000001	0.535904136390029
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.014354333	0.532465963902583
HEMOCHROMATOSIS, TYPE 2B	0.014320799999999998	0.5312220760000559
HYPERMANGANESEMIA WITH DYSTONIA 1; HMNDYT1	0.014320799999999998	0.5312220760000559
HURLER SYNDROME	0.014297334000000002	0.5303516178388207
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.014244153999999998	0.528378935446658
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.014232973000000001	0.5279641824976777
DYSKERATOSIS CONGENITA	0.014223474	0.5276118223990852
HUNTINGTON DISEASE-LIKE 1	0.014153339000000001	0.5250102037534604
ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD	0.0140845	0.5224566595038537
EPISODIC ATAXIA TYPE 5	0.0140845	0.5224566595038537
BRANCHIAL MYOCLONUS WITH SPASTIC PARAPARESIS AND CEREBELLAR ATAXIA	0.0140845	0.5224566595038537
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.014066719000000002	0.5217970832418183
SPONTANEOUS PERIODIC HYPOTHERMIA	0.014066719000000002	0.5217970832418183
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.014022063	0.5201405938679105
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.013996993999999999	0.5192106733171559
BANGSTAD SYNDROME	0.013923318999999998	0.5164777403490741
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.013903939999999998	0.5157588871697263
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.013903939999999998	0.5157588871697263
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.013901653	0.5156740521823087
PIERPONT SYNDROME	0.013895643	0.5154511145896629
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.013854968999999998	0.5139423352812983
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.013854968999999998	0.5139423352812983
MONOSOMY 13Q34	0.013828354000000001	0.5129550667241829
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.013812913999999999	0.5123823285493991
SPINOCEREBELLAR ATAXIA TYPE 3	0.013809559999999999	0.5122579137930375
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.013808779	0.5122289430343261
4Q21 MICRODELETION SYNDROME	0.013790599	0.5115545660901831
MÜLLERIAN DERIVATIVES-LYMPHANGIECTASIA-POLYDACTYLY SYNDROME	0.013751780000000002	0.5101145969705637
PERLMAN SYNDROME	0.013743433999999999	0.509805006762873
MENTAL RETARDATION, X-LINKED 77	0.013698599999999998	0.508141914578401
EPILEPSY, HOT WATER, 1	0.013698599999999998	0.508141914578401
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.013698599999999998	0.508141914578401
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.013698599999999998	0.508141914578401
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.013698599999999998	0.508141914578401
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.013698599999999998	0.508141914578401
SEA-BLUE HISTIOCYTOSIS	0.01360296	0.5045942022055836
PONTINE TEGMENTAL CAP DYSPLASIA	0.013572062999999999	0.5034480952505129
MONOSOMY 18P	0.013561414	0.5030530765443426
ICHTHYOSIS, HEPATOSPLENOMEGALY, AND CEREBELLAR DEGENERATION	0.013525300000000002	0.5017134478886345
SANDHOFF DISEASE	0.013525300000000002	0.5017134478886345
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.013516954	0.5014038576809438
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.013516954	0.5014038576809438
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.013516954	0.5014038576809438
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.013493944	0.5005503145849741
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.013480529000000002	0.5000526926539689
1Q44 MICRODELETION SYNDROME	0.013429574	0.4981625453938589
CRONKHITE-CANADA SYNDROME	0.013356099	0.49543703131405165
COG8-CDG	0.013347498999999999	0.49511801911825243
WARBURG MICRO SYNDROME 2; WARBM2	0.01331355	0.49385869992811465
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.013301314000000002	0.493404812343487
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.013301314000000002	0.493404812343487
MITOCHONDRIAL DNA DEPLETION SYNDROME 16 (HEPATIC TYPE); MTDPS16	0.01329795	0.4932800266427115
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.013291073	0.49302492816939636
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.013267359999999999	0.4921453076811422
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2EE; CMT2EE	0.013267359999999999	0.4921453076811422
DISTAL MONOSOMY 1Q	0.013135173000000002	0.48724190475950246
KOOLEN-DE VRIES SYNDROME	0.013135173000000002	0.48724190475950246
DONNAI-BARROW SYNDROME	0.013135173000000002	0.48724190475950246
MICRO SYNDROME	0.013135173000000002	0.48724190475950246
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.013135173000000002	0.48724190475950246
SCHIZENCEPHALY	0.013135173000000002	0.48724190475950246
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.013027312999999999	0.4832408983131191
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.012991772999999998	0.4819225618667584
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.0129714	0.48116683681268674
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.012922429	0.47935028492425885
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.01281468	0.4753533959608679
HEMOCHROMATOSIS, TYPE 3; HFE3	0.012617219999999998	0.4680287275675538
PETERS PLUS SYNDROME	0.012593754000000002	0.46715826940631866
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.012593754000000002	0.46715826940631866
OCULO-PALATO-CEREBRAL SYNDROME	0.012593754000000002	0.46715826940631866
TEMTAMY SYNDROME	0.012593754000000002	0.46715826940631866
TRISOMY 18	0.012593754000000002	0.46715826940631866
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.012589619000000002	0.46700488389124545
LINEAR NEVUS SEBACEUS SYNDROME	0.012589619000000002	0.46700488389124545
FRONTAL ENCEPHALOCELE	0.012589619000000002	0.46700488389124545
3-HYDROXYISOBUTYRIC ACIDURIA	0.012589619000000002	0.46700488389124545
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.012589619000000002	0.46700488389124545
MOWAT-WILSON SYNDROME	0.012589619000000002	0.46700488389124545
PRIMARY CUTIS VERTICIS GYRATA	0.012589619000000002	0.46700488389124545
WHIM SYNDROME	0.012589619000000002	0.46700488389124545
MICROPHTHALMIA, LENZ TYPE	0.012589619000000002	0.46700488389124545
OCULOCEREBROCUTANEOUS SYNDROME	0.012589619000000002	0.46700488389124545
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.012589619000000002	0.46700488389124545
MARBURG HEMORRHAGIC FEVER	0.01246342	0.46232360248454113
RELAPSING FEVER	0.01246342	0.46232360248454113
SECONDARY SYRINGOMYELIA	0.012446218999999998	0.46168554099850145
ALLAN-HERNDON-DUDLEY SYNDROME	0.012381010000000001	0.45926664957107516
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.012381010000000001	0.45926664957107516
BETA-KETOTHIOLASE DEFICIENCY	0.012342789000000002	0.4578488629273961
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.012300984	0.45629812980583984
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.012282263	0.4556036847689148
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.012252714000000001	0.4545075811208138
OCULOECTODERMAL SYNDROME; OES	0.012198073	0.4524807037498066
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.012198073	0.4524807037498066
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.012136343	0.45019086388391344
XQ28 (MECP2) DUPLICATION	0.012121323	0.449633705374506
HARTSFIELD SYNDROME	0.012048200000000002	0.4469212485380617
PAI SYNDROME	0.012048200000000002	0.4469212485380617
INTERMEDIATE OSTEOPETROSIS	0.012048200000000002	0.4469212485380617
FRONTONASAL DYSPLASIA	0.012048200000000002	0.4469212485380617
ISOLATED DANDY-WALKER MALFORMATION	0.012048200000000002	0.4469212485380617
RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA	0.012048200000000002	0.4469212485380617
HOLZGREVE SYNDROME	0.012048200000000002	0.4469212485380617
FEMORAL-FACIAL SYNDROME	0.012048200000000002	0.4469212485380617
8Q21.11 MICRODELETION SYNDROME	0.012048200000000002	0.4469212485380617
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.012048200000000002	0.4469212485380617
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.012048200000000002	0.4469212485380617
LAURIN-SANDROW SYNDROME	0.012048200000000002	0.4469212485380617
ACROCALLOSAL SYNDROME	0.012048200000000002	0.4469212485380617
DISTAL MONOSOMY 13Q	0.012048200000000002	0.4469212485380617
CRANE-HEISE SYNDROME	0.012048200000000002	0.4469212485380617
SHORT RIB-POLYDACTYLY SYNDROME	0.012048200000000002	0.4469212485380617
FGFR2-RELATED BENT BONE DYSPLASIA	0.012048200000000002	0.4469212485380617
ANEMIA, SIDEROBLASTIC, PYRIDOXINE-RESPONSIVE, AUTOSOMAL RECESSIVE	0.012048200000000002	0.4469212485380617
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3	0.012048200000000002	0.4469212485380617
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO JAK3 DEFICIENCY	0.012048200000000002	0.4469212485380617
HEMOLYTIC ANEMIA, LETHAL CONGENITAL NONSPHEROCYTIC, WITH GENITAL AND OTHER ABNORMALITIES	0.012048200000000002	0.4469212485380617
JUNG SYNDROME	0.012048200000000002	0.4469212485380617
IMMUNE DEFECT DUE TO ABSENCE OF THYMUS	0.012048200000000002	0.4469212485380617
BENT BONE DYSPLASIA SYNDROME; BBDS	0.012048200000000002	0.4469212485380617
HOLOPROSENCEPHALY-POSTAXIAL POLYDACTYLY SYNDROME	0.012048200000000002	0.4469212485380617
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 12	0.012048200000000002	0.4469212485380617
UNVERRICHT-LUNDBORG DISEASE	0.012048200000000002	0.4469212485380617
LOWRY-WOOD SYNDROME	0.012048200000000002	0.4469212485380617
LETHAL INTRAUTERINE GROWTH RESTRICTION-CORTICAL MALFORMATION-CONGENITAL CONTRACTURES SYNDROME	0.012048200000000002	0.4469212485380617
DIABETIC EMBRYOPATHY	0.012048200000000002	0.4469212485380617
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 19	0.012048200000000002	0.4469212485380617
NEUTROPHILIA, HEREDITARY	0.012048200000000002	0.4469212485380617
ACROCEPHALOPOLYDACTYLY	0.012048200000000002	0.4469212485380617
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.012048200000000002	0.4469212485380617
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.012039854	0.446611658330371
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.012039854	0.446611658330371
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.012039854	0.446611658330371
BETA-UREIDOPROPIONASE DEFICIENCY	0.012039854	0.446611658330371
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.012039854	0.446611658330371
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.012039854	0.446611658330371
RING CHROMOSOME 14 SYNDROME	0.012039854	0.446611658330371
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.012039854	0.446611658330371
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.012039854	0.446611658330371
SEA-BLUE HISTIOCYTE DISEASE	0.01197434	0.44418145309832613
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 4	0.011904799999999998	0.44160190564531765
%611694 DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA	0.011904799999999998	0.44160190564531765
SPINOCEREBELLAR ATAXIA TYPE 11	0.011904799999999998	0.44160190564531765
MYOPATHY AND DIABETES MELLITUS	0.011904799999999998	0.44160190564531765
SPINOCEREBELLAR ATAXIA TYPE 32	0.011904799999999998	0.44160190564531765
CEREBELLAR ATAXIA, BENIGN, WITH THERMOANALGESIA	0.011904799999999998	0.44160190564531765
FRONTOTEMPORAL DEMENTIA WITH MOTOR NEURON DISEASE	0.011904799999999998	0.44160190564531765
SPINOCEREBELLAR DEGENERATION-CORNEAL DYSTROPHY SYNDROME	0.011904799999999998	0.44160190564531765
FRYNS SYNDROME	0.011885838999999999	0.44089855794246324
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.011885838999999999	0.44089855794246324
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.011885838999999999	0.44089855794246324
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.011885838999999999	0.44089855794246324
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.011835568999999999	0.43903382037469313
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.011736709	0.43536666390065776
SPINOCEREBELLAR ATAXIA 48; SCA48	0.011707160000000001	0.4342705602525567
SPASTIC PARAPLEGIA 76, AUTOSOMAL RECESSIVE	0.011707160000000001	0.4342705602525567
SPINOCEREBELLAR ATAXIA TYPE 18	0.011707160000000001	0.4342705602525567
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.011707160000000001	0.4342705602525567
FRAGILE X-ASSOCIATED TREMOR/ATAXIA SYNDROME	0.011707160000000001	0.4342705602525567
GLYCINE ENCEPHALOPATHY	0.0116689	0.4328513269256642
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.011656654	0.43239706839662284
CARDIOFACIOCUTANEOUS SYNDROME	0.011656654	0.43239706839662284
GERMAN SYNDROME	0.011656654	0.43239706839662284
FABRY DISEASE	0.011652519	0.43224368288154963
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.011652519	0.43224368288154963
PROTEUS SYNDROME	0.011652519	0.43224368288154963
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.011652519	0.43224368288154963
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.011652519	0.43224368288154963
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.011602933000000001	0.43040431791167794
PITT-HOPKINS SYNDROME	0.011575769	0.429396684506249
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.011571749	0.4292475648519336
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.011494299999999999	0.426374637462114
X-LINKED SPASTICITY-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.011494299999999999	0.426374637462114
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.011445329	0.42455808557368613
HALL-RIGGS SYNDROME	0.011445329	0.42455808557368613
TEMPLE-BARAITSER SYNDROME	0.011445329	0.42455808557368613
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.011445329	0.42455808557368613
WOLCOTT-RALLISON SYNDROME	0.011429729	0.42397941228828295
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.01135665	0.42126858760725905
BIOTINIDASE DEFICIENCY	0.011281914	0.4184962974368817
KRABBE DISEASE	0.011281914	0.4184962974368817
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.011277779	0.4183429119218085
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.011277779	0.4183429119218085
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.011184763	0.41489253536315107
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.011162423000000001	0.4140638455429007
SCHNECKENBECKEN DYSPLASIA	0.0111111	0.4121600475283658
LYMPHEDEMA AND CEREBRAL ARTERIOVENOUS ANOMALY	0.0111111	0.4121600475283658
LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA	0.0111111	0.4121600475283658
IDIOPATHIC STEROID-SENSITIVE NEPHROTIC SYNDROME	0.0111111	0.4121600475283658
LYMPHEDEMA, HEREDITARY, ID; LMPH1D	0.0111111	0.4121600475283658
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 2	0.0111111	0.4121600475283658
PROXIMAL SPINAL MUSCULAR ATROPHY	0.0111111	0.4121600475283658
TERMINAL TRANSVERSE LIMB DEFECT	0.0111111	0.4121600475283658
LYMPHEDEMA-CEREBRAL ARTERIOVENOUS ANOMALY SYNDROME	0.0111111	0.4121600475283658
DAHLBERG-BORER-NEWCOMER SYNDROME	0.0111111	0.4121600475283658
ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.0111111	0.4121600475283658
LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME	0.0111111	0.4121600475283658
GERMAN SYNDROME	0.0111111	0.4121600475283658
MELORHEOSTOSIS	0.0111111	0.4121600475283658
CHYLOUS ASCITES	0.0111111	0.4121600475283658
ALG8-CDG	0.0111111	0.4121600475283658
INFANTILE SYSTEMIC HYALINOSIS	0.0111111	0.4121600475283658
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.0111111	0.4121600475283658
DOHLE BODIES AND LEUKEMIA	0.0111111	0.4121600475283658
CAPILLARY MALFORMATION OF THE LOWER LIP, LYMPHATIC MALFORMATION OF FACE AND NECK, ASYMMETRY OF FACE AND LIMBS, AND PARTIAL/GENERALIZED OVERGROWTH	0.0111111	0.4121600475283658
CLAPO SYNDROME	0.0111111	0.4121600475283658
APLASIA CUTIS CONGENITA-INTESTINAL LYMPHANGIECTASIA SYNDROME	0.0111111	0.4121600475283658
BUSCHKE-OLLENDORFF SYNDROME	0.0111111	0.4121600475283658
LYMPHEDEMA, HEREDITARY, IB	0.0111111	0.4121600475283658
NOONAN SYNDROME 6; NS6	0.011071004	0.4106727088071143
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34	0.01104937	0.40987020766247256
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2	0.01104937	0.40987020766247256
AUTOSOMAL SEMI-DOMINANT SEVERE LIPODYSTROPHIC LAMINOPATHY	0.01104937	0.40987020766247256
FAMILIAL PARTIAL LIPODYSTROPHY, DUNNIGAN TYPE	0.01104937	0.40987020766247256
AKT2-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.01104937	0.40987020766247256
DYSBETALIPOPROTEINEMIA	0.01104937	0.40987020766247256
FAMILIAL PARTIAL LIPODYSTROPHY, KÖBBERLING TYPE	0.01104937	0.40987020766247256
LIPE-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.01104937	0.40987020766247256
CIDEC-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.01104937	0.40987020766247256
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.010969664	0.4069135581184764
GAUCHER DISEASE TYPE 2	0.01096284	0.40666042565055394
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.01096284	0.40666042565055394
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.010930123	0.4054468068121864
WEBB-DATTANI SYNDROME; WEDAS	0.010904022999999999	0.4044786418923773
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.010904022999999999	0.4044786418923773
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.01090391	0.40447445022050227
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.01089335	0.40408273291961405
HEPATIC VENO-OCCLUSIVE DISEASE	0.01088831	0.4038957769350992
VERY LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.01088831	0.4038957769350992
PELGER-HUET ANOMALY; PHA	0.010866494	0.4030865246021278
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.01083013	0.4017376223360766
CONGENITAL RUBELLA SYNDROME	0.010786849000000001	0.4001321378190553
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.01073636	0.3982592765686247
MERRF	0.01073636	0.3982592765686247
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.010643344	0.3948089000099673
JOUBERT SYNDROME 24	0.010621004	0.39398021018971685
OLIVER SYNDROME	0.01053875	0.3909290440091049
MEHMO SYNDROME; MEHMO	0.010529583	0.39058899926504786
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.010432763	0.38699751545141126
AGGRESSIVE SYSTEMIC MASTOCYTOSIS	0.010399229999999999	0.3857536275488842
HEMOCHROMATOSIS, TYPE 2A	0.010399229999999999	0.3857536275488842
GALACTOSEMIA	0.010399229999999999	0.3857536275488842
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.010374973000000001	0.3848538276845238
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.010358468999999999	0.38424162102412035
MAJEED SYNDROME	0.01032427	0.38297302822363954
NODULAR NON-SUPPURATIVE PANNICULITIS	0.01032427	0.38297302822363954
PLAGUE	0.01032427	0.38297302822363954
OMENN SYNDROME	0.01032427	0.38297302822363954
CLASSIC MYCOSIS FUNGOIDES	0.01032427	0.38297302822363954
SÉZARY SYNDROME	0.01032427	0.38297302822363954
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.010271803	0.3810267941681751
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.010271703	0.38102308472403795
BABESIOSIS	0.01024543	0.38004850246587146
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.009997444	0.3708496003277961
ACQUIRED PARTIAL LIPODYSTROPHY	0.009887209	0.3667604945831543
OROFACIODIGITAL SYNDROME TYPE 1	0.009877099	0.3663854697808835
SMITH-FINEMAN-MYERS SYNDROME	0.009853589	0.36551337946422785
CRANIOFACIAL DYSSYNOSTOSIS	0.009817049999999999	0.36415798567093655
ROIFMAN-CHITAYAT SYNDROME	0.009804814	0.3637040980863089
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.009804814	0.3637040980863089
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.009804814	0.3637040980863089
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.009804814	0.3637040980863089
INFANTILE LIVER FAILURE SYNDROME 2	0.009726149	0.36078606385578094
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.009711683	0.3602494556668937
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.009711683	0.3602494556668937
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.009707663	0.3601003360125783
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.009652409	0.35805071974901015
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.009652409	0.35805071974901015
AICARDI-GOUTIERES SYNDROME 7	0.009565743000000002	0.3548358928930649
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.009534144	0.3536637456401512
NIEMANN-PICK DISEASE TYPE C	0.009530813	0.35354018405594106
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.009492564	0.3521213587679037
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.009449394	0.35051999173387466
PSEUDO-TORCH SYNDROME 2	0.009445259000000001	0.3503666062188015
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.009445259000000001	0.3503666062188015
GALACTOSE EPIMERASE DEFICIENCY	0.009417054000000001	0.34932035749990437
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.00934579	0.34667685922997055
PHOSPHOENOLPYRUVATE CARBOXYKINASE 2, MITOCHONDRIAL	0.00934579	0.34667685922997055
MICROCEPHALIC PRIMORDIAL DWARFISM-INSULIN RESISTANCE SYNDROME	0.00934579	0.34667685922997055
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 6; FPLD6	0.00934579	0.34667685922997055
INCLUSION BODY MYOPATHY WITH PAGET DISEASE OF BONE AND FRONTOTEMPORAL DEMENTIA	0.00934579	0.34667685922997055
%613387 FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 2; NAFLD2	0.00934579	0.34667685922997055
AROMATASE DEFICIENCY	0.00934579	0.34667685922997055
%613282 FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1; NAFLD1LIVER DISEASE, ALCOHOLIC, SUSCEPTIBILITY TO, 1, INCLUDED	0.00934579	0.34667685922997055
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 2; CEMCOX2	0.00934579	0.34667685922997055
ATYPICAL WERNER SYNDROME	0.00934579	0.34667685922997055
PATENT DUCTUS VENOSUS	0.00934579	0.34667685922997055
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.009338383	0.3464021007027282
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.009338383	0.3464021007027282
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.00925926	0.3434670772180519
SEIZURES-INTELLECTUAL DISABILITY DUE TO HYDROXYLYSINURIA SYNDROME	0.00925926	0.3434670772180519
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.00925926	0.3434670772180519
CARNOSINASE DEFICIENCY	0.00925926	0.3434670772180519
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.00925926	0.3434670772180519
CARNOSINEMIA	0.00925926	0.3434670772180519
HYDROXYLYSINURIA	0.00925926	0.3434670772180519
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.00925926	0.3434670772180519
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.00925926	0.3434670772180519
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.00925926	0.3434670772180519
PAINE SYNDROME	0.00925926	0.3434670772180519
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.00925926	0.3434670772180519
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.009241204	0.34279729998463915
SCLERODERMA	0.009237068999999999	0.34264391446956594
EMANUEL SYNDROME	0.009189253	0.34087020666092266
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.009189253	0.34087020666092266
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.009170264000000001	0.3401658203137099
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.009170264000000001	0.3401658203137099
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.009166244	0.3400167006593945
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.009166244	0.3400167006593945
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.009166244	0.3400167006593945
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.009162109	0.3398633151443213
SYSTEMIC SCLEROSIS	0.009162109	0.3398633151443213
PAPILLORENAL SYNDROME	0.009162109	0.3398633151443213
FAMILIAL MULTIPLE NEVI FLAMMEI	0.009162109	0.3398633151443213
SARCOSINEMIA	0.009064903999999999	0.3362575499707565
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.009064903999999999	0.3362575499707565
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.009029264	0.3349355040802587
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.009029264	0.3349355040802587
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.009029264	0.3349355040802587
SPINOCEREBELLAR ATAXIA 47; SCA47	0.009025129	0.33478211856518547
7Q11.23 MICRODUPLICATION SYNDROME	0.009025129	0.33478211856518547
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.008988073000000001	0.33340754694570496
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.00894701	0.33188433789964666
ALLAN-HERNDON-DUDLEY SYNDROME	0.00888451	0.329565935313897
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.008811863000000001	0.32687113543154583
BARAITSER-WINTER SYNDROME 1; BRWS1	0.008811863	0.3268711354315457
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.008792829	0.32616507983447124
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.00874583	0.32442167818442885
CRANIOECTODERMAL DYSPLASIA 3	0.00869565	0.3225602791163822
PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 2; PFBMFT2	0.00869565	0.3225602791163822
PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 1; PFBMFT1	0.00869565	0.3225602791163822
PULMONARY FIBROSIS, IDIOPATHIC; IPF	0.00869565	0.3225602791163822
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.00869565	0.3225602791163822
PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	0.00862069	0.3197796797911375
DERMATITIS HERPETIFORMIS	0.00862069	0.3197796797911375
KERATOENDOTHELIITIS FUGAX HEREDITARIA; KEFH	0.00862069	0.3197796797911375
BAZEX SYNDROME	0.00862069	0.3197796797911375
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.00862069	0.3197796797911375
CLUSTER HEADACHE, FAMILIAL	0.00862069	0.3197796797911375
CHRONIC NONBACTERIAL OSTEOMYELITIS/CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS	0.00862069	0.3197796797911375
ANEURYSM OF SINUS OF VALSALVA	0.00862069	0.3197796797911375
CONGENITAL ENTEROCYTE HEPARAN SULFATE DEFICIENCY	0.00862069	0.3197796797911375
KAPOSI SARCOMA, SUSCEPTIBILITY TO	0.00862069	0.3197796797911375
OPSISMODYSPLASIA; OPSMD	0.00862069	0.3197796797911375
NEPHROTIC SYNDROME, TYPE 1; NPHS1	0.00862069	0.3197796797911375
NEPHROTIC SYNDROME, TYPE 9; NPHS9	0.00862069	0.3197796797911375
EOSINOPHILIC ESOPHAGITIS	0.00862069	0.3197796797911375
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1	0.00862069	0.3197796797911375
%610158 CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 2; FECD2;;FCD1 LOCUS;;CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, LATE-ONSET	0.00862069	0.3197796797911375
EOSINOPHILIC GASTROENTERITIS	0.00862069	0.3197796797911375
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00862069	0.3197796797911375
JOHANSON-BLIZZARD SYNDROME	0.00862069	0.3197796797911375
DISSECTING CELLULITIS OF THE SCALP	0.00862069	0.3197796797911375
CARDIOMYOPATHY, DILATED, WITH WOOLLY HAIR AND KERATODERMA; DCWHK	0.00862069	0.3197796797911375
KNIEST-LIKE DYSPLASIA, LETHAL	0.00862069	0.3197796797911375
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.00862069	0.3197796797911375
NK-CELL ENTEROPATHY	0.00862069	0.3197796797911375
WHITE SPONGE NEVUS 2; WSN2	0.00862069	0.3197796797911375
LETHAL CONGENITAL CONTRACTURE SYNDROME 2	0.00862069	0.3197796797911375
SUPERFICIAL EPIDERMOLYTIC ICHTHYOSIS	0.00862069	0.3197796797911375
LETHAL KNIEST-LIKE DYSPLASIA	0.00862069	0.3197796797911375
ENTEROPATHY, FAMILIAL, WITH VILLOUS EDEMA AND IMMUNOGLOBULIN G2 DEFICIENCY	0.00862069	0.3197796797911375
THORACIC OUTLET SYNDROME	0.00862069	0.3197796797911375
RARE CUTANEOUS LUPUS ERYTHEMATOSUS	0.00862069	0.3197796797911375
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.00862069	0.3197796797911375
SAPHO SYNDROME	0.00862069	0.3197796797911375
CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 3; FECD3	0.00862069	0.3197796797911375
GLAUCOMA 3, PRIMARY CONGENITAL, E; GLC3E	0.00862069	0.3197796797911375
MASTOCYTOSIS, CUTANEOUS; MASTC	0.00862069	0.3197796797911375
CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION	0.00862069	0.3197796797911375
CHILBLAIN LUPUS 2; CHBL2	0.00862069	0.3197796797911375
GENERALIZED JUVENILE POLYPOSIS/JUVENILE POLYPOSIS COLI	0.00862069	0.3197796797911375
LIPEDEMA	0.00862069	0.3197796797911375
PIERSON SYNDROME	0.00862069	0.3197796797911375
WELLS SYNDROME	0.00862069	0.3197796797911375
INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2; NISBD2	0.00862069	0.3197796797911375
LETHAL RECESSIVE CHONDRODYSPLASIA	0.00862069	0.3197796797911375
ANTISYNTHETASE SYNDROME	0.00862069	0.3197796797911375
THYMIC EPITHELIAL NEOPLASM	0.00862069	0.3197796797911375
DEAFNESS, UNILATERAL, WITH DELAYED ENDOLYMPHATIC HYDROPS	0.00862069	0.3197796797911375
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.008601604	0.31907169528311163
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.008520483000000002	0.31606255710457415
MELAS	0.00851935	0.3160205291024996
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.008494383	0.315094392184765
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.00848371	0.3146984832120017
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.00848371	0.3146984832120017
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8	0.00848371	0.3146984832120017
MENTAL RETARDATION, X-LINKED 104; MRX104	0.008470213	0.314197819536804
LISSENCEPHALY 3; LIS3	0.008365169	0.3103012710373242
JACOBSEN SYNDROME	0.008302673	0.30798301682934
SALLA DISEASE	0.008256713	0.3062781563038831
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.008189222999999999	0.3037746524556872
16Q24.3 MICRODELETION SYNDROME	0.008134509	0.3017450671904599
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.008119943000000001	0.3012047495574355
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.007952964	0.29501075683158123
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.007952964	0.29501075683158123
DPM1-CDG	0.007948829	0.294857371316508
INTELLECTUAL DISABILITY, WOLFF TYPE	0.007948829	0.294857371316508
BOWEN-CONRADI SYNDROME	0.007948829	0.294857371316508
1Q41Q42 MICRODELETION SYNDROME	0.007948829	0.294857371316508
HENNEKAM-BEEMER SYNDROME	0.007948829	0.294857371316508
MEHMO SYNDROME	0.007948829	0.294857371316508
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.007948829	0.294857371316508
HEREDITARY METHEMOGLOBINEMIA	0.007948829	0.294857371316508
2Q24 MICRODELETION SYNDROME	0.007948829	0.294857371316508
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.007948829	0.294857371316508
SECKEL SYNDROME 7; SCKL7	0.007948829	0.294857371316508
QAZI-MARKOUIZOS SYNDROME	0.007948829	0.294857371316508
KEPPEN-LUBINSKY SYNDROME	0.007948829	0.294857371316508
CROME SYNDROME	0.007948829	0.294857371316508
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.007948829	0.294857371316508
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.007948829	0.294857371316508
ASPARTYLGLUCOSAMINURIA; AGU	0.007937639	0.2944422845175554
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.00772489	0.286550479210105
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.00772489	0.286550479210105
LISSENCEPHALY TYPE III AND BONE DYSPLASIA	0.00772489	0.286550479210105
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.007665923	0.28436313128572266
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.007665923	0.28436313128572266
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.007665923	0.28436313128572266
CHOREOACANTHOCYTOSIS	0.0076436690000000005	0.2835376315874303
X SMALL RINGS	0.007587804	0.2814653506201838
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.007587804	0.2814653506201838
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.007587804	0.2814653506201838
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.007587804	0.2814653506201838
OROFACIODIGITAL SYNDROME TYPE 2	0.007587804	0.2814653506201838
W SYNDROME	0.007587804	0.2814653506201838
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.0075836689999999995	0.2813119651051106
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.0075836689999999995	0.2813119651051106
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.0075785240000000005	0.28112111420425173
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.007546343	0.27992737798645956
GALACTOSE EPIMERASE DEFICIENCY	0.007512294	0.2786643493521845
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.007508159	0.2785109638371113
HEREDITARY FRUCTOSE INTOLERANCE	0.007508159	0.2785109638371113
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.007508159	0.2785109638371113
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.007433623	0.2757460925550083
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.007433623	0.2757460925550083
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.007433623	0.2757460925550083
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.007433623	0.2757460925550083
BOHRING-OPITZ SYNDROME	0.007433623	0.2757460925550083
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.007433623	0.2757460925550083
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.007418183	0.2751733543802248
MONOSOMY 5P	0.00740741	0.2747737359633243
DISTAL MONOSOMY 10P	0.00740741	0.2747737359633243
INTELLECTUAL DISABILITY-OBESITY-PROGNATHISM-EYE AND SKIN ANOMALIES SYNDROME	0.00740741	0.2747737359633243
14Q11.2 MICRODELETION SYNDROME	0.00740741	0.2747737359633243
TRISOMY XQ28	0.00740741	0.2747737359633243
RING CHROMOSOME 7 SYNDROME	0.00740741	0.2747737359633243
SPORADIC FETAL BRAIN DISRUPTION SEQUENCE	0.00740741	0.2747737359633243
KID SYNDROME	0.00740741	0.2747737359633243
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.00740741	0.2747737359633243
MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS	0.00740741	0.2747737359633243
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.00740741	0.2747737359633243
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.00740741	0.2747737359633243
OSTEOCHONDRODYSPLASIA, RHIZOMELIC, WITH CALLOSAL AGENESIS, THROMBOCYTOPENIA,HYDROCEPHALUS, AND HYPERTENSION	0.0072157	0.2676623606078993
NEUROLEPTIC MALIGNANT SYNDROME	0.00720026	0.2670896224331156
TOXIC EPIDERMAL NECROLYSIS	0.00720026	0.2670896224331156
STEVENS-JOHNSON SYNDROME	0.00720026	0.2670896224331156
CENTRAL CONGENITAL HYPOTHYROIDISM	0.00716792	0.26588998819914533
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.007124504	0.26427949593253885
PEROXISOME BIOGENESIS DISORDER 5B	0.007124504	0.26427949593253885
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.007124504	0.26427949593253885
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.007124504	0.26427949593253885
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.007120369	0.26412611041746564
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.007120369	0.26412611041746564
MYOCLONIC EPILEPSY, JUVENILE, 2	0.00704225	0.26122832975192684
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.00704225	0.26122832975192684
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.00704225	0.26122832975192684
HALLERMANN-STREIFF SYNDROME; HSS	0.00704225	0.26122832975192684
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.00704225	0.26122832975192684
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00704225	0.26122832975192684
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.00704225	0.26122832975192684
EPILEPSY, BENIGN NEONATAL, 3	0.00704225	0.26122832975192684
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.00704225	0.26122832975192684
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.00704225	0.26122832975192684
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.00704225	0.26122832975192684
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.00704225	0.26122832975192684
FAMILIAL INFANTILE BILATERAL STRIATAL NECROSIS	0.00703297	0.2608840933359947
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.00703297	0.2608840933359947
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.00703297	0.2608840933359947
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.0069931130000000005	0.25940562018623115
LISSENCEPHALY 8; LIS8	0.0069931130000000005	0.25940562018623115
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.0069931130000000005	0.25940562018623115
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.0069931130000000005	0.25940562018623115
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.0069931130000000005	0.25940562018623115
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.0069931130000000005	0.25940562018623115
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.0069931130000000005	0.25940562018623115
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.0069931130000000005	0.25940562018623115
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.0069931130000000005	0.25940562018623115
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.0069931130000000005	0.25940562018623115
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.0069931130000000005	0.25940562018623115
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.0069931130000000005	0.25940562018623115
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.0069931130000000005	0.25940562018623115
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.0069931130000000005	0.25940562018623115
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.0069931130000000005	0.25940562018623115
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.0069931130000000005	0.25940562018623115
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.0069931130000000005	0.25940562018623115
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.0069931130000000005	0.25940562018623115
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.0069931130000000005	0.25940562018623115
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.0069931130000000005	0.25940562018623115
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.0069931130000000005	0.25940562018623115
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.0069931130000000005	0.25940562018623115
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.0069931130000000005	0.25940562018623115
COFFIN-SIRIS SYNDROME 5	0.0069931130000000005	0.25940562018623115
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.0069931130000000005	0.25940562018623115
HYPERBILIRUBINEMIA, SHUNT, PRIMARY; PSHB	0.00696674	0.2584273284839275
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO GAMMA CHAIN DEFICIENCY	0.00696674	0.2584273284839275
DEHYDRATED HEREDITARY STOMATOCYTOSIS 2; DHS2	0.00696674	0.2584273284839275
EMANUEL SYNDROME	0.006928743	0.25701785099511587
GENITOPATELLAR SYNDROME	0.006928743	0.25701785099511587
KLEEFSTRA SYNDROME	0.006928743	0.25701785099511587
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.006892204000000001	0.2556624572018246
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.006892204	0.25566245720182457
MICROPHTHALMIA, SYNDROMIC 3	0.006892204	0.25566245720182457
CRANIOFRONTONASAL SYNDROME; CFNS	0.006892204	0.25566245720182457
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.006892204	0.25566245720182457
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.006888069	0.25550907168675135
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.006888069	0.25550907168675135
OCULOCEREBROCUTANEOUS SYNDROME	0.006888069	0.25550907168675135
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.0068784729999999995	0.2551531134273457
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.0068784729999999995	0.2551531134273457
CHROMOSOME 10Q26 DELETION SYNDROME	0.006779613	0.2514859569533104
CLASSIC GALACTOSEMIA	0.00674026	0.2500261794019983
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.006712123	0.24898245310511447
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.0066605499999999995	0.24706938148023658
BOUCHER-NEUHAUSER SYNDROME	0.00660531	0.2450202845388476
SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE; SPG79	0.00657895	0.2440424750642819
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5; PEOB5	0.00657895	0.2440424750642819
ATAXIA-OCULOMOTOR APRAXIA 3; AOA3	0.00657895	0.2440424750642819
BEHR SYNDROME	0.00657895	0.2440424750642819
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 7, AUTOSOMAL RECESSIVE; IBGC7	0.00657895	0.2440424750642819
HUNTINGTON DISEASE-LIKE 1	0.00657895	0.2440424750642819
SPASTIC PARAPLEGIA 2, X-LINKED; SPG2	0.00657895	0.2440424750642819
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.00657895	0.2440424750642819
JOUBERT SYNDROME WITH OCULAR DEFECT	0.006501083	0.2411540421979688
JOUBERT SYNDROME WITH RENAL DEFECT	0.006501083	0.2411540421979688
CHROMOSOME 16P13.2 DELETION SYNDROME	0.006488233	0.2406773786263387
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.006488233	0.2406773786263387
SRD5A3-CDG	0.006485643	0.24058130402318517
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.006451694	0.23932198483304734
HADZISELIMOVIC SYNDROME	0.006451694	0.23932198483304734
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.006451694	0.23932198483304734
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.006451694	0.23932198483304734
OROFACIODIGITAL SYNDROME XIV; OFD14	0.006451694	0.23932198483304734
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.006451694	0.23932198483304734
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.006447559	0.23916859931797418
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.006447559	0.23916859931797418
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.006447559	0.23916859931797418
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.006447559	0.23916859931797418
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.006447559	0.23916859931797418
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.006383189	0.2367808301268589
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.006383189	0.2367808301268589
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.0063519530000000005	0.23562214815616328
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.0063519530000000005	0.23562214815616328
WARBURG MICRO SYNDROME 1	0.0063466500000000006	0.23542543633356763
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.006215183000000001	0.23054874140971565
PETTIGREW SYNDROME	0.006215183	0.2305487414097156
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.006215183	0.2305487414097156
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.006215183	0.2305487414097156
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.006166569	0.2287454322368575
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.006166569	0.2287454322368575
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.006166569	0.2287454322368575
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.006166569	0.2287454322368575
CLASSIC HOMOCYSTINURIA	0.006166569	0.2287454322368575
GAUCHER DISEASE, TYPE II	0.006069243	0.22513517863588678
PROPIONIC ACIDEMIA	0.006069243	0.22513517863588678
METHYLMALONIC ACIDURIA, CBLA TYPE	0.006069243	0.22513517863588678
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.006069243	0.22513517863588678
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.0060605730000000005	0.22481356982919162
CHROMOSOME 1P35 DELETION SYNDROME	0.0060605730000000005	0.22481356982919162
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.0060605730000000005	0.22481356982919162
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.0060605730000000005	0.22481356982919162
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.006060573	0.22481356982919157
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.006060573	0.22481356982919157
GAPO SYNDROME; GAPOS	0.006032879	0.22378627636983556
BRAIN-LUNG-THYROID SYNDROME	0.005959664	0.22107040684478502
LISSENCEPHALY, X-LINKED, 1; LISX1	0.005955529000000001	0.22091702132971186
ALEXANDER DISEASE	0.005955529	0.2209170213297118
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.005946814000000001	0.22059374327315492
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.005940089	0.2203442831549282
ATAXIA-TELANGIECTASIA	0.005940089	0.2203442831549282
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.005906140000000001	0.2190849639647904
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.005906140000000001	0.2190849639647904
FOLATE MALABSORPTION, HEREDITARY	0.005842763	0.21673402955395749
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.0058417700000000005	0.21669719477367513
MASA SYNDROME	0.0058417700000000005	0.21669719477367513
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.0058417700000000005	0.21669719477367513
BARDET-BIEDL SYNDROME 21; BBS21	0.00582633	0.2161244565988915
REVESZ SYNDROME	0.005810533999999999	0.21553851280297948
FAMILIAL THYROID DYSHORMONOGENESIS	0.005808714	0.2154710009196825
PRIMARY CONGENITAL HYPOTHYROIDISM	0.005808714	0.2154710009196825
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.005808714	0.2154710009196825
PERIPHERAL HYPOTHYROIDISM	0.005808714	0.2154710009196825
PERMANENT CONGENITAL HYPOTHYROIDISM	0.005808714	0.2154710009196825
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.005808714	0.2154710009196825
THYROID HEMIAGENESIS	0.005808714	0.2154710009196825
THYROID ECTOPIA	0.005808714	0.2154710009196825
THYROID HYPOPLASIA	0.005808714	0.2154710009196825
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.005808714	0.2154710009196825
NEURONAL CEROID LIPOFUSCINOSIS	0.005806399	0.21538512728790632
RIFT VALLEY FEVER	0.005804579000000001	0.21531761540460928
224250 DYSMYELINATION WITH JAUNDICE	0.005804579000000001	0.21531761540460928
ACTH DEFICIENCY, ISOLATED; IAD	0.005804579000000001	0.21531761540460928
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.005804579000000001	0.21531761540460928
CRIGLER-NAJJAR SYNDROME	0.005804579000000001	0.21531761540460928
TRANSKETOLASE DEFICIENCY	0.005745634	0.21313108355793708
FORSYTHE-WAKELING SYNDROME; FWS	0.005729004	0.2125142029979208
LIG4 SYNDROME	0.005729003999999999	0.2125142029979208
CORNELIA DE LANGE SYNDROME 1	0.005724869	0.21236081748284757
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.005673764	0.21046510605653188
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.005673764	0.21046510605653188
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.005673764	0.21046510605653188
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.005673764	0.21046510605653188
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.005673764	0.21046510605653188
ATYPICAL JUVENILE PARKINSONISM	0.005669629000000001	0.21031172054145866
RAPID-ONSET DYSTONIA-PARKINSONISM	0.005669629000000001	0.21031172054145866
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.005669629000000001	0.21031172054145866
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.005669629000000001	0.21031172054145866
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.005669629000000001	0.21031172054145866
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.005669629000000001	0.21031172054145866
HUNTINGTON DISEASE; HD	0.005669629000000001	0.21031172054145866
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.00564059	0.2092345350584573
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.005626859	0.20872519128397843
NEUROENDOCRINE TUMOR OF STOMACH	0.00562515	0.20866179688367367
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.00562515	0.20866179688367367
GLYCOGEN STORAGE DISEASE IXA	0.00562515	0.20866179688367367
NEUROENDOCRINE NEOPLASM OF APPENDIX	0.00562515	0.20866179688367367
NEUROENDOCRINE TUMOR OF THE COLON	0.00562515	0.20866179688367367
GLYCINE N-METHYLTRANSFERASE DEFICIENCY	0.00562515	0.20866179688367367
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.00562515	0.20866179688367367
NEUROENDOCRINE TUMOR OF THE RECTUM	0.00562515	0.20866179688367367
NEUROENDOCRINE TUMOR OF ANAL CANAL	0.00562515	0.20866179688367367
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.005527824	0.205051543282703
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.005527824	0.205051543282703
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.005527824	0.205051543282703
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.005527824	0.205051543282703
METHYLMALONIC ACIDURIA, CBLB TYPE	0.005527824	0.205051543282703
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.005527824	0.205051543282703
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.005527824	0.205051543282703
SHWACHMAN-DIAMOND SYNDROME	0.005527824	0.205051543282703
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.005523689	0.2048981577676298
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.005519154	0.2047299344760078
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.005519154	0.2047299344760078
ANGELMAN SYNDROME	0.005515019	0.20457654896093463
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.005515019	0.20457654896093463
CHIARI MALFORMATION TYPE II	0.00541411	0.20083338597652803
11Q22.2Q22.3 MICRODELETION SYNDROME	0.005401373	0.20036091407677295
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.005401373	0.20036091407677295
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.005401373	0.20036091407677295
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.005401373	0.20036091407677295
DESANTO-SHINAWI SYNDROME	0.005401373	0.20036091407677295
AL KAISSI SYNDROME; ALKAS	0.005401373	0.20036091407677295
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.005401373	0.20036091407677295
XQ25 DUPLICATION SYNDROME	0.005401372999999999	0.2003609140767729
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.005297209	0.1964970086857005
46,XX GONADAL DYSGENESIS	0.00526498	0.19530149193472252
CEREBELLOPARENCHYMAL DISORDER V	0.00526498	0.19530149193472252
SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	0.00526498	0.19530149193472252
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.00526498	0.19530149193472252
REFSUM DISEASE	0.00526498	0.19530149193472252
TREMOR OF INTENTION, ATAXIA, AND LIPOFUSCINOSIS	0.00526498	0.19530149193472252
ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE III	0.00526316	0.1952339800514255
GILBERT SYNDROME	0.00526316	0.1952339800514255
SPECTRIN, BETA, ERYTHROCYTIC	0.00526316	0.1952339800514255
ROTOR SYNDROME	0.00526316	0.1952339800514255
CONGENITAL PANCREATIC CYST	0.00526316	0.1952339800514255
RH-NULL, REGULATOR TYPE; RHNR	0.00526316	0.1952339800514255
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, POSSIBLY DUE TO DEFECT IN PORPHYRINMETABOLISM	0.00526316	0.1952339800514255
AUTOIMMUNE HEMOLYTIC ANEMIA, WARM TYPE	0.00526316	0.1952339800514255
PANCREATOBLASTOMA	0.00526316	0.1952339800514255
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.00526316	0.1952339800514255
JAUNDICE, FAMILIAL OBSTRUCTIVE, OF INFANCY	0.00526316	0.1952339800514255
NEUROFIBROMATOSIS-PHEOCHROMOCYTOMA-DUODENAL CARCINOID SYNDROME	0.00526316	0.1952339800514255
HEREDITARY CHRONIC PANCREATITIS	0.00526316	0.1952339800514255
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.00526316	0.1952339800514255
SOLUTE CARRIER FAMILY 4 (ANION EXCHANGER), MEMBER 1; SLC4A1	0.00526316	0.1952339800514255
HYPERBILIRUBINEMIA, ROTOR TYPE	0.00526316	0.1952339800514255
HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATALBREASTFEEDING JAUNDICE, INCLUDED	0.00526316	0.1952339800514255
HEMOLYTIC ANEMIA, CONGENITAL, X-LINKED	0.00526316	0.1952339800514255
CRIGLER-NAJJAR SYNDROME, TYPE II	0.00526316	0.1952339800514255
ACETAMINOPHEN METABOLISM	0.00526316	0.1952339800514255
YELLOW FEVER	0.00526316	0.1952339800514255
HYPERBILIRUBINEMIA, CONJUGATED, TYPE III	0.00526316	0.1952339800514255
SPHEROCYTOSIS, TYPE 2	0.00526316	0.1952339800514255
DOMINANT BETA-THALASSEMIA	0.00526316	0.1952339800514255
EDINBURGH MALFORMATION SYNDROME	0.00526316	0.1952339800514255
HYPOTHYROIDISM DUE TO TSH RECEPTOR MUTATIONS	0.00526316	0.1952339800514255
ELLIPTOCYTOSIS 1; EL1	0.00526316	0.1952339800514255
VISCERAL NEUROPATHY, FAMILIAL, AUTOSOMAL RECESSIVE	0.00512821	0.19022808518827486
SPINOCEREBELLAR ATAXIA TYPE 20	0.00512821	0.19022808518827486
EPISODIC ATAXIA WITH SLURRED SPEECH	0.00512821	0.19022808518827486
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5	0.00512821	0.19022808518827486
SYRINGOMYELIA, ISOLATED	0.00512821	0.19022808518827486
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.00512821	0.19022808518827486
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.00512821	0.19022808518827486
ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS; ACPHD	0.00512821	0.19022808518827486
DYSTONIA 4, TORSION, AUTOSOMAL DOMINANT; DYT4	0.00512821	0.19022808518827486
SPINOCEREBELLAR ATAXIA TYPE 41	0.00512821	0.19022808518827486
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 39	0.00512821	0.19022808518827486
SPINOCEREBELLAR ATAXIA TYPE 31	0.00512821	0.19022808518827486
CREUTZFELDT-JAKOB DISEASE; CJD	0.00512821	0.19022808518827486
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00512821	0.19022808518827486
SPINOCEREBELLAR ATAXIA TYPE 15/16	0.00512821	0.19022808518827486
JUVENILE-ONSET DIABETES MELLITUS-CENTRAL AND PERIPHERAL NEURODEGENERATION SYNDROME	0.00512821	0.19022808518827486
AUTOSOMAL DOMINANT DOPA-RESPONSIVE DYSTONIA	0.00512821	0.19022808518827486
SPINOCEREBELLAR ATAXIA TYPE 38	0.00512821	0.19022808518827486
CHIARI MALFORMATION TYPE I	0.00512821	0.19022808518827486
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27; SCAR27	0.00512821	0.19022808518827486
258650 OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALRECESSIVE	0.00512821	0.19022808518827486
DYSTONIA, DOPA-RESPONSIVE; DRD	0.00512821	0.19022808518827486
GABA-TRANSAMINASE DEFICIENCY	0.005023983000000001	0.18636184284739607
LISSENCEPHALY 4	0.005023983000000001	0.18636184284739607
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.005023983000000001	0.18636184284739607
BAND HETEROTOPIA; BH	0.005023983000000001	0.18636184284739607
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.005023983000000001	0.18636184284739607
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.005023983000000001	0.18636184284739607
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.005023983000000001	0.18636184284739607
XP21 MICRODELETION SYNDROME	0.005023983	0.18636184284739601
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.005023983	0.18636184284739601
HOLOPROSENCEPHALY 7	0.005023983	0.18636184284739601
HOLOPROSENCEPHALY 1; HPE1	0.005023983	0.18636184284739601
1Q21.1 MICRODELETION SYNDROME	0.005023983	0.18636184284739601
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.005023983	0.18636184284739601
MONOSOMY 9P	0.005023983	0.18636184284739601
ACROMELIC FRONTONASAL DYSPLASIA	0.005023983	0.18636184284739601
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.005023983	0.18636184284739601
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.005023983	0.18636184284739601
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.005023983	0.18636184284739601
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.005023983	0.18636184284739601
HOLOPROSENCEPHALY 2; HPE2	0.005023983	0.18636184284739601
VICI SYNDROME; VICIS	0.005023983	0.18636184284739601
6Q25 MICRODELETION SYNDROME	0.005023983	0.18636184284739601
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.005023983	0.18636184284739601
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.005023983	0.18636184284739601
VICI SYNDROME	0.005023983	0.18636184284739601
PHACE SYNDROME	0.005023983	0.18636184284739601
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.005023983	0.18636184284739601
WALKER-WARBURG SYNDROME	0.005023983	0.18636184284739601
TEMTAMY SYNDROME; TEMTYS	0.005023983	0.18636184284739601
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.005008543000000001	0.18578910467261245
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.005008543	0.18578910467261242
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.005008543	0.18578910467261242
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.005008543	0.18578910467261242
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.005008543	0.18578910467261242
17Q12 MICRODELETION SYNDROME	0.005008543	0.18578910467261242
DENGUE FEVER	0.00498227	0.184814522414446
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.00498227	0.184814522414446
ACQUIRED IDIOPATHIC SIDEROBLASTIC ANEMIA	0.00498227	0.184814522414446
COMBINED IMMUNODEFICIENCY DUE TO CRAC CHANNEL DYSFUNCTION	0.00498227	0.184814522414446
FELTY SYNDROME	0.00498227	0.184814522414446
GAUCHER DISEASE, TYPE I	0.00498227	0.184814522414446
ERYTHROLEUKEMIA, FAMILIAL, SUSCEPTIBILITY TO; FERLK	0.00498227	0.184814522414446
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.004973712999999999	0.18449710527962584
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.004973712999999999	0.18449710527962584
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.004973712999999999	0.18449710527962584
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.004973712999999999	0.18449710527962584
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.004973712999999999	0.18449710527962584
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.004973712999999999	0.18449710527962584
MUCOLIPIDOSIS TYPE IV	0.0049736	0.1844929136077508
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.004874853	0.1808299488055905
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.004874853	0.1808299488055905
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.004859954	0.18027727872358915
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.004859954	0.18027727872358915
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.004859954	0.18027727872358915
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.004859954	0.18027727872358915
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.004859954	0.18027727872358915
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.004859954	0.18027727872358915
OKAMOTO SYNDROME	0.004859954	0.18027727872358915
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.004855819	0.18012389320851596
FAMILIAL MULTIPLE LIPOMATOSIS	0.004855819	0.18012389320851596
5Q14.3 MICRODELETION SYNDROME	0.004855819	0.18012389320851596
20Q13.33 MICRODELETION SYNDROME	0.004855819	0.18012389320851596
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.004855819	0.18012389320851596
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.004583473000000001	0.17002137047861884
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.004583473000000001	0.17002137047861884
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.004583473000000001	0.17002137047861884
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.004583473000000001	0.17002137047861884
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.004583473000000001	0.17002137047861884
MENTAL RETARDATION, X-LINKED 101; MRX101	0.004583473000000001	0.17002137047861884
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.004583473000000001	0.17002137047861884
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.004583473000000001	0.17002137047861884
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.004583473000000001	0.17002137047861884
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.004583473000000001	0.17002137047861884
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.004583473000000001	0.17002137047861884
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.004583473000000001	0.17002137047861884
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.004583473000000001	0.17002137047861884
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.004583473000000001	0.17002137047861884
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.004583473000000001	0.17002137047861884
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.004583473	0.17002137047861882
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.004583473	0.17002137047861882
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.004583473	0.17002137047861882
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.004583473	0.17002137047861882
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.004583473	0.17002137047861882
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.004583473	0.17002137047861882
IMMUNODEFICIENCY 49; IMD49	0.004583473	0.17002137047861882
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.004583473	0.17002137047861882
MENTAL RETARDATION, X-LINKED 103	0.004583473	0.17002137047861882
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.004583473	0.17002137047861882
SCHAAF-YANG SYNDROME; SHFYNG	0.004583473	0.17002137047861882
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.004583473	0.17002137047861882
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.004583473	0.17002137047861882
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.004583473	0.17002137047861882
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.004583473	0.17002137047861882
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.004583473	0.17002137047861882
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.004583473	0.17002137047861882
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.004583473	0.17002137047861882
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.004583473	0.17002137047861882
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.004583473	0.17002137047861882
FOIX-CHAVANY-MARIE SYNDROME	0.004583473	0.17002137047861882
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.004583473	0.17002137047861882
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.004583473	0.17002137047861882
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.004583473	0.17002137047861882
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.004583473	0.17002137047861882
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.004583473	0.17002137047861882
MENTAL RETARDATION, X-LINKED 91; MRX91	0.004583473	0.17002137047861882
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.004583473	0.17002137047861882
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.004583473	0.17002137047861882
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.004583473	0.17002137047861882
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.004583473	0.17002137047861882
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.004583473	0.17002137047861882
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.004583473	0.17002137047861882
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.004583473	0.17002137047861882
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.004583473	0.17002137047861882
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.004583473	0.17002137047861882
14Q22Q23 MICRODELETION SYNDROME	0.0044825640000000005	0.16627820749421227
CRANIOTELENCEPHALIC DYSPLASIA	0.0044825640000000005	0.16627820749421227
CURRY-JONES SYNDROME	0.0044825640000000005	0.16627820749421227
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.0044825640000000005	0.16627820749421227
CRANIOSYNOSTOSIS 6; CRS6	0.0044825640000000005	0.16627820749421227
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.0044825640000000005	0.16627820749421227
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.0044825640000000005	0.16627820749421227
CRANIOTELENCEPHALIC DYSPLASIA	0.0044825640000000005	0.16627820749421227
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.0044825640000000005	0.16627820749421227
HARTSFIELD SYNDROME; HRTFDS	0.0044825640000000005	0.16627820749421227
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.0044825640000000005	0.16627820749421227
MARDEN-WALKER SYNDROME	0.0044825640000000005	0.16627820749421227
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.0044825640000000005	0.16627820749421227
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.0044825640000000005	0.16627820749421227
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.0044825640000000005	0.16627820749421227
GENITOPATELLAR SYNDROME; GTPTS	0.0044825640000000005	0.16627820749421227
SEPTOOPTIC DYSPLASIA	0.0044825640000000005	0.16627820749421227
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.0044825640000000005	0.16627820749421227
HOLOPROSENCEPHALY 11	0.0044825640000000005	0.16627820749421227
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.0044825640000000005	0.16627820749421227
DUPLICATION OF THE PITUITARY GLAND	0.0044825640000000005	0.16627820749421227
MICROFORM HOLOPROSENCEPHALY	0.004478429000000001	0.16612482197913908
MARDEN-WALKER SYNDROME	0.004478429000000001	0.16612482197913908
GLYCINE ENCEPHALOPATHY; GCE	0.004478429000000001	0.16612482197913908
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.004478429000000001	0.16612482197913908
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.004478429000000001	0.16612482197913908
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.004478429000000001	0.16612482197913908
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.004478429000000001	0.16612482197913908
15Q OVERGROWTH SYNDROME	0.004478429000000001	0.16612482197913908
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.004478429000000001	0.16612482197913908
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.004478429000000001	0.16612482197913908
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.004478429000000001	0.16612482197913908
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.004478429000000001	0.16612482197913908
BARAITSER-WINTER SYNDROME 2; BRWS2	0.004478429000000001	0.16612482197913908
15Q11Q13 MICRODUPLICATION SYNDROME	0.004468833	0.16576886371973337
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.004468833	0.16576886371973337
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.004468833	0.16576886371973337
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.004468833	0.16576886371973337
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.004468833	0.16576886371973337
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.004468833	0.16576886371973337
DISTAL MONOSOMY 10Q	0.004468833	0.16576886371973337
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.004468833	0.16576886371973337
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.004468833	0.16576886371973337
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.004468833	0.16576886371973337
PELIZAEUS-MERZBACHER DISEASE	0.004468833	0.16576886371973337
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.004468833	0.16576886371973337
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.004432294	0.16441346992644207
JOUBERT SYNDROME 21	0.004432294	0.16441346992644207
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.004432294	0.16441346992644207
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.004428158999999999	0.16426008441136886
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.004428158999999999	0.16426008441136886
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.004365663	0.16194183020338473
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.004365663	0.16194183020338473
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.004365663	0.16194183020338473
HEREDITARY FOLATE MALABSORPTION	0.004365663	0.16194183020338473
MIRAGE SYNDROME; MIRAGE	0.004365663	0.16194183020338473
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.004365663	0.16194183020338473
STT3B-CDG	0.004365663	0.16194183020338473
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.004365663	0.16194183020338473
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.004333434	0.16074631345240672
LARSEN-LIKE SYNDROME	0.004333434	0.16074631345240672
CUTIS LAXA	0.004333434	0.16074631345240672
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.004333434	0.16074631345240672
XYLOSIDASE DEFICIENCY	0.004329299	0.16059292793733354
HYPERLEUCINE-ISOLEUCINEMIA	0.004329299	0.16059292793733354
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.004329299	0.16059292793733354
ICHTHYOSIS AND MALE HYPOGONADISM	0.004329299	0.16059292793733354
EPILEPSY-TELANGIECTASIA	0.004329299	0.16059292793733354
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.004329299	0.16059292793733354
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.004329299	0.16059292793733354
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.0043143999999999995	0.16004025785533216
CHROMOSOME 13Q14 DELETION SYNDROME	0.0043143999999999995	0.16004025785533216
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.004267653	0.15830620400451556
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.004267653	0.15830620400451556
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.004267653	0.15830620400451556
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.004267653	0.15830620400451556
INFANTILE REFSUM DISEASE	0.004267653	0.15830620400451556
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.004267653	0.15830620400451556
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.004267653	0.15830620400451556
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.004267653	0.15830620400451556
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.004267653	0.15830620400451556
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.004267653	0.15830620400451556
TAY-SACHS DISEASE	0.004267653	0.15830620400451556
ASPARTYLGLUCOSAMINURIA	0.004149759	0.15393299193340568
AL-RAQAD SYNDROME; ARS	0.004042054000000001	0.14993773512543507
HOLMES-GANG SYNDROME	0.004042054000000001	0.14993773512543507
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.004042054000000001	0.14993773512543507
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.004042054000000001	0.14993773512543507
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.004042054000000001	0.14993773512543507
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.004042054000000001	0.14993773512543507
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.004042054000000001	0.14993773512543507
INFANTILE DYSTONIA-PARKINSONISM	0.004042054000000001	0.14993773512543507
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.004042054000000001	0.14993773512543507
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.004042054000000001	0.14993773512543507
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.004042054000000001	0.14993773512543507
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.004042054000000001	0.14993773512543507
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.004042054000000001	0.14993773512543507
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.004037919000000001	0.14978434961036186
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.004037919000000001	0.14978434961036186
CHILDHOOD DISINTEGRATIVE DISORDER	0.004037919000000001	0.14978434961036186
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.004037919000000001	0.14978434961036186
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.004037919000000001	0.14978434961036186
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.004037919000000001	0.14978434961036186
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.004037919000000001	0.14978434961036186
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.004037919000000001	0.14978434961036186
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.004037919000000001	0.14978434961036186
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.004037919000000001	0.14978434961036186
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.004037919000000001	0.14978434961036186
ASPLENIA WITH CARDIOVASCULAR ANOMALIES	0.00393701	0.14604118662595528
APERT SYNDROME	0.00393701	0.14604118662595528
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.00393701	0.14604118662595528
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.00393701	0.14604118662595528
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00393701	0.14604118662595528
OTOMANDIBULAR SYNDROME	0.00393701	0.14604118662595528
FRONTONASAL DYSPLASIA-BIFID NOSE-UPPER LIMB ANOMALIES SYNDROME	0.00393701	0.14604118662595528
HYDROCEPHALUS DUE TO CONGENITAL STENOSIS OF AQUEDUCT OF SYLVIUS	0.00393701	0.14604118662595528
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	0.00393701	0.14604118662595528
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.00393701	0.14604118662595528
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE	0.00393701	0.14604118662595528
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.00393701	0.14604118662595528
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.00393701	0.14604118662595528
AGNATHIA-HOLOPROSENCEPHALY-SITUS INVERSUS SYNDROME	0.00393701	0.14604118662595528
FAMILIAL CONGENITAL MIRROR MOVEMENTS	0.00393701	0.14604118662595528
TETRAAMELIA-MULTIPLE MALFORMATIONS SYNDROME	0.00393701	0.14604118662595528
CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY-COLOBOMA-MICROGNATHIA SYNDROME	0.00393701	0.14604118662595528
MICROCEPHALY-POLYMICROGYRIA-CORPUS CALLOSUM AGENESIS SYNDROME	0.00393701	0.14604118662595528
THAKKER-DONNAI SYNDROME	0.00393701	0.14604118662595528
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.00393701	0.14604118662595528
MARSHALL-SMITH SYNDROME; MRSHSS	0.00393701	0.14604118662595528
MOSAIC TRISOMY 8	0.00393701	0.14604118662595528
MECKEL SYNDROME 12; MKS12	0.00393701	0.14604118662595528
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.00393701	0.14604118662595528
PSEUDOTRISOMY 13 SYNDROME	0.00393701	0.14604118662595528
MIRROR MOVEMENTS 1; MRMV1	0.00393701	0.14604118662595528
FOCAL DERMAL HYPOPLASIA; FDH	0.00393701	0.14604118662595528
HYDROLETHALUS	0.00393701	0.14604118662595528
SCHIZENCEPHALY	0.00393701	0.14604118662595528
TORIELLO-LACASSIE-DROSTE SYNDROME	0.00393701	0.14604118662595528
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.00393701	0.14604118662595528
OROFACIODIGITAL SYNDROME XV; OFD15	0.00393701	0.14604118662595528
AGNATHIA-OTOCEPHALY COMPLEX	0.00393701	0.14604118662595528
MULTIPLE EPIPHYSEAL DYSPLASIA, AL-GAZALI TYPE	0.00393701	0.14604118662595528
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.00393701	0.14604118662595528
FETAL AKINESIA SYNDROME, X-LINKED	0.00393701	0.14604118662595528
CLOVERLEAF SKULL-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00393701	0.14604118662595528
FRONTONASAL DYSPLASIA-ALOPECIA-GENITAL ANOMALIES SYNDROME	0.00393701	0.14604118662595528
TOWNES-BROCKS SYNDROME	0.00393701	0.14604118662595528
MASA SYNDROME	0.00393701	0.14604118662595528
GOLDENHAR SYNDROME	0.00393701	0.14604118662595528
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.00393701	0.14604118662595528
OROFACIODIGITAL SYNDROME TYPE 5	0.00393701	0.14604118662595528
HEMIFACIAL MICROSOMIA	0.00393701	0.14604118662595528
CURRY-JONES SYNDROME	0.00393701	0.14604118662595528
STROMME SYNDROME; STROMS	0.00393701	0.14604118662595528
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.00393701	0.14604118662595528
HYDROLETHALUS SYNDROME 1	0.00393701	0.14604118662595528
OROFACIODIGITAL SYNDROME V; OFD5	0.00393701	0.14604118662595528
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.003927414	0.1456852283665496
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.003927414	0.1456852283665496
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.003927414	0.1456852283665496
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.003927414	0.1456852283665496
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.003927414	0.1456852283665496
2Q23.1 MICRODELETION SYNDROME	0.003923279	0.14553184285147638
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.003923279	0.14553184285147638
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.003923279	0.14553184285147638
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.00392157	0.14546844845117168
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 15; MDDGC15	0.00392157	0.14546844845117168
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 5; MC3DN5	0.00392157	0.14546844845117168
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.00392157	0.14546844845117168
MCCUNE-ALBRIGHT SYNDROME	0.00392157	0.14546844845117168
CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE III	0.00392157	0.14546844845117168
XFE PROGEROID SYNDROME; XFEPS	0.00392157	0.14546844845117168
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.00392157	0.14546844845117168
STEVENS-JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS SPECTRUM	0.00392157	0.14546844845117168
INTERSTITIAL NEPHRITIS, KARYOMEGALIC	0.00392157	0.14546844845117168
X-LINKED SIDEROBLASTIC ANEMIA	0.00392157	0.14546844845117168
BECKER MUSCULAR DYSTROPHY	0.00392157	0.14546844845117168
PRIMARY HYPEROXALURIA	0.00392157	0.14546844845117168
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 6; MC3DN6	0.00392157	0.14546844845117168
DPM3-CDG	0.00392157	0.14546844845117168
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.003824244	0.14185819485020096
ROBERTS SYNDROME	0.003824244	0.14185819485020096
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.003824244	0.14185819485020096
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.003824244	0.14185819485020096
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.003824244	0.14185819485020096
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.003824244	0.14185819485020096
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.003824244	0.14185819485020096
VIRAL HEMORRHAGIC FEVER	0.003820109	0.14170480933512775
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.003820109	0.14170480933512775
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.003820109	0.14170480933512775
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.003820109	0.14170480933512775
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.003820109	0.14170480933512775
EBOLA HEMORRHAGIC FEVER	0.003820109	0.14170480933512775
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.003820109	0.14170480933512775
SMITH-KINGSMORE SYNDROME; SKS	0.003820109	0.14170480933512775
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.003820109	0.14170480933512775
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.00378788	0.14050929258414976
103230 ADRENOCORTICAL HYPOFUNCTION, CHRONIC PRIMARY CONGENITAL;;ADDISON DISEASE, CONGENITAL	0.00378788	0.14050929258414976
%608572 BURN-MCKEOWN SYNDROME	0.00378788	0.14050929258414976
MYOPATHY, GRANULOVACUOLAR LOBULAR, WITH ELECTRICAL MYOTONIA	0.00378788	0.14050929258414976
SPINAL ARACHNOIDITIS	0.00378788	0.14050929258414976
TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN	0.00378788	0.14050929258414976
OSTEOGENIC SARCOMA	0.00378788	0.14050929258414976
CITRULLINE TRANSPORT DEFECT	0.00378788	0.14050929258414976
HYPOGONADOTROPIC HYPOGONADISM 24 WITHOUT ANOSMIA; HH24	0.00378788	0.14050929258414976
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00378788	0.14050929258414976
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.00378788	0.14050929258414976
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00378788	0.14050929258414976
257960 OCULOTRICHODYSPLASIA; OTD	0.00378788	0.14050929258414976
GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUETO	0.00378788	0.14050929258414976
600333 MOTOR NEURON DISEASE WITH DEMENTIA AND OPHTHALMOPLEGIA	0.00378788	0.14050929258414976
256720 NEUROLOGIC DISEASE, INFANTILE MULTISYSTEM, WITH OSSEOUS FRAGILITY	0.00378788	0.14050929258414976
%257600 OCULAR MYOPATHY WITH CURARE SENSITIVITY	0.00378788	0.14050929258414976
PACMAN DYSPLASIA	0.00378788	0.14050929258414976
T-SUBSTANCE ANOMALY	0.00378788	0.14050929258414976
MYASTHENIA, CONGENITAL, REFRACTORY TO ACETYLCHOLINESTERASE INHIBITORS	0.00378788	0.14050929258414976
MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS	0.00378788	0.14050929258414976
MICROCEPHALY-BRAIN DEFECT-SPASTICITY-HYPERNATREMIA SYNDROME	0.00378788	0.14050929258414976
COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING	0.00378788	0.14050929258414976
MACULAR DYSTROPHY, CORNEAL, 1	0.00378788	0.14050929258414976
MYOPATHY, SPHEROID BODY	0.00378788	0.14050929258414976
FETAL IODINE DEFICIENCY DISORDER	0.00378788	0.14050929258414976
AREDYLD	0.00378788	0.14050929258414976
DOPAMINE BETA-HYDROXYLASE, PLASMA, THERMOLABILITY OF	0.00378788	0.14050929258414976
APOLIPOPROTEIN(A)	0.00378788	0.14050929258414976
ALPHA-2-DEFICIENT COLLAGEN DISEASE	0.00378788	0.14050929258414976
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.00378788	0.14050929258414976
BARTTER SYNDROME	0.00378788	0.14050929258414976
OVARIAN CANCER	0.00378788	0.14050929258414976
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 1; EV1	0.00378788	0.14050929258414976
OSTEOGENESIS IMPERFECTA, TYPE V	0.00378788	0.14050929258414976
EHLERS-DANLOS SYNDROME, TYPE VI	0.00378788	0.14050929258414976
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.00378788	0.14050929258414976
DELETED IN AZOOSPERMIA	0.00378788	0.14050929258414976
POLYCYSTIC OVARY SYNDROME 1	0.00378788	0.14050929258414976
CILIARY DISCOORDINATION DUE TO RANDOM CILIARY ORIENTATION	0.00378788	0.14050929258414976
THYROID CANCER, NONMEDULLARY, 2; NMTC2	0.00378788	0.14050929258414976
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.00378788	0.14050929258414976
SPONDYLOEPIPHYSEAL DYSPLASIA WITH PUNCTATE CORNEAL DYSTROPHY	0.00378788	0.14050929258414976
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 2	0.00378788	0.14050929258414976
LACTOSE INTOLERANCE, ADULT TYPE	0.00378788	0.14050929258414976
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.00378788	0.14050929258414976
KERATOSIS, FAMILIAL ACTINIC	0.00378788	0.14050929258414976
ONCOCYTOMA	0.00378788	0.14050929258414976
XM SYSTEM	0.00378788	0.14050929258414976
HYPOGONADOTROPIC HYPOGONADISM 23 WITHOUT ANOSMIA; HH23	0.00378788	0.14050929258414976
DERMATOLEUKODYSTROPHY	0.00378788	0.14050929258414976
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.00378788	0.14050929258414976
GONADOBLASTOMA	0.00378788	0.14050929258414976
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.00378788	0.14050929258414976
CUTANEOUS COLLAGENOUS VASCULOPATHY	0.00378788	0.14050929258414976
EPOXIDE HYDROLASE 1, MICROSOMAL	0.00378788	0.14050929258414976
DRUG METABOLISM, POOR, CYP2D6-RELATEDDRUG METABOLISM, ULTRARAPID, CYP2D6-RELATED, INCLUDED	0.00378788	0.14050929258414976
OCULORENOCEREBELLAR SYNDROME	0.00378788	0.14050929258414976
SPERMATOGENIC FAILURE 1; SPGF1	0.00378788	0.14050929258414976
NEPHROSIALIDOSIS	0.00378788	0.14050929258414976
SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL	0.00378788	0.14050929258414976
ETHANOLAMINOSIS	0.00378788	0.14050929258414976
PSEUDOURIDINURIA AND MENTAL DEFECT	0.00378788	0.14050929258414976
CALVARIAL HYPEROSTOSIS	0.00378788	0.14050929258414976
GLUTATHIONURIA	0.00378788	0.14050929258414976
HEREDITARY HYPERFERRITINEMIA-CATARACT SYNDROME	0.00378788	0.14050929258414976
245650 LARSEN-LIKE SYNDROME, LETHAL TYPE	0.00378788	0.14050929258414976
GLOMUVENOUS MALFORMATIONS	0.00378788	0.14050929258414976
NEURAL TUBE DEFECTS, FOLATE-SENSITIVE	0.00378788	0.14050929258414976
SCHIZOPHRENIA 4	0.00378788	0.14050929258414976
ZINC, ELEVATED PLASMA	0.00378788	0.14050929258414976
METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA; METAG	0.00378788	0.14050929258414976
ANEMIA, AUTOIMMUNE HEMOLYTIC	0.00378788	0.14050929258414976
BEETURIA	0.00378788	0.14050929258414976
ACETYLATION, SLOW	0.00378788	0.14050929258414976
WHITE SPONGE NEVUS OF CANNON	0.00378788	0.14050929258414976
X-LINKED ADRENOLEUKODYSTROPHY	0.00378788	0.14050929258414976
CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 2	0.00378788	0.14050929258414976
ICHTHYOSIS, X-LINKED	0.00378788	0.14050929258414976
PREMATURE CENTROMERE DIVISION; PCD	0.00378788	0.14050929258414976
PREMATURE OVARIAN FAILURE 1	0.00378788	0.14050929258414976
INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP	0.00378788	0.14050929258414976
CONE-ROD DYSTROPHY 1; CORD1	0.00378788	0.14050929258414976
PLATELET PROSTACYCLIN RECEPTOR DEFECT	0.00378788	0.14050929258414976
PITUITARY DWARFISM IV	0.00378788	0.14050929258414976
%270150 SJOGREN SYNDROME;;SICCA SYNDROME	0.00378788	0.14050929258414976
DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES	0.00378788	0.14050929258414976
SODIUM-POTASSIUM-ATPASE ACTIVITY OF RED CELL	0.00378788	0.14050929258414976
LARON SYNDROME	0.00378788	0.14050929258414976
HYPOASCORBEMIA	0.00378788	0.14050929258414976
PSEUDOCHOLINESTERASE, INCREASE IN PLASMA LEVEL OF	0.00378788	0.14050929258414976
MACULAR CORNEAL DYSTROPHY	0.00378788	0.14050929258414976
MYOTONIC MYOPATHY WITH CYLINDRICAL SPIRALS	0.00378788	0.14050929258414976
GLUTATHIONE REDUCTASE	0.00378788	0.14050929258414976
LIPASE DEFICIENCY, COMBINED	0.00378788	0.14050929258414976
MITOCHONDRIAL MYOPATHY WITH A DEFECT IN MITOCHONDRIAL-PROTEIN TRANSPORT	0.00378788	0.14050929258414976
AMOBARBITAL, DEFICIENT N-HYDROXYLATION OF	0.00378788	0.14050929258414976
HEINZ BODY ANEMIAS	0.00378788	0.14050929258414976
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.00378788	0.14050929258414976
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	0.00378788	0.14050929258414976
17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	0.00378788	0.14050929258414976
NORMOKALEMIC PERIODIC PARALYSIS	0.00378788	0.14050929258414976
CARDIAC LIPIDOSIS, FAMILIAL	0.00378788	0.14050929258414976
CORONARY ARTERY DISSECTION, SPONTANEOUS	0.00378788	0.14050929258414976
CHOROIDAL OSTEOMA, BILATERAL	0.00378788	0.14050929258414976
TRISOMY 18-LIKE SYNDROME	0.00378788	0.14050929258414976
PYGMY	0.00378788	0.14050929258414976
601195 IRON OVERLOAD IN AFRICA;;AFRICAN IRON OVERLOAD;;BANTU SIDEROSIS	0.00378788	0.14050929258414976
ALAND ISLAND EYE DISEASE	0.00378788	0.14050929258414976
NEURONAL INTESTINAL DYSPLASIA, TYPE B	0.00378788	0.14050929258414976
MAGNESIUM, ELEVATED RED CELL	0.00378788	0.14050929258414976
CONGENITAL ADRENAL HYPERPLASIA	0.00378788	0.14050929258414976
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.00378788	0.14050929258414976
CATECHOL-O-METHYLTRANSFERASE	0.00378788	0.14050929258414976
LYMPHOKINE DEFICIENCY	0.00378788	0.14050929258414976
SHORT STATURE SYNDROME, BRUSSELS TYPE	0.00378788	0.14050929258414976
METAPHYSEAL CHONDRODYSPLASIA, PENA TYPE	0.00378788	0.14050929258414976
SPERMATOGENIC FAILURE, X-LINKED, 2; SPGFX2	0.00378788	0.14050929258414976
LYMPHOBLASTIC TRANSFORMATION, INTRINSIC DEFECT IN	0.00378788	0.14050929258414976
LYMPHOBLASTIC TRANSFORMATION, INHIBITION OF	0.00378788	0.14050929258414976
LUTHERAN SUPPRESSOR, X-LINKED	0.00378788	0.14050929258414976
CARBOXYLESTERASE 1	0.00378788	0.14050929258414976
PROGESTERONE RESISTANCE	0.00378788	0.14050929258414976
HYPERPROGLUCAGONEMIA	0.00378788	0.14050929258414976
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.00378788	0.14050929258414976
NEUTROPHIL ACTIN DYSFUNCTION	0.00378788	0.14050929258414976
SERTOLI CELL-ONLY SYNDROME	0.00378788	0.14050929258414976
PARAOXONASE 1	0.00378788	0.14050929258414976
PENDRED SYNDROME	0.00378788	0.14050929258414976
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2A	0.00378788	0.14050929258414976
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00378788	0.14050929258414976
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00378788	0.14050929258414976
CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN	0.00378788	0.14050929258414976
CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	0.00378788	0.14050929258414976
VENTRICULAR TACHYCARDIA, FAMILIAL	0.00378788	0.14050929258414976
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00378788	0.14050929258414976
VASCULITIS, LYMPHOCYTIC, NODULAR	0.00378788	0.14050929258414976
TESTICULAR GERM CELL TUMOR; TGCT	0.00378788	0.14050929258414976
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.00378788	0.14050929258414976
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.00378788	0.14050929258414976
HOOFT DISEASE	0.00378788	0.14050929258414976
PERRY SYNDROME	0.00378788	0.14050929258414976
PROPERDIN DEFICIENCY, X-LINKED	0.00378788	0.14050929258414976
ADRENAL HYPOPLASIA, CONGENITAL, WITH ABSENT PITUITARY LUTEINIZINGHORMONE	0.00378788	0.14050929258414976
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, ASSOCIATED WITH ABNORMALITY OF REDCELL MEMBRANE	0.00378788	0.14050929258414976
URATE-BINDING GLOBULIN, DECREASE IN	0.00378788	0.14050929258414976
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00378788	0.14050929258414976
%253240 MUCUS INSPISSATION OF RESPIRATORY TRACT	0.00378788	0.14050929258414976
ICHTHYOSIS HYSTRIX, CURTH-MACKLIN TYPE	0.00378788	0.14050929258414976
SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY	0.00378788	0.14050929258414976
DERMATITIS, ATOPIC	0.00378788	0.14050929258414976
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.00378788	0.14050929258414976
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.00378788	0.14050929258414976
600459 ARTERIAL DISSECTION WITH LENTIGINOSIS	0.00378788	0.14050929258414976
FINGERPRINT BODY MYOPATHY	0.00378788	0.14050929258414976
VERTEBRAL FUSION, POSTERIOR LUMBOSACRAL, WITH BLEPHAROPTOSIS	0.00378788	0.14050929258414976
238800 HYPERMETABOLISM DUE TO DEFECT IN MITOCHONDRIA	0.00378788	0.14050929258414976
TINEA IMBRICATA, SUSCEPTIBILITY TO	0.00378788	0.14050929258414976
SUCROSURIA, HIATUS HERNIA AND MENTAL RETARDATION	0.00378788	0.14050929258414976
%193090 TRANSCOBALAMIN I DEFICIENCY;;TCN1 DEFICIENCY;;COBALAMIN PSEUDODEFICIENCY DUE TO TRANSCOBALAMIN DEFICIENCY;;COBALAMIN R BINDER PROTEIN DEFICIENCYTRANSCOBALAMIN I DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED;;R BINDER DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED	0.00378788	0.14050929258414976
OSTEOMESOPYKNOSIS	0.00378788	0.14050929258414976
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.00378788	0.14050929258414976
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.0037262339999999997	0.13822256865133178
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.003722099	0.13806918313625857
MUCOPOLYSACCHARIDOSIS TYPE 3	0.003722099	0.13806918313625857
SANDHOFF DISEASE	0.003722099	0.13806918313625857
COCKAYNE SYNDROME A; CSA	0.003722099	0.13806918313625857
RETT SYNDROME	0.003722099	0.13806918313625857
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.003722099	0.13806918313625857
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.003496613	0.1297049059290531
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.003496613	0.1297049059290531
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.003496613	0.1297049059290531
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.003496613	0.1297049059290531
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.003496613	0.1297049059290531
ZTTK SYNDROME; ZTTKS	0.003496613	0.1297049059290531
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.003496613	0.1297049059290531
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.003496613	0.1297049059290531
49,XXXXY SYNDROME	0.003496613	0.1297049059290531
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.003496613	0.1297049059290531
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.003496613	0.1297049059290531
611961 STEVENSON-CAREY SYNDROME	0.003496613	0.1297049059290531
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.003496613	0.1297049059290531
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.003496613	0.1297049059290531
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.003496613	0.1297049059290531
XQ25 MICRODUPLICATION SYNDROME	0.003496613	0.1297049059290531
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.003496613	0.1297049059290531
MATERNAL PHENYLKETONURIA	0.003496613	0.1297049059290531
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.003496613	0.1297049059290531
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.003496613	0.1297049059290531
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.003496613	0.1297049059290531
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.003496613	0.1297049059290531
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.003496613	0.1297049059290531
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.003496613	0.1297049059290531
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.003496613	0.1297049059290531
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.003496613	0.1297049059290531
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.003496613	0.1297049059290531
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.003496613	0.1297049059290531
MEND SYNDROME	0.003496613	0.1297049059290531
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.003496613	0.1297049059290531
CODAS SYNDROME	0.003496613	0.1297049059290531
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.003496613	0.1297049059290531
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.003496613	0.1297049059290531
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.003496613	0.1297049059290531
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.003496613	0.1297049059290531
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13	0.0034965000000000005	0.12970071425717808
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.0034965000000000005	0.12970071425717808
MENTAL RETARDATION, X-LINKED 105; MRX105	0.0034965000000000005	0.12970071425717808
HYPERURICEMIA, INFANTILE, WITH ABNORMAL BEHAVIOR AND NORMAL HYPOXANTHINEGUANINE PHOSPHORIBOSYLTRANSFERASE	0.0034965000000000005	0.12970071425717808
MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE	0.0034965000000000005	0.12970071425717808
INTELLECTUAL DISABILITY-CATARACTS-KYPHOSIS SYNDROME	0.0034965000000000005	0.12970071425717808
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 29	0.0034965000000000005	0.12970071425717808
OPTICOCOCHLEODENTATE DEGENERATION	0.0034965000000000005	0.12970071425717808
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.0033818599999999996	0.1254482074982926
THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	0.00327869	0.12162117398194397
OSTEOPETROSIS AND RELATED DISORDERS	0.00327869	0.12162117398194397
GRAY PLATELET SYNDROME	0.00327869	0.12162117398194397
FIBULAR HEMIMELIA	0.00327869	0.12162117398194397
ACUTE MYELOMONOCYTIC LEUKEMIA	0.00327869	0.12162117398194397
ACUTE PROMYELOCYTIC LEUKEMIA	0.00327869	0.12162117398194397
TRANSCOBALAMIN DEFICIENCY	0.00327869	0.12162117398194397
CHRONIC MYELOID LEUKEMIA	0.00327869	0.12162117398194397
OSTEOGENESIS IMPERFECTA	0.00327869	0.12162117398194397
MOYAMOYA DISEASE WITH EARLY-ONSET ACHALASIA	0.00327869	0.12162117398194397
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.00327869	0.12162117398194397
ROCH-LERI MESOSOMATOUS LIPOMATOSIS	0.00327869	0.12162117398194397
ACQUIRED PURPURA FULMINANS	0.00327869	0.12162117398194397
CONGENITAL AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.00327869	0.12162117398194397
REFRACTORY ANEMIA	0.00327869	0.12162117398194397
IDIOPATHIC APLASTIC ANEMIA	0.00327869	0.12162117398194397
THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME	0.00327869	0.12162117398194397
WISKOTT-ALDRICH SYNDROME	0.00327869	0.12162117398194397
SLC35A1-CDG	0.00327869	0.12162117398194397
IMMUNE THROMBOCYTOPENIC PURPURA	0.00327869	0.12162117398194397
CYCLIC NEUTROPENIA	0.00327869	0.12162117398194397
NIJMEGEN BREAKAGE SYNDROME	0.00327869	0.12162117398194397
IMMUNODEFICIENCY 52; IMD52	0.00327869	0.12162117398194397
STORMORKEN SYNDROME; STRMK	0.00327869	0.12162117398194397
AUTOINFLAMMATORY SYNDROME, FAMILIAL, BEHCET-LIKE	0.00327869	0.12162117398194397
HEMANGIOMA-THROMBOCYTOPENIA SYNDROME	0.00327869	0.12162117398194397
DIAMOND-BLACKFAN ANEMIA 1	0.00327869	0.12162117398194397
FANCONI ANEMIA	0.00327869	0.12162117398194397
167850 PANCYTOPENIA AND OCCLUSIVE VASCULAR DISEASE	0.00327869	0.12162117398194397
IVIC SYNDROME	0.00327869	0.12162117398194397
BLEEDING DISORDER, PLATELET-TYPE, 20	0.00327869	0.12162117398194397
THROMBOCYTOPENIA 6	0.00327869	0.12162117398194397
PLATELET DISORDER, FAMILIAL, WITH ASSOCIATED MYELOID MALIGNANCY	0.00327869	0.12162117398194397
600903 WISKOTT-ALDRICH SYNDROME, AUTOSOMAL DOMINANT FORM	0.00327869	0.12162117398194397
BEEMER-ERTBRUGGEN SYNDROME	0.00327869	0.12162117398194397
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.00327869	0.12162117398194397
VON WILLEBRAND DISEASE, TYPE 3; VWD3	0.00327869	0.12162117398194397
NIJMEGEN BREAKAGE SYNDROME	0.00327869	0.12162117398194397
DEAFNESS, AUTOSOMAL DOMINANT 1	0.00327869	0.12162117398194397
FANCONI ANEMIA, COMPLEMENTATION GROUP V	0.00327869	0.12162117398194397
IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED; IPEX	0.00327869	0.12162117398194397
THROMBOCYTOPENIA, ANEMIA, AND MYELOFIBROSIS; THAMY	0.00327869	0.12162117398194397
BLEEDING DISORDER, PLATELET-TYPE, 21; BDPLT21	0.00327869	0.12162117398194397
TUFTED ANGIOMA	0.00327869	0.12162117398194397
AREGENERATIVE ANEMIA	0.00327869	0.12162117398194397
MONOSOMY 7 OF BONE MARROW	0.00327869	0.12162117398194397
ATYPICAL HEMOLYTIC UREMIC SYNDROME	0.00327869	0.12162117398194397
EOSINOPHILIA, FAMILIAL	0.00327869	0.12162117398194397
PLATELET ABNORMALITIES WITH EOSINOPHILIA AND IMMUNE-MEDIATED INFLAMMATORY DISEASE; PLTEID	0.00327869	0.12162117398194397
MACROTHROMBOCYTOPENIA AND GRANULOCYTE INCLUSIONS WITH OR WITHOUT NEPHRITIS OR SENSORINEURAL HEARING LOSS; MATINS	0.00327869	0.12162117398194397
THROMBOCYTOPENIA 3	0.00327869	0.12162117398194397
FANCONI ANEMIA, COMPLEMENTATION GROUP B; FANCB	0.00327869	0.12162117398194397
SENGERS SYNDROME	0.00327869	0.12162117398194397
GIANT PLATELET SYNDROME WITH THROMBOCYTOPENIA	0.00327869	0.12162117398194397
IMMUNODEFICIENCY, COMMON VARIABLE, 12; CVID12	0.00327869	0.12162117398194397
SCHIMKE IMMUNO-OSSEOUS DYSPLASIA	0.00327869	0.12162117398194397
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.00327869	0.12162117398194397
BLEEDING DISORDER, PLATELET-TYPE, 17; BDPLT17	0.00327869	0.12162117398194397
VON WILLEBRAND DISEASE, TYPE 2; VWD2	0.00327869	0.12162117398194397
HERMANSKY-PUDLAK SYNDROME 5; HPS5	0.00327869	0.12162117398194397
THROMBOCYTOPENIA 2	0.00327869	0.12162117398194397
HERMANSKY-PUDLAK SYNDROME 9	0.00327869	0.12162117398194397
ALPHA-THALASSEMIA-MYELODYSPLASTIC SYNDROME	0.00327869	0.12162117398194397
BETA-THALASSEMIA-X-LINKED THROMBOCYTOPENIA SYNDROME	0.00327869	0.12162117398194397
%614200 BLEEDING DISORDER, PLATELET-TYPE, 9; BDPLT9;;GLYCOPROTEIN IA DEFICIENCY;;GP IA DEFICIENCY;;COLLAGEN PLATELET RECEPTOR DEFICIENCY	0.00327869	0.12162117398194397
THROMBOCYTOPENIA, CYCLIC	0.00327869	0.12162117398194397
188030 THROMBOCYTOPENIC PURPURA, AUTOIMMUNE; AITP;;IMMUNE THROMBOCYTOPENIC PURPURA; ITP;;IDIOPATHIC THROMBOCYTOPENIC PURPURA	0.00327869	0.12162117398194397
WT LIMB-BLOOD SYNDROME	0.00327869	0.12162117398194397
DRUG-INDUCED LUPUS ERYTHEMATOSUS	0.00327869	0.12162117398194397
FANCONI ANEMIA, COMPLEMENTATION GROUP T; FANCT	0.00327869	0.12162117398194397
BLEEDING DISORDER, PLATELET-TYPE, 15; BDPLT15	0.00327869	0.12162117398194397
JACOBSEN SYNDROME	0.00327869	0.12162117398194397
IVIC SYNDROME	0.00327869	0.12162117398194397
CERNUNNOS-XLF DEFICIENCY	0.00327869	0.12162117398194397
SEBASTIAN SYNDROME	0.00327869	0.12162117398194397
PLATELET DISORDER, UNDEFINED	0.00327869	0.12162117398194397
THROMBOCYTOPENIA 5; THC5	0.00327869	0.12162117398194397
ISOLATED AGAMMAGLOBULINEMIA	0.00327869	0.12162117398194397
BEEMER LETHAL MALFORMATION SYNDROME	0.00327869	0.12162117398194397
PLATELET SIGNAL PROCESSING DEFECT	0.00327869	0.12162117398194397
HODGKIN LYMPHOMA	0.00318068	0.11798554778307481
TYPHOID	0.00318068	0.11798554778307481
CLASSIC HODGKIN LYMPHOMA	0.00318068	0.11798554778307481
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.00318068	0.11798554778307481
CAMURATI-ENGELMANN DISEASE	0.00318068	0.11798554778307481
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.00318068	0.11798554778307481
ICHTHYOSIS-HEPATOSPLENOMEGALY-CEREBELLAR DEGENERATION SYNDROME	0.00318068	0.11798554778307481
WEAVER SYNDROME	0.002991733	0.1109766643691606
17Q11.2 MICRODUPLICATION SYNDROME	0.002991733	0.1109766643691606
11P15.4 MICRODUPLICATION SYNDROME	0.002991733	0.1109766643691606
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.002991733	0.1109766643691606
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.002991733	0.1109766643691606
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.002991733	0.1109766643691606
LANDAU-KLEFFNER SYNDROME	0.002991733	0.1109766643691606
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.002991733	0.1109766643691606
DISTAL MONOSOMY 15Q	0.002991733	0.1109766643691606
15Q14 MICRODELETION SYNDROME	0.002991733	0.1109766643691606
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.002991733	0.1109766643691606
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.002991733	0.1109766643691606
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.002991733	0.1109766643691606
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.002991733	0.1109766643691606
LUSCAN-LUMISH SYNDROME; LLS	0.002991733	0.1109766643691606
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.002991733	0.1109766643691606
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.002991733	0.1109766643691606
WIEDEMANN-STEINER SYNDROME; WDSTS	0.002991733	0.1109766643691606
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.002991733	0.1109766643691606
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.002991733	0.1109766643691606
CHROMOSOME 5Q12 DELETION SYNDROME	0.002991733	0.1109766643691606
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.002991733	0.1109766643691606
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.002991733	0.1109766643691606
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.002991733	0.1109766643691606
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.002991733	0.1109766643691606
GLASS SYNDROME	0.002991733	0.1109766643691606
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.002991733	0.1109766643691606
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.002991733	0.1109766643691606
CHROMOSOME 19P13.13 DELETION SYNDROME	0.002991733	0.1109766643691606
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.002991733	0.1109766643691606
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.002991733	0.1109766643691606
WIEACKER-WOLFF SYNDROME	0.002991733	0.1109766643691606
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.002991733	0.1109766643691606
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.002991733	0.1109766643691606
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.002991733	0.1109766643691606
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.002991733	0.1109766643691606
KLEEFSTRA SYNDROME 2; KLEFS2	0.002991733	0.1109766643691606
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.002991733	0.1109766643691606
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.002991733	0.1109766643691606
JOUBERT SYNDROME 30; JBTS30	0.002991733	0.1109766643691606
MENTAL RETARDATION, X-LINKED 9	0.002991733	0.1109766643691606
48,XXXY SYNDROME	0.002991733	0.1109766643691606
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.002991733	0.1109766643691606
SHUKLA-VERNON SYNDROME; SHUVER	0.002991733	0.1109766643691606
SHASHI-PENA SYNDROME; SHAPNS	0.002991733	0.1109766643691606
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.002991733	0.1109766643691606
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.002991733	0.1109766643691606
MENTAL RETARDATION, X-LINKED 90	0.002991733	0.1109766643691606
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.002991733	0.1109766643691606
PRADER-WILLI SYNDROME; PWS	0.002991733	0.1109766643691606
CK SYNDROME	0.002991733	0.1109766643691606
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.0029551939999999995	0.10962127057586929
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.0029551939999999995	0.10962127057586929
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.0029551939999999995	0.10962127057586929
17P13.3 MICRODUPLICATION SYNDROME	0.0029551939999999995	0.10962127057586929
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.0029551939999999995	0.10962127057586929
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.0029551939999999995	0.10962127057586929
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.0029551939999999995	0.10962127057586929
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.0029551939999999995	0.10962127057586929
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.0029551939999999995	0.10962127057586929
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.0029551939999999995	0.10962127057586929
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.0029551939999999995	0.10962127057586929
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.0029551939999999995	0.10962127057586929
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.0029551939999999995	0.10962127057586929
GOLDBERG-SHPRINTZEN SYNDROME	0.0029551939999999995	0.10962127057586929
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.0029551939999999995	0.10962127057586929
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.0029551939999999995	0.10962127057586929
TYSHCHENKO SYNDROME	0.0029551939999999995	0.10962127057586929
XIA-GIBBS SYNDROME	0.0029551939999999995	0.10962127057586929
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.0029551939999999995	0.10962127057586929
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.0029551939999999995	0.10962127057586929
TURNPENNY-FRY SYNDROME; TPFS	0.0029551939999999995	0.10962127057586929
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.002951059	0.1094678850607961
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.002951059	0.1094678850607961
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.002951059	0.1094678850607961
RETT SYNDROME, CONGENITAL VARIANT	0.002951059	0.1094678850607961
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.002951059	0.1094678850607961
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.002951059	0.1094678850607961
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.002951059	0.1094678850607961
MENTAL RETARDATION, X-LINKED 102	0.002951059	0.1094678850607961
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.002951059	0.1094678850607961
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.002951059	0.1094678850607961
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.002951059	0.1094678850607961
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.002951059	0.1094678850607961
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.002951059	0.1094678850607961
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.002951059	0.1094678850607961
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.002951059	0.1094678850607961
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.002951059	0.1094678850607961
WARBURG MICRO SYNDROME 3; WARBM3	0.002951059	0.1094678850607961
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.002951059	0.1094678850607961
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.002951059	0.1094678850607961
MUCOPOLYSACCHARIDOSIS TYPE 2	0.0027905530000000003	0.10351400465394281
C SYNDROME	0.0027905530000000003	0.10351400465394281
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.0027905530000000003	0.10351400465394281
MULTIPLE SULFATASE DEFICIENCY	0.0027905530000000003	0.10351400465394281
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.0027905530000000003	0.10351400465394281
KAGAMI-OGATA SYNDROME	0.0027905530000000003	0.10351400465394281
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.0027905530000000003	0.10351400465394281
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.0027905530000000003	0.10351400465394281
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.0027905530000000003	0.10351400465394281
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.0027905530000000003	0.10351400465394281
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.0027905530000000003	0.10351400465394281
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.002564073	0.09511285557201353
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.002564073	0.09511285557201353
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.002564073	0.09511285557201353
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.002564073	0.09511285557201353
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.002564073	0.09511285557201353
MEVALONIC ACIDURIA	0.002564073	0.09511285557201353
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.002564073	0.09511285557201353
48,XXYY SYNDROME	0.002564073	0.09511285557201353
ELEJALDE DISEASE	0.002564073	0.09511285557201353
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.002564073	0.09511285557201353
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.002564073	0.09511285557201353
HARTNUP DISEASE	0.002564073	0.09511285557201353
MYHRE SYNDROME	0.002564073	0.09511285557201353
GRISCELLI SYNDROME TYPE 1	0.002564073	0.09511285557201353
CENTRAL BILATERAL MACROGYRIA	0.002564073	0.09511285557201353
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.002564073	0.09511285557201353
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.002564073	0.09511285557201353
SULFOCYSTEINURIA	0.002564073	0.09511285557201353
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.002564073	0.09511285557201353
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.002564073	0.09511285557201353
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.002564073	0.09511285557201353
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.002564073	0.09511285557201353
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.002564073	0.09511285557201353
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.002564073	0.09511285557201353
EAST SYNDROME	0.002564073	0.09511285557201353
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.002564073	0.09511285557201353
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.002564073	0.09511285557201353
MAPLE SYRUP URINE DISEASE	0.002564073	0.09511285557201353
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.002564073	0.09511285557201353
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.002564073	0.09511285557201353
COWDEN SYNDROME	0.002564073	0.09511285557201353
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.002564073	0.09511285557201353
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.002564073	0.09511285557201353
6Q16 MICRODELETION SYNDROME	0.002450314	0.09089302901597682
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.002450314	0.09089302901597682
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.002450314	0.09089302901597682
BARATELA-SCOTT SYNDROME	0.002450314	0.09089302901597682
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.002450314	0.09089302901597682
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.002450314	0.09089302901597682
16P11.2P12.2 MICRODELETION SYNDROME	0.002450314	0.09089302901597682
LAMB-SHAFFER SYNDROME	0.002450314	0.09089302901597682
COHEN-GIBSON SYNDROME; COGIS	0.002450314	0.09089302901597682
TONNE-KALSCHEUER SYNDROME; TOKAS	0.002450314	0.09089302901597682
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.002450314	0.09089302901597682
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.002450314	0.09089302901597682
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.002450314	0.09089302901597682
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.002450314	0.09089302901597682
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.002450314	0.09089302901597682
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.002450314	0.09089302901597682
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.002450314	0.09089302901597682
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.002450314	0.09089302901597682
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.002450314	0.09089302901597682
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.002450314	0.09089302901597682
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.002450314	0.09089302901597682
48,XYYY SYNDROME	0.002450314	0.09089302901597682
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.002450314	0.09089302901597682
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.002450314	0.09089302901597682
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.002450314	0.09089302901597682
1P21.3 MICRODELETION SYNDROME	0.002450314	0.09089302901597682
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.002450314	0.09089302901597682
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.002450314	0.09089302901597682
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.002450314	0.09089302901597682
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.002450314	0.09089302901597682
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.002450314	0.09089302901597682
SAUL-WILSON SYNDROME; SWILS	0.002450314	0.09089302901597682
SAY-BARBER-MILLER SYNDROME	0.002450314	0.09089302901597682
3Q29 MICRODELETION SYNDROME	0.002450314	0.09089302901597682
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.002450314	0.09089302901597682
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.002450314	0.09089302901597682
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.002450314	0.09089302901597682
DUCHENNE MUSCULAR DYSTROPHY	0.002450314	0.09089302901597682
2Q32Q33 MICRODELETION SYNDROME	0.002450314	0.09089302901597682
DISTAL MONOSOMY 6P	0.002450314	0.09089302901597682
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.002450314	0.09089302901597682
COFFIN-SIRIS SYNDROME 7; CSS7	0.002450314	0.09089302901597682
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.002450314	0.09089302901597682
CHROMOSOME 9P DELETION SYNDROME	0.002450314	0.09089302901597682
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.002450314	0.09089302901597682
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.002450314	0.09089302901597682
2P15P16.1 MICRODELETION SYNDROME	0.002450314	0.09089302901597682
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.002450314	0.09089302901597682
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.002450314	0.09089302901597682
DESBUQUOIS DYSPLASIA 2; DBQD2	0.002450314	0.09089302901597682
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.002450314	0.09089302901597682
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.002450314	0.09089302901597682
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.002450314	0.09089302901597682
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.002450314	0.09089302901597682
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.002450314	0.09089302901597682
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.002450314	0.09089302901597682
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.002450314	0.09089302901597682
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.002450314	0.09089302901597682
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.002450314	0.09089302901597682
ABLEPHARON MACROSTOMIA SYNDROME	0.002450314	0.09089302901597682
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.002450314	0.09089302901597682
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.002450314	0.09089302901597682
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.002450314	0.09089302901597682
8P23.1 DUPLICATION SYNDROME	0.002450314	0.09089302901597682
COFFIN-SIRIS SYNDROME 8; CSS8	0.0024461789999999997	0.09073964350090363
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.0024461789999999997	0.09073964350090363
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.0024461789999999997	0.09073964350090363
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.0024461789999999997	0.09073964350090363
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.0024461789999999997	0.09073964350090363
20P13 MICRODELETION SYNDROME	0.0024461789999999997	0.09073964350090363
17Q12 MICRODUPLICATION SYNDROME	0.0024461789999999997	0.09073964350090363
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.0024461789999999997	0.09073964350090363
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.0024461789999999997	0.09073964350090363
TENORIO SYNDROME; TNORS	0.0024461789999999997	0.09073964350090363
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.0024461789999999997	0.09073964350090363
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.0024461789999999997	0.09073964350090363
KLEEFSTRA SYNDROME	0.0024461789999999997	0.09073964350090363
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.0024461789999999997	0.09073964350090363
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.0024461789999999997	0.09073964350090363
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.0024461789999999997	0.09073964350090363
PARTINGTON SYNDROME	0.0024461789999999997	0.09073964350090363
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.0024461789999999997	0.09073964350090363
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.0024461789999999997	0.09073964350090363
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.0024461789999999997	0.09073964350090363
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.0024461789999999997	0.09073964350090363
17Q24.2 MICRODELETION SYNDROME	0.0024461789999999997	0.09073964350090363
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.0024461789999999997	0.09073964350090363
AUTISM	0.0024461789999999997	0.09073964350090363
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.0024461789999999997	0.09073964350090363
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.0024461789999999997	0.09073964350090363
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.0024461789999999997	0.09073964350090363
47,XYY SYNDROME	0.0024461789999999997	0.09073964350090363
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.0024461789999999997	0.09073964350090363
CRANIOFRONTONASAL DYSPLASIA	0.00240964	0.08938424970761233
FONTAINE PROGEROID SYNDROME; FPS	0.00240964	0.08938424970761233
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 32	0.00240964	0.08938424970761233
MONOSOMY 13Q14	0.00240964	0.08938424970761233
ANIRIDIA	0.00240964	0.08938424970761233
PRIMROSE SYNDROME; PRIMS	0.00240964	0.08938424970761233
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.00240964	0.08938424970761233
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.00240964	0.08938424970761233
VAN MALDERGEM SYNDROME 1; VMLDS1	0.00240964	0.08938424970761233
FRONTONASAL DYSPLASIA 2; FND2	0.00240964	0.08938424970761233
LEUKOENCEPHALOPATHY-PALMOPLANTAR KERATODERMA SYNDROME	0.00240964	0.08938424970761233
FRONTOFACIONASAL DYSPLASIA	0.00240964	0.08938424970761233
%611252 SPASTIC PARAPLEGIA 32, AUTOSOMAL RECESSIVE; SPG32	0.00240964	0.08938424970761233
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.00240964	0.08938424970761233
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.00240964	0.08938424970761233
VAN MALDERGEM SYNDROME 2; VMLDS2	0.00240964	0.08938424970761233
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.00240964	0.08938424970761233
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.00240964	0.08938424970761233
LETHAL CONGENITAL CONTRACTURE SYNDROME 7; LCCS7	0.00240964	0.08938424970761233
SPASTIC PARAPLEGIA-INTELLECTUAL DISABILITY-NYSTAGMUS-OBESITY SYNDROME	0.00240964	0.08938424970761233
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 66	0.00240964	0.08938424970761233
CEREBROOCULONASAL SYNDROME	0.00240964	0.08938424970761233
CEREBROFACIOTHORACIC DYSPLASIA	0.00240964	0.08938424970761233
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B	0.00240964	0.08938424970761233
ROIFMAN SYNDROME; RFMN	0.002249134	0.083430369300759
WOLMAN DISEASE	0.002249134	0.083430369300759
ALPHA-MANNOSIDOSIS	0.002249134	0.083430369300759
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.002249134	0.083430369300759
MACROCEPHALY/AUTISM SYNDROME	0.002249134	0.083430369300759
LIG4 SYNDROME	0.002249134	0.083430369300759
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.002249134	0.083430369300759
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.002249134	0.083430369300759
PEROXISOME BIOGENESIS DISORDER 3B	0.002249134	0.083430369300759
HURLER SYNDROME	0.002249134	0.083430369300759
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.002249134	0.083430369300759
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.002249134	0.083430369300759
OCULOSKELETODENTAL SYNDROME; OCSKD	0.002249134	0.083430369300759
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.002249134	0.083430369300759
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.002244999	0.08327698378568582
GLUTARIC ACIDEMIA I; GA1	0.002244999	0.08327698378568582
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.002244999	0.08327698378568582
MUCOPOLYSACCHARIDOSIS, TYPE II	0.002244999	0.08327698378568582
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.002244999	0.08327698378568582
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.002244999	0.08327698378568582
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.002244999	0.08327698378568582
ZIMMERMANN-LABAND SYNDROME 1	0.002244999	0.08327698378568582
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.002244999	0.08327698378568582
ZIMMERMANN-LABAND SYNDROME	0.002244999	0.08327698378568582
GAUCHER DISEASE, TYPE IIIC	0.002244999	0.08327698378568582
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.002244999	0.08327698378568582
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.002244999	0.08327698378568582
USHER SYNDROME TYPE 1	0.0020226539999999996	0.07502922021882973
JOUBERT SYNDROME 25	0.0020226539999999996	0.07502922021882973
BAKER-GORDON SYNDROME; BAGOS	0.0020226539999999996	0.07502922021882973
OXOGLUTARIC ACIDURIA	0.0020226539999999996	0.07502922021882973
JOUBERT SYNDROME 27	0.0020226539999999996	0.07502922021882973
JOUBERT SYNDROME 28	0.0020226539999999996	0.07502922021882973
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.0020226539999999996	0.07502922021882973
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.0020226539999999996	0.07502922021882973
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.0020226539999999996	0.07502922021882973
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.0020226539999999996	0.07502922021882973
WAARDENBURG-SHAH SYNDROME	0.0020226539999999996	0.07502922021882973
MARINESCO-SJÖGREN SYNDROME	0.0020226539999999996	0.07502922021882973
JOUBERT SYNDROME 35; JBTS35	0.0020226539999999996	0.07502922021882973
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.0020226539999999996	0.07502922021882973
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.0020226539999999996	0.07502922021882973
JOUBERT SYNDROME 8	0.0020226539999999996	0.07502922021882973
JOUBERT SYNDROME 17; JBTS17	0.0020226539999999996	0.07502922021882973
MECKEL SYNDROME 13; MKS13	0.0020226539999999996	0.07502922021882973
OROFACIODIGITAL SYNDROME XVI; OFD16	0.0020226539999999996	0.07502922021882973
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.0020226539999999996	0.07502922021882973
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.0020226539999999996	0.07502922021882973
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.0020226539999999996	0.07502922021882973
JOUBERT SYNDROME 32; JBTS32	0.0020226539999999996	0.07502922021882973
JOUBERT SYNDROME 33; JBTS33	0.0020226539999999996	0.07502922021882973
JOUBERT SYNDROME 15	0.0020226539999999996	0.07502922021882973
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.0020226539999999996	0.07502922021882973
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.0020226539999999996	0.07502922021882973
JOUBERT SYNDROME 14	0.0020226539999999996	0.07502922021882973
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.0020226539999999996	0.07502922021882973
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.0020226539999999996	0.07502922021882973
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.0020226539999999996	0.07502922021882973
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.0020226539999999996	0.07502922021882973
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.0020226539999999996	0.07502922021882973
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.0020226539999999996	0.07502922021882973
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.0020226539999999996	0.07502922021882973
PELLAGRA-LIKE SYNDROME	0.0020226539999999996	0.07502922021882973
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.0020226539999999996	0.07502922021882973
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.0020226539999999996	0.07502922021882973
RICHARDS-RUNDLE SYNDROME; RRNS	0.0020226539999999996	0.07502922021882973
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.0020226539999999996	0.07502922021882973
CEREBELLOPARENCHYMAL DISORDER II	0.002018519	0.07487583470375654
GM1 GANGLIOSIDOSIS	0.002018519	0.07487583470375654
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.002018519	0.07487583470375654
KEARNS-SAYRE SYNDROME; KSS	0.002018519	0.07487583470375654
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.002018519	0.07487583470375654
WOLFRAM SYNDROME	0.002018519	0.07487583470375654
X-LINKED INTELLECTUAL DISABILITY-ATAXIA-APRAXIA SYNDROME	0.002018519	0.07487583470375654
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.002018519	0.07487583470375654
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.002018519	0.07487583470375654
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.002018519	0.07487583470375654
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.002018519	0.07487583470375654
CYCLIC VOMITING SYNDROME	0.002018519	0.07487583470375654
EARLY-ONSET LAFORA BODY DISEASE	0.002018519	0.07487583470375654
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.002018519	0.07487583470375654
ALEXANDER DISEASE	0.002018519	0.07487583470375654
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.002018519	0.07487583470375654
CITRULLINEMIA TYPE I	0.002018519	0.07487583470375654
TRIPLE A SYNDROME	0.002018519	0.07487583470375654
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.002018519	0.07487583470375654
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.002018519	0.07487583470375654
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.002018519	0.07487583470375654
FAMILIAL DYSAUTONOMIA	0.002018519	0.07487583470375654
TYROSINEMIA TYPE 2	0.002018519	0.07487583470375654
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.002018519	0.07487583470375654
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.002018519	0.07487583470375654
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.002018519	0.07487583470375654
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.002018519	0.07487583470375654
LEIGH SYNDROME	0.002018519	0.07487583470375654
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.002018519	0.07487583470375654
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.002018519	0.07487583470375654
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.002018519	0.07487583470375654
DYSEQUILIBRIUM SYNDROME	0.002018519	0.07487583470375654
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.002018519	0.07487583470375654
HEREDITARY HYPEREKPLEXIA	0.002018519	0.07487583470375654
METACHROMATIC LEUKODYSTROPHY	0.002018519	0.07487583470375654
FLYNN-AIRD SYNDROME	0.002018519	0.07487583470375654
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.002018519	0.07487583470375654
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.002018519	0.07487583470375654
DIAMINOPENTANURIA	0.002018519	0.07487583470375654
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.002018519	0.07487583470375654
CAMOS SYNDROME	0.002018519	0.07487583470375654
GLUTATHIONE SYNTHETASE DEFICIENCY	0.002018519	0.07487583470375654
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.002018519	0.07487583470375654
SYMMETRICAL THALAMIC CALCIFICATIONS	0.002018519	0.07487583470375654
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.002018519	0.07487583470375654
ATYPICAL TERATOID RHABDOID TUMOR	0.002018519	0.07487583470375654
GITELMAN SYNDROME	0.002018519	0.07487583470375654
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.002018519	0.07487583470375654
SIALIDOSIS TYPE 1	0.002018519	0.07487583470375654
COCKAYNE SYNDROME	0.002018519	0.07487583470375654
CONGENITAL MYASTHENIC SYNDROME	0.002018519	0.07487583470375654
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.002018519	0.07487583470375654
KNOBLOCH SYNDROME 1; KNO1	0.002018519	0.07487583470375654
ISOLATED CEREBELLAR AGENESIS	0.002018519	0.07487583470375654
KUFOR-RAKEB SYNDROME	0.002018519	0.07487583470375654
NEUROFIBROMATOSIS, TYPE II	0.002018519	0.07487583470375654
KALLMANN SYNDROME	0.002018519	0.07487583470375654
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.002018519	0.07487583470375654
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.002018519	0.07487583470375654
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.002018519	0.07487583470375654
LHERMITTE-DUCLOS DISEASE	0.002018519	0.07487583470375654
PERRAULT SYNDROME 5; PRLTS5	0.002018519	0.07487583470375654
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.002018519	0.07487583470375654
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.002018519	0.07487583470375654
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.002018519	0.07487583470375654
XERODERMA PIGMENTOSUM	0.002018519	0.07487583470375654
FLYNN-AIRD SYNDROME	0.002018519	0.07487583470375654
EPISODIC ATAXIA TYPE 6	0.002018519	0.07487583470375654
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.002018519	0.07487583470375654
TEMPLE SYNDROME	0.00190476	0.07065600814771986
SEVERE EARLY-ONSET OBESITY-INSULIN RESISTANCE SYNDROME DUE TO SH2B1 DEFICIENCY	0.00190476	0.07065600814771986
CRANIOSYNOSTOSIS 7	0.00190476	0.07065600814771986
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00190476	0.07065600814771986
RECURRENT 16P12.1 MICRODELETION (NEURODEVELOPMENTAL SUSCEPTIBILITY LOCUS)	0.00190476	0.07065600814771986
22Q11 DELETION SYNDROME (VELOCARDIOFACIAL / DIGEORGE SYNDROME)	0.00190476	0.07065600814771986
TEMPLE SYNDROME	0.00190476	0.07065600814771986
EPISODIC ATAXIA TYPE 1	0.00190476	0.07065600814771986
129540 ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE ANDPREAXIAL POLYDACTYLY OF FEET	0.00190476	0.07065600814771986
SPECIFIC LANGUAGE IMPAIRMENT 1; SLI1	0.00190476	0.07065600814771986
DYSTONIA 16; DYT16	0.00190476	0.07065600814771986
AUTOSOMAL RECESSIVE CENTRONUCLEAR MYOPATHY	0.00190476	0.07065600814771986
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.00190476	0.07065600814771986
LARYNGOTRACHEAL ANGIOMA	0.00190476	0.07065600814771986
CHITAYAT SYNDROME	0.00190476	0.07065600814771986
SPEECH-LANGUAGE DISORDER 1	0.00190476	0.07065600814771986
BETA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R4	0.00190476	0.07065600814771986
NAGER SYNDROME	0.00190476	0.07065600814771986
224550 DYSTONIA WITH RINGBINDEN	0.00190476	0.07065600814771986
BRACHYDACTYLY, TYPE A1, D	0.00190476	0.07065600814771986
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.00190476	0.07065600814771986
PRIMARY CILIARY DYSKINESIA	0.00190476	0.07065600814771986
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.00190476	0.07065600814771986
PROGRESSIVE SUPRANUCLEAR PALSY	0.00190476	0.07065600814771986
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.00190476	0.07065600814771986
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.00190476	0.07065600814771986
POSTORGASMIC ILLNESS SYNDROME	0.00190476	0.07065600814771986
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 54	0.00190476	0.07065600814771986
STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET	0.00190476	0.07065600814771986
GERODERMA OSTEODYSPLASTICUM; GO	0.00190476	0.07065600814771986
DUBOWITZ SYNDROME	0.00190476	0.07065600814771986
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.00190476	0.07065600814771986
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.00190476	0.07065600814771986
MENTAL RETARDATION, TRUNCAL OBESITY, RETINAL DYSTROPHY, AND MICROPENIS SYNDROME; MORMS	0.00190476	0.07065600814771986
MEIER-GORLIN SYNDROME 6; MGORS6	0.00190476	0.07065600814771986
DELAYED SPEECH-FACIAL ASYMMETRY-STRABISMUS-EAR LOBE CREASES SYNDROME	0.00190476	0.07065600814771986
HYPOGLOSSIA WITH SITUS INVERSUS	0.00190476	0.07065600814771986
FG SYNDROME 2; FGS2	0.00190476	0.07065600814771986
DEAFNESS, AUTOSOMAL RECESSIVE 79; DFNB79	0.00190476	0.07065600814771986
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.00190476	0.07065600814771986
X-LINKED INTELLECTUAL DISABILITY-PLAGIOCEPHALY SYNDROME	0.00190476	0.07065600814771986
CLEFT LIP/PALATE	0.00190476	0.07065600814771986
MENTAL RETARDATION, X-LINKED 93	0.00190476	0.07065600814771986
THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT	0.00190476	0.07065600814771986
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.00190476	0.07065600814771986
MENTAL RETARDATION, X-LINKED 97; MRX97	0.00190476	0.07065600814771986
MICROTRIPLICATION 11Q24.1	0.00190476	0.07065600814771986
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.00190476	0.07065600814771986
OROFACIODIGITAL SYNDROME XVII	0.00190476	0.07065600814771986
HYPERPARATHYROIDISM, TRANSIENT NEONATAL; HRPTTN	0.00190476	0.07065600814771986
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 8; MDDGC8	0.00190476	0.07065600814771986
MENTAL RETARDATION, X-LINKED 95	0.00190476	0.07065600814771986
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.00190476	0.07065600814771986
7Q11.23 DUPLICATION SYNDROME	0.00190476	0.07065600814771986
VERVERI-BRADY SYNDROME; VERBRAS	0.00190476	0.07065600814771986
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 25	0.00190476	0.07065600814771986
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00190476	0.07065600814771986
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00190476	0.07065600814771986
ABLEPHARON-MACROSTOMIA SYNDROME	0.00190476	0.07065600814771986
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 53	0.00190476	0.07065600814771986
MAXILLOFACIAL DYSOSTOSIS	0.00190476	0.07065600814771986
MENTAL RETARDATION, X-LINKED 19	0.00190476	0.07065600814771986
SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, ANDTRANSVERSE EARLOBE CREASE	0.00190476	0.07065600814771986
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.00190476	0.07065600814771986
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28	0.00190476	0.07065600814771986
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.00190476	0.07065600814771986
SOTOS SYNDROME 2	0.00190476	0.07065600814771986
DISTAL 7Q11.23 MICRODUPLICATION SYNDROME	0.00190476	0.07065600814771986
19Q13.11 MICRODELETION SYNDROME	0.00190476	0.07065600814771986
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.00190476	0.07065600814771986
FRAXE INTELLECTUAL DISABILITY	0.00190476	0.07065600814771986
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 14	0.00190476	0.07065600814771986
MICROTIA	0.00190476	0.07065600814771986
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00190476	0.07065600814771986
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.00190476	0.07065600814771986
MEIER-GORLIN SYNDROME 3; MGORS3	0.00190476	0.07065600814771986
22Q13 DELETION SYNDROME (PHELAN-MCDERMID SYNDROME)	0.00190476	0.07065600814771986
CONGENITAL MUSCULAR DYSTROPHY-RESPIRATORY FAILURE-SKIN ABNORMALITIES-JOINT HYPERLAXITY SYNDROME	0.00190476	0.07065600814771986
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.00190476	0.07065600814771986
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.00190476	0.07065600814771986
FISH-EYE DISEASE	0.00170358	0.06319334843250204
FAMILIAL TUMORAL CALCINOSIS	0.00170358	0.06319334843250204
HYPERZINCEMIA WITH FUNCTIONAL ZINC DEPLETION	0.00170358	0.06319334843250204
IMMUNODEFICIENCY 63 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD63	0.00170358	0.06319334843250204
FAMILIAL MEDITERRANEAN FEVER; FMF	0.00170358	0.06319334843250204
CUTANEOUS MASTOCYTOSIS	0.00170358	0.06319334843250204
SCHEIE SYNDROME	0.00170358	0.06319334843250204
MAST CELL SARCOMA	0.00170358	0.06319334843250204
AUTOSOMAL RECESSIVE MALIGNANT OSTEOPETROSIS	0.00170358	0.06319334843250204
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.00170358	0.06319334843250204
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE	0.00170358	0.06319334843250204
CYSTINOSIS, NEPHROPATHIC; CTNS	0.00170358	0.06319334843250204
APOLIPOPROTEIN C-II DEFICIENCY	0.00170358	0.06319334843250204
HYPERLIPOPROTEINEMIA, TYPE ID	0.00170358	0.06319334843250204
MACROSOMIA-MICROPHTHALMIA-CLEFT PALATE SYNDROME	0.00170358	0.06319334843250204
SCHNITZLER SYNDROME	0.00170358	0.06319334843250204
DESMOPLASTIC SMALL ROUND CELL TUMOR	0.00170358	0.06319334843250204
LYMPHOPROLIFERATIVE SYNDROME 3; LPFS3	0.00170358	0.06319334843250204
GLYCOGEN STORAGE DISEASE II	0.00170358	0.06319334843250204
XYLT1-CDG	0.00170358	0.06319334843250204
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE-2 DEFICIENCY	0.00170358	0.06319334843250204
HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN-BETA-THALASSEMIA SYNDROME	0.00170358	0.06319334843250204
SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1	0.00170358	0.06319334843250204
COLD AGGLUTININ DISEASE	0.00170358	0.06319334843250204
MULIBREY NANISM	0.00170358	0.06319334843250204
OPSISMODYSPLASIA	0.00170358	0.06319334843250204
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.00170358	0.06319334843250204
X-LINKED LYMPHOPROLIFERATIVE DISEASE	0.00170358	0.06319334843250204
HURLER-SCHEIE SYNDROME	0.00170358	0.06319334843250204
DIFFUSE CUTANEOUS MASTOCYTOSIS	0.00170358	0.06319334843250204
IMMUNODEFICIENCY, COMMON VARIABLE, 2; CVID2	0.00170358	0.06319334843250204
NIEMANN-PICK DISEASE, TYPE B	0.00170358	0.06319334843250204
LCAT DEFICIENCY	0.00170358	0.06319334843250204
FETAL CYTOMEGALOVIRUS SYNDROME	0.00170358	0.06319334843250204
OSTEOPETROSIS, AUTOSOMAL DOMINANT 3; OPTA3	0.00170358	0.06319334843250204
THROMBOCYTOSIS, FAMILIAL X-LINKED	0.00170358	0.06319334843250204
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.00170358	0.06319334843250204
SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED	0.00170358	0.06319334843250204
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE; SEMDSH	0.00170358	0.06319334843250204
FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG; FRTS4	0.00170358	0.06319334843250204
PERSISTENT POLYCLONAL B-CELL LYMPHOCYTOSIS; PPBL	0.00170358	0.06319334843250204
PROLIDASE DEFICIENCY	0.00170358	0.06319334843250204
NEONATAL SEVERE PRIMARY HYPERPARATHYROIDISM	0.00170358	0.06319334843250204
PALMOPLANTAR KERATODERMA-ESOPHAGEAL CARCINOMA SYNDROME	0.00170358	0.06319334843250204
POLYMYOSITIS	0.00170358	0.06319334843250204
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 3; MC3DN3	0.00170358	0.06319334843250204
MU-HEAVY CHAIN DISEASE	0.00170358	0.06319334843250204
AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS; AIADK	0.00170358	0.06319334843250204
PACHYONYCHIA CONGENITA	0.00170358	0.06319334843250204
NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA	0.00170358	0.06319334843250204
MUCKLE-WELLS SYNDROME	0.00170358	0.06319334843250204
MORQUIO SYNDROME A	0.00170358	0.06319334843250204
ALPHA-HEAVY CHAIN DISEASE	0.00170358	0.06319334843250204
SARCOIDOSIS, SUSCEPTIBILITY TO, 2; SS2	0.00170358	0.06319334843250204
LEBER CONGENITAL AMAUROSIS, TYPE I	0.00170358	0.06319334843250204
BONE DYSPLASIA, LETHAL HOLMGREN TYPE	0.00170358	0.06319334843250204
BRONCHIAL NEUROENDOCRINE TUMOR	0.00170358	0.06319334843250204
CONGENITAL TOTAL PULMONARY VENOUS RETURN ANOMALY	0.00170358	0.06319334843250204
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.00170358	0.06319334843250204
TANGIER DISEASE; TGD	0.00170358	0.06319334843250204
AREDYLD SYNDROME	0.00170358	0.06319334843250204
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 2; AHMIO2	0.00170358	0.06319334843250204
PYCNODYSOSTOSIS	0.00170358	0.06319334843250204
PFAPA SYNDROME	0.00170358	0.06319334843250204
ACROOSTEOLYSIS DOMINANT TYPE	0.00170358	0.06319334843250204
DISTAL MONOSOMY 17Q	0.00170358	0.06319334843250204
NAKAJO-NISHIMURA SYNDROME	0.00170358	0.06319334843250204
POIKILODERMA, HEREDITARY FIBROSING, WITH TENDON CONTRACTURES, MYOPATHY, AND PULMONARY FIBROSIS; POIKTMP	0.00170358	0.06319334843250204
HURLER-SCHEIE SYNDROME	0.00170358	0.06319334843250204
CARTILAGE-HAIR HYPOPLASIA	0.00170358	0.06319334843250204
SEVERE COMBINED IMMUNODEFICIENCY	0.00170358	0.06319334843250204
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE	0.00170358	0.06319334843250204
THORACO-ABDOMINAL ENTERIC DUPLICATION	0.00170358	0.06319334843250204
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.00170358	0.06319334843250204
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.00170358	0.06319334843250204
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.00170358	0.06319334843250204
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00170358	0.06319334843250204
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.00170358	0.06319334843250204
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.00170358	0.06319334843250204
MULTIPLE SYMMETRIC LIPOMATOSIS	0.00170358	0.06319334843250204
ATAXIA, DEAFNESS, AND CARDIOMYOPATHY	0.0014770999999999999	0.05479219935057277
USHER SYNDROME TYPE 2	0.0014770999999999999	0.05479219935057277
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.0014770999999999999	0.05479219935057277
SPINOCEREBELLAR ATAXIA WITH RIGIDITY AND PERIPHERAL NEUROPATHY	0.0014770999999999999	0.05479219935057277
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.0014770999999999999	0.05479219935057277
GILLESPIE SYNDROME; GLSP	0.0014770999999999999	0.05479219935057277
MYOCLONUS, FAMILIAL CORTICAL; FCM	0.0014770999999999999	0.05479219935057277
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.0014770999999999999	0.05479219935057277
FAMILIAL OR SPORADIC HEMIPLEGIC MIGRAINE	0.0014770999999999999	0.05479219935057277
ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.0014770999999999999	0.05479219935057277
SPINOCEREBELLAR ATAXIA 32; SCA32	0.0014770999999999999	0.05479219935057277
ATAXIA-TELANGIECTASIA WITH GENERALIZED SKIN PIGMENTATION AND EARLY DEATH	0.0014770999999999999	0.05479219935057277
MUSCULAR ATROPHY-ATAXIA-RETINITIS PIGMENTOSA-DIABETES MELLITUS SYNDROME	0.0014770999999999999	0.05479219935057277
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.0014770999999999999	0.05479219935057277
PIEBALD TRAIT WITH NEUROLOGIC DEFECTS	0.0014770999999999999	0.05479219935057277
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.0014770999999999999	0.05479219935057277
229310 FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA	0.0014770999999999999	0.05479219935057277
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.0014770999999999999	0.05479219935057277
KEARNS-SAYRE SYNDROME	0.0014770999999999999	0.05479219935057277
POLYENDOCRINE-POLYNEUROPATHY SYNDROME	0.0014770999999999999	0.05479219935057277
GÓMEZ-LÓPEZ-HERNÁNDEZ SYNDROME	0.0014770999999999999	0.05479219935057277
CLEFT LIP/PALATE-DEAFNESS-SACRAL LIPOMA SYNDROME	0.0014770999999999999	0.05479219935057277
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.0014770999999999999	0.05479219935057277
HUNTINGTON DISEASE-LIKE SYNDROME DUE TO C9ORF72 EXPANSIONS	0.0014770999999999999	0.05479219935057277
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.0014770999999999999	0.05479219935057277
CEREBELLAR HYPOPLASIA	0.0014770999999999999	0.05479219935057277
POSTERIOR COLUMN ATAXIA	0.0014770999999999999	0.05479219935057277
CHARCOT-MARIE-TOOTH DISEASE/HEREDITARY MOTOR AND SENSORY NEUROPATHY	0.0014770999999999999	0.05479219935057277
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.0014770999999999999	0.05479219935057277
ARGININOSUCCINIC ACIDURIA	0.0014770999999999999	0.05479219935057277
RETINAL CILIOPATHY DUE TO MUTATION IN USHER GENE	0.0014770999999999999	0.05479219935057277
JOUBERT SYNDROME 3; JBTS3	0.0014770999999999999	0.05479219935057277
NEUROFERRITINOPATHY	0.0014770999999999999	0.05479219935057277
PEROXISOME BIOGENESIS DISORDER 9B; PBD9B	0.0014770999999999999	0.05479219935057277
NON-DISTAL MONOSOMY 10Q	0.0014770999999999999	0.05479219935057277
ABETALIPOPROTEINEMIA	0.0014770999999999999	0.05479219935057277
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2	0.0014770999999999999	0.05479219935057277
SPINOCEREBELLAR ATAXIA 37; SCA37	0.0014770999999999999	0.05479219935057277
SPINOCEREBELLAR ATAXIA 30; SCA30	0.0014770999999999999	0.05479219935057277
CEREBELLAR ATAXIA AND NEUROSENSORY DEAFNESS	0.0014770999999999999	0.05479219935057277
ATAXIA-OCULOMOTOR APRAXIA TYPE 4	0.0014770999999999999	0.05479219935057277
JOUBERT SYNDROME 4	0.0014770999999999999	0.05479219935057277
USHER SYNDROME TYPE 3	0.0014770999999999999	0.05479219935057277
212835 CEREBELLAR ATAXIA AND ECTODERMAL DYSPLASIA	0.0014770999999999999	0.05479219935057277
CATARACT-ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.0014770999999999999	0.05479219935057277
RAVINE SYNDROME	0.0014770999999999999	0.05479219935057277
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.0014770999999999999	0.05479219935057277
POSTERIOR CORTICAL ATROPHY	0.0014770999999999999	0.05479219935057277
ENCEPHALOPATHY WITH INTRACRANIAL CALCIFICATION, GROWTH HORMONE DEFICIENCY, MICROCEPHALY, AND RETINAL DEGENERATION	0.0014770999999999999	0.05479219935057277
SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION	0.0014770999999999999	0.05479219935057277
JOUBERT SYNDROME 5	0.0014770999999999999	0.05479219935057277
NEUHAUSER-EICHNER-OPITZ SYNDROME	0.0014770999999999999	0.05479219935057277
FAMILIAL PAROXYSMAL ATAXIA	0.0014770999999999999	0.05479219935057277
CHAND SYNDROME	0.0014770999999999999	0.05479219935057277
CEREBELLAR ATAXIA-HYPOGONADISM SYNDROME	0.0014770999999999999	0.05479219935057277
GEMIGNANI SYNDROME	0.0014770999999999999	0.05479219935057277
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.0014770999999999999	0.05479219935057277
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G; CMTDIG	0.0014770999999999999	0.05479219935057277
HYPOGONADOTROPIC HYPOGONADISM 1 WITH OR WITHOUT ANOSMIA; HH1	0.0014770999999999999	0.05479219935057277
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.0014770999999999999	0.05479219935057277
KALLMANN SYNDROME WITH SPASTIC PARAPLEGIA	0.0014770999999999999	0.05479219935057277
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 5	0.0014770999999999999	0.05479219935057277
SPASTIC PARAPLEGIA TYPE 2	0.0014770999999999999	0.05479219935057277
OLIVOPONTOCEREBELLAR ATROPHY II, AUTOSOMAL RECESSIVE	0.0014770999999999999	0.05479219935057277
ATAXIA-OCULOMOTOR APRAXIA TYPE 1	0.0014770999999999999	0.05479219935057277
USHER SYNDROME	0.0014770999999999999	0.05479219935057277
TREMOR-NYSTAGMUS-DUODENAL ULCER SYNDROME	0.0014770999999999999	0.05479219935057277
PENDRED SYNDROME	0.0014770999999999999	0.05479219935057277
SPINOCEREBELLAR ATAXIA TYPE 17	0.0014770999999999999	0.05479219935057277
DEMENTIA, FAMILIAL DANISH	0.0014770999999999999	0.05479219935057277
CENTRAL NEUROCYTOMA	0.0014770999999999999	0.05479219935057277
CEREBELLAR ATAXIA-ECTODERMAL DYSPLASIA SYNDROME	0.0014770999999999999	0.05479219935057277
ATAXIA-TAPETORETINAL DEGENERATION SYNDROME	0.0014770999999999999	0.05479219935057277
MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1	0.0014770999999999999	0.05479219935057277
ATAXIA-HYPOGONADISM-CHOROIDAL DYSTROPHY SYNDROME	0.0014770999999999999	0.05479219935057277
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.0014770999999999999	0.05479219935057277
BENIGN PAROXYSMAL TORTICOLLIS OF INFANCY	0.0014770999999999999	0.05479219935057277
SPASTIC ATAXIA 9, AUTOSOMAL RECESSIVE; SPAX9	0.0014770999999999999	0.05479219935057277
INFANTILE ONSET SPINOCEREBELLAR ATAXIA	0.0014770999999999999	0.05479219935057277
NEUROPATHY, HEREDITARY SENSORY, ATYPICAL	0.0014770999999999999	0.05479219935057277
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.0014770999999999999	0.05479219935057277
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.0014770999999999999	0.05479219935057277
SPASTIC PARAPARESIS-DEAFNESS SYNDROME	0.0014770999999999999	0.05479219935057277
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.0014770999999999999	0.05479219935057277
EPISODIC ATAXIA TYPE 4	0.0014770999999999999	0.05479219935057277
BIRK-LANDAU-PEREZ SYNDROME; BILAPES	0.0014770999999999999	0.05479219935057277
MUSCULAR ATROPHY, ATAXIA, RETINITIS PIGMENTOSA, AND DIABETES MELLITUS	0.0014770999999999999	0.05479219935057277
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 30	0.0014770999999999999	0.05479219935057277
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 1	0.0014770999999999999	0.05479219935057277
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.0014770999999999999	0.05479219935057277
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.0014770999999999999	0.05479219935057277
PIEBALDISM	0.0014770999999999999	0.05479219935057277
MYOCLONUS, CEREBELLAR ATAXIA, AND DEAFNESS	0.0014770999999999999	0.05479219935057277
LEBER HEREDITARY OPTIC NEUROPATHY	0.0014770999999999999	0.05479219935057277
PIEBALD TRAIT-NEUROLOGIC DEFECTS SYNDROME	0.0014770999999999999	0.05479219935057277
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.0014770999999999999	0.05479219935057277
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.0014770999999999999	0.05479219935057277
STIMMLER SYNDROME	0.0014770999999999999	0.05479219935057277
ADULT-ONSET MULTIPLE MITOCHONDRIAL DNA DELETION SYNDROME DUE TO DGUOK DEFICIENCY	0.0014770999999999999	0.05479219935057277
%300703 SPINOCEREBELLAR ATAXIA, X-LINKED 5; SCAX5	0.0014770999999999999	0.05479219935057277
FRIEDREICH ATAXIA, SO-CALLED, WITH OPTIC ATROPHY AND SENSORINEURALDEAFNESS	0.0014770999999999999	0.05479219935057277
SPINOCEREBELLAR ATAXIA, X-LINKED 4	0.0014770999999999999	0.05479219935057277
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.0014770999999999999	0.05479219935057277
SPINOCEREBELLAR ATAXIA, X-LINKED 2	0.0014770999999999999	0.05479219935057277
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.0014770999999999999	0.05479219935057277
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.0014770999999999999	0.05479219935057277
SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT; SPG80	0.0014770999999999999	0.05479219935057277
MITOCHONDRIAL MYOPATHY WITH DIABETES	0.0014770999999999999	0.05479219935057277
LEUKOENCEPHALOPATHY, ACUTE REVERSIBLE, WITH INCREASED URINARY ALPHA-KETOGLUTARATE; ARLIAK	0.0014770999999999999	0.05479219935057277
ADULT POLYGLUCOSAN BODY DISEASE	0.0014770999999999999	0.05479219935057277
KURU, SUSCEPTIBILITY TO	0.0014770999999999999	0.05479219935057277
OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, MENTAL RETARDATION, AND SEIZURES	0.0014770999999999999	0.05479219935057277
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	0.0014770999999999999	0.05479219935057277
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.0014770999999999999	0.05479219935057277
164700 OLIVOPONTOCEREBELLAR ATROPHY V; OPCA V;;OPCA WITH DEMENTIA AND EXTRAPYRAMIDAL SIGNS	0.0014770999999999999	0.05479219935057277
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.0014770999999999999	0.05479219935057277
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.0014770999999999999	0.05479219935057277
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 3	0.0014770999999999999	0.05479219935057277
WERNICKE-KORSAKOFF SYNDROME	0.0014770999999999999	0.05479219935057277
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 2	0.0014770999999999999	0.05479219935057277
CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT; ADCADN	0.0014770999999999999	0.05479219935057277
VITAMIN E, FAMILIAL ISOLATED DEFICIENCY OF	0.0014770999999999999	0.05479219935057277
ACERULOPLASMINEMIA	0.0014770999999999999	0.05479219935057277
DE SANCTIS-CACCHIONE SYNDROME	0.0014770999999999999	0.05479219935057277
NEUROFIBROMATOSIS TYPE 2	0.0014770999999999999	0.05479219935057277
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.0014770999999999999	0.05479219935057277
TRYPTOPHANURIA WITH DWARFISM	0.0014770999999999999	0.05479219935057277
SPINOCEREBELLAR ATAXIA 41; SCA41	0.0014770999999999999	0.05479219935057277
165200 OPTIC ATROPHY WITH DEMYELINATING DISEASE OF CNS	0.0014770999999999999	0.05479219935057277
CATARACT-ATAXIA-DEAFNESS SYNDROME	0.0014770999999999999	0.05479219935057277
272600 TAPETORETINAL DEGENERATION WITH ATAXIA	0.0014770999999999999	0.05479219935057277
OPTIC ATROPHY 1; OPA1	0.0014770999999999999	0.05479219935057277
HYDROCEPHALY-CEREBELLAR AGENESIS SYNDROME	0.0014770999999999999	0.05479219935057277
ATAXIA-OCULOMOTOR APRAXIA 4; AOA4	0.0014770999999999999	0.05479219935057277
RICHARDS-RUNDLE SYNDROME	0.0014770999999999999	0.05479219935057277
ABETALIPOPROTEINEMIA	0.0014770999999999999	0.05479219935057277
NYSTAGMUS, HEREDITARY VERTICAL	0.0014770999999999999	0.05479219935057277
PITUITARY CARCINOMA	0.0014770999999999999	0.05479219935057277
AUTOSOMAL DOMINANT OPTIC ATROPHY AND CATARACT	0.0014770999999999999	0.05479219935057277
SPINOCEREBELLAR ATAXIA TYPE 4	0.0014770999999999999	0.05479219935057277
245800 LAURENCE-MOON SYNDROME	0.0014770999999999999	0.05479219935057277
HEREDITARY SPASTIC PARAPLEGIA	0.0014770999999999999	0.05479219935057277
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.0014770999999999999	0.05479219935057277
CEREBELLAR HYPOPLASIA-TAPETORETINAL DEGENERATION SYNDROME	0.0014770999999999999	0.05479219935057277
POLYMYOCLONUS, INFANTILE	0.0014770999999999999	0.05479219935057277
PERIPHERAL NEUROPATHY, ATAXIA, FOCAL NECROTIZING ENCEPHALOPATHY, AND	0.0014770999999999999	0.05479219935057277
3-METHYLGLUTACONIC ACIDURIA TYPE 3	0.0014770999999999999	0.05479219935057277
%601992 FRIEDREICH ATAXIA 2; FRDA2	0.0014770999999999999	0.05479219935057277
MATERNALLY-INHERITED DIABETES AND DEAFNESS	0.0014770999999999999	0.05479219935057277
HYPOMYELINATION-HYPOGONADOTROPIC HYPOGONADISM-HYPODONTIA SYNDROME	0.0014770999999999999	0.05479219935057277
ATAXIA-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.0014770999999999999	0.05479219935057277
ATAXIA WITH FASCICULATIONS	0.0014770999999999999	0.05479219935057277
GM2-GANGLIOSIDOSIS, AB VARIANT	0.001086973	0.04032065622144075
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.001086973	0.04032065622144075
MENTAL RETARDATION, X-LINKED 72	0.001086973	0.04032065622144075
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.001086973	0.04032065622144075
PALLISTER-HALL SYNDROME	0.001086973	0.04032065622144075
ALG3-CDG	0.001086973	0.04032065622144075
DPAGT1-CDG	0.001086973	0.04032065622144075
MENTAL RETARDATION, X-LINKED 88	0.001086973	0.04032065622144075
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.001086973	0.04032065622144075
KBG SYNDROME	0.001086973	0.04032065622144075
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.001086973	0.04032065622144075
POTOCKI-SHAFFER SYNDROME	0.001086973	0.04032065622144075
CLASSIC PHENYLKETONURIA	0.001086973	0.04032065622144075
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.001086973	0.04032065622144075
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.001086973	0.04032065622144075
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.001086973	0.04032065622144075
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.001086973	0.04032065622144075
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.001086973	0.04032065622144075
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.001086973	0.04032065622144075
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.001086973	0.04032065622144075
RECOMBINANT CHROMOSOME 8 SYNDROME	0.001086973	0.04032065622144075
DISTAL MONOSOMY 19P13.3	0.001086973	0.04032065622144075
KEUTEL SYNDROME	0.001086973	0.04032065622144075
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.001086973	0.04032065622144075
GLYCEROL KINASE DEFICIENCY; GKD	0.001086973	0.04032065622144075
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.001086973	0.04032065622144075
GRACILE BONE DYSPLASIA; GCLEB	0.001086973	0.04032065622144075
CHROMOSOME 2Q37 DELETION SYNDROME	0.001086973	0.04032065622144075
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.001086973	0.04032065622144075
TIMOTHY SYNDROME; TS	0.001086973	0.04032065622144075
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.001086973	0.04032065622144075
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.001086973	0.04032065622144075
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.001086973	0.04032065622144075
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.001086973	0.04032065622144075
GRISCELLI SYNDROME, TYPE 1	0.001086973	0.04032065622144075
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.001086973	0.04032065622144075
MACDERMOT-WINTER SYNDROME	0.001086973	0.04032065622144075
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.001086973	0.04032065622144075
PFEIFFER SYNDROME TYPE 2	0.001086973	0.04032065622144075
MELANOSIS, NEUROCUTANEOUS; NCMS	0.001086973	0.04032065622144075
WYBURN-MASON SYNDROME	0.001086973	0.04032065622144075
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.001086973	0.04032065622144075
MUENKE SYNDROME	0.001086973	0.04032065622144075
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.001086973	0.04032065622144075
LEBER CONGENITAL AMAUROSIS	0.001086973	0.04032065622144075
CRANIOPHARYNGIOMA	0.001086973	0.04032065622144075
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001086973	0.04032065622144075
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.001086973	0.04032065622144075
NETHERTON SYNDROME	0.001086973	0.04032065622144075
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.001086973	0.04032065622144075
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.001086973	0.04032065622144075
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.001086973	0.04032065622144075
SCHINDLER DISEASE, TYPE I	0.001086973	0.04032065622144075
PITUITARY STALK INTERRUPTION SYNDROME	0.001086973	0.04032065622144075
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.001086973	0.04032065622144075
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.001086973	0.04032065622144075
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.001086973	0.04032065622144075
MEND SYNDROME; MEND	0.001086973	0.04032065622144075
RUBINSTEIN-TAYBI SYNDROME	0.001086973	0.04032065622144075
TEMPLE-BARAITSER SYNDROME; TMBTS	0.001086973	0.04032065622144075
MONOSOMY 9Q22.3	0.001086973	0.04032065622144075
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.001086973	0.04032065622144075
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.001086973	0.04032065622144075
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.001086973	0.04032065622144075
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.001086973	0.04032065622144075
15Q13.3 MICRODELETION SYNDROME	0.001086973	0.04032065622144075
CORNELIA DE LANGE SYNDROME 3	0.001086973	0.04032065622144075
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.001086973	0.04032065622144075
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.001086973	0.04032065622144075
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.001086973	0.04032065622144075
PHACE ASSOCIATION	0.001086973	0.04032065622144075
15Q24 MICRODELETION SYNDROME	0.001086973	0.04032065622144075
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.001086973	0.04032065622144075
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.001086973	0.04032065622144075
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.001086973	0.04032065622144075
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.001086973	0.04032065622144075
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.001086973	0.04032065622144075
WAISMAN SYNDROME; WSMN	0.001086973	0.04032065622144075
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.001086973	0.04032065622144075
ARGININEMIA	0.001086973	0.04032065622144075
KBG SYNDROME	0.001086973	0.04032065622144075
COHEN SYNDROME	0.001086973	0.04032065622144075
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.001086973	0.04032065622144075
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.001086973	0.04032065622144075
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.001086973	0.04032065622144075
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.001086973	0.04032065622144075
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001086973	0.04032065622144075
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.001086973	0.04032065622144075
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.001086973	0.04032065622144075
DYSTONIA-APHONIA SYNDROME	0.001086973	0.04032065622144075
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.001086973	0.04032065622144075
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.001086973	0.04032065622144075
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.001086973	0.04032065622144075
ISOLATED GLYCEROL KINASE DEFICIENCY	0.001086973	0.04032065622144075
1Q21.1 MICRODUPLICATION SYNDROME	0.001086973	0.04032065622144075
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.001086973	0.04032065622144075
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.001086973	0.04032065622144075
2P21 MICRODELETION SYNDROME	0.001086973	0.04032065622144075
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.001086973	0.04032065622144075
FILIPPI SYNDROME	0.001086973	0.04032065622144075
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.001086973	0.04032065622144075
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.001086973	0.04032065622144075
8P23.1 MICRODELETION SYNDROME	0.001086973	0.04032065622144075
8P11.2 DELETION SYNDROME	0.001086973	0.04032065622144075
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.001086973	0.04032065622144075
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.001086973	0.04032065622144075
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001086973	0.04032065622144075
NEPHROGENIC DIABETES INSIPIDUS	0.001086973	0.04032065622144075
2Q31.1 MICRODELETION SYNDROME	0.001086973	0.04032065622144075
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.001086973	0.04032065622144075
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.001086973	0.04032065622144075
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.001086973	0.04032065622144075
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.001086973	0.04032065622144075
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.001086973	0.04032065622144075
3Q29 MICRODUPLICATION SYNDROME	0.001086973	0.04032065622144075
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.001086973	0.04032065622144075
MOSAIC TRISOMY 14	0.001086973	0.04032065622144075
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.001086973	0.04032065622144075
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.001086973	0.04032065622144075
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.001086973	0.04032065622144075
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.001086973	0.04032065622144075
HYPEREKPLEXIA 4; HKPX4	0.001086973	0.04032065622144075
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.001086973	0.04032065622144075
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.001086973	0.04032065622144075
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.001086973	0.04032065622144075
CATEL-MANZKE SYNDROME; CATMANS	0.001086973	0.04032065622144075
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.001086973	0.04032065622144075
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.001086973	0.04032065622144075
SEVERE CANAVAN DISEASE	0.001086973	0.04032065622144075
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.001086973	0.04032065622144075
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.001086973	0.04032065622144075
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.001086973	0.04032065622144075
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.001086973	0.04032065622144075
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.001086973	0.04032065622144075
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.001086973	0.04032065622144075
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.001086973	0.04032065622144075
HYDRANENCEPHALY	0.001086973	0.04032065622144075
MAN1B1-CDG	0.001086973	0.04032065622144075
RUVALCABA SYNDROME	0.001086973	0.04032065622144075
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.001086973	0.04032065622144075
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.001086973	0.04032065622144075
PRADER-WILLI-LIKE SYNDROME	0.001086973	0.04032065622144075
20P12.3 MICRODELETION SYNDROME	0.001086973	0.04032065622144075
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.001086973	0.04032065622144075
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.001086973	0.04032065622144075
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001086973	0.04032065622144075
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.001086973	0.04032065622144075
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001086973	0.04032065622144075
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.001086973	0.04032065622144075
HELSMOORTEL-VAN DER AA SYNDROME	0.001086973	0.04032065622144075
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.001086973	0.04032065622144075
STT3A-CDG	0.001086973	0.04032065622144075
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.001086973	0.04032065622144075
L1 SYNDROME	0.001086973	0.04032065622144075
TRISOMY X	0.001086973	0.04032065622144075
OPTIC PATHWAY GLIOMA	0.001086973	0.04032065622144075
2Q37 MICRODELETION SYNDROME	0.001086973	0.04032065622144075
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.001086973	0.04032065622144075
INCONTINENTIA PIGMENTI	0.001086973	0.04032065622144075
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.001086973	0.04032065622144075
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.001086973	0.04032065622144075
CANAVAN DISEASE	0.001086973	0.04032065622144075
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.001086973	0.04032065622144075
DUANE RETRACTION SYNDROME	0.001086973	0.04032065622144075
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.001086973	0.04032065622144075
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.001086973	0.04032065622144075
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001086973	0.04032065622144075
WILSON-TURNER SYNDROME	0.001086973	0.04032065622144075
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.001086973	0.04032065622144075
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.001086973	0.04032065622144075
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.001086973	0.04032065622144075
ADAMS-OLIVER SYNDROME 2; AOS2	0.001086973	0.04032065622144075
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.001086973	0.04032065622144075
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.001086973	0.04032065622144075
ADULT-ONSET DYSTONIA-PARKINSONISM	0.001086973	0.04032065622144075
DISTAL TRISOMY 17Q	0.001086973	0.04032065622144075
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.001086973	0.04032065622144075
MULTIPLE CARBOXYLASE DEFICIENCY	0.001086973	0.04032065622144075
ISOVALERIC ACIDEMIA	0.001086973	0.04032065622144075
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.001086973	0.04032065622144075
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.001086973	0.04032065622144075
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.001086973	0.04032065622144075
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.001086973	0.04032065622144075
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.001086973	0.04032065622144075
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.001086973	0.04032065622144075
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.001086973	0.04032065622144075
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.001086973	0.04032065622144075
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.001086973	0.04032065622144075
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.001086973	0.04032065622144075
10Q22.3Q23.3 MICRODELETION SYNDROME	0.001086973	0.04032065622144075
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.001086973	0.04032065622144075
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.001086973	0.04032065622144075
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.001086973	0.04032065622144075
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.001086973	0.04032065622144075
JOUBERT SYNDROME 10	0.000545554	0.020237020868256975
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.000545554	0.020237020868256975
MEIER-GORLIN SYNDROME 7	0.000545554	0.020237020868256975
ARTERIAL TORTUOSITY SYNDROME	0.000545554	0.020237020868256975
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.000545554	0.020237020868256975
ALAZAMI-YUAN SYNDROME	0.000545554	0.020237020868256975
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000545554	0.020237020868256975
TOLUENE EMBRYOPATHY	0.000545554	0.020237020868256975
SWEENEY-COX SYNDROME; SWCOS	0.000545554	0.020237020868256975
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.000545554	0.020237020868256975
CHAR SYNDROME	0.000545554	0.020237020868256975
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.020237020868256975
THANATOPHORIC DYSPLASIA, TYPE I	0.000545554	0.020237020868256975
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.000545554	0.020237020868256975
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.020237020868256975
COLE-CARPENTER SYNDROME	0.000545554	0.020237020868256975
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.000545554	0.020237020868256975
PHENOBARBITAL EMBRYOPATHY	0.000545554	0.020237020868256975
OTOPALATODIGITAL SYNDROME TYPE 2	0.000545554	0.020237020868256975
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.000545554	0.020237020868256975
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.000545554	0.020237020868256975
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000545554	0.020237020868256975
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.000545554	0.020237020868256975
MENTAL RETARDATION, X-LINKED 99	0.000545554	0.020237020868256975
ABETAL34V AMYLOIDOSIS	0.000545554	0.020237020868256975
RABSON-MENDENHALL SYNDROME	0.000545554	0.020237020868256975
EAR-PATELLA-SHORT STATURE SYNDROME	0.000545554	0.020237020868256975
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.000545554	0.020237020868256975
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.000545554	0.020237020868256975
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000545554	0.020237020868256975
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000545554	0.020237020868256975
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.000545554	0.020237020868256975
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000545554	0.020237020868256975
MIETENS SYNDROME	0.000545554	0.020237020868256975
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000545554	0.020237020868256975
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.000545554	0.020237020868256975
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.000545554	0.020237020868256975
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.000545554	0.020237020868256975
RAHMAN SYNDROME	0.000545554	0.020237020868256975
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.000545554	0.020237020868256975
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000545554	0.020237020868256975
OGDEN SYNDROME; OGDNS	0.000545554	0.020237020868256975
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.000545554	0.020237020868256975
RIGID SPINE SYNDROME	0.000545554	0.020237020868256975
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.000545554	0.020237020868256975
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.000545554	0.020237020868256975
ZEBRA BODY MYOPATHY	0.000545554	0.020237020868256975
MENTAL RETARDATION, X-LINKED 106; MRX106	0.000545554	0.020237020868256975
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.020237020868256975
DYSTONIA 28, CHILDHOOD-ONSET	0.000545554	0.020237020868256975
HYDROXYKYNURENINURIA	0.000545554	0.020237020868256975
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.000545554	0.020237020868256975
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.000545554	0.020237020868256975
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.000545554	0.020237020868256975
CURRARINO SYNDROME	0.000545554	0.020237020868256975
AARSKOG-SCOTT SYNDROME	0.000545554	0.020237020868256975
2Q23.1 MICRODUPLICATION SYNDROME	0.000545554	0.020237020868256975
DISTAL TRISOMY 6P	0.000545554	0.020237020868256975
FETAL TRIMETHADIONE SYNDROME	0.000545554	0.020237020868256975
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000545554	0.020237020868256975
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.000545554	0.020237020868256975
VASCULAR EHLERS-DANLOS SYNDROME	0.000545554	0.020237020868256975
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.000545554	0.020237020868256975
TREACHER-COLLINS SYNDROME	0.000545554	0.020237020868256975
COSTELLO SYNDROME; CSTLO	0.000545554	0.020237020868256975
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.000545554	0.020237020868256975
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000545554	0.020237020868256975
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000545554	0.020237020868256975
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.000545554	0.020237020868256975
OROFACIODIGITAL SYNDROME IX; OFD9	0.000545554	0.020237020868256975
RITSCHER-SCHINZEL SYNDROME 1	0.000545554	0.020237020868256975
OROTIC ACIDURIA	0.000545554	0.020237020868256975
CONGENITAL VARICELLA SYNDROME	0.000545554	0.020237020868256975
FRIED SYNDROME	0.000545554	0.020237020868256975
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.000545554	0.020237020868256975
NOONAN SYNDROME 11; NS11	0.000545554	0.020237020868256975
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020237020868256975
POPOV-CHANG SYNDROME; POPCHAS	0.000545554	0.020237020868256975
RAINE SYNDROME	0.000545554	0.020237020868256975
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.000545554	0.020237020868256975
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.000545554	0.020237020868256975
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020237020868256975
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.000545554	0.020237020868256975
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.000545554	0.020237020868256975
HYDROCEPHALUS, NORMAL-PRESSURE	0.000545554	0.020237020868256975
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.000545554	0.020237020868256975
AURICULOCONDYLAR SYNDROME	0.000545554	0.020237020868256975
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.000545554	0.020237020868256975
OROFACIODIGITAL SYNDROME TYPE 4	0.000545554	0.020237020868256975
OGDEN SYNDROME	0.000545554	0.020237020868256975
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.000545554	0.020237020868256975
OPITZ G/BBB SYNDROME	0.000545554	0.020237020868256975
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.020237020868256975
RING CHROMOSOME 12 SYNDROME	0.000545554	0.020237020868256975
JAWAD SYNDROME	0.000545554	0.020237020868256975
LATERAL MENINGOCELE SYNDROME	0.000545554	0.020237020868256975
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000545554	0.020237020868256975
OTOFACIOCERVICAL SYNDROME	0.000545554	0.020237020868256975
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.000545554	0.020237020868256975
ROSSELLI-GULIENETTI SYNDROME	0.000545554	0.020237020868256975
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.000545554	0.020237020868256975
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.000545554	0.020237020868256975
OCULOFACIOCARDIODENTAL SYNDROME	0.000545554	0.020237020868256975
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.020237020868256975
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.000545554	0.020237020868256975
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000545554	0.020237020868256975
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000545554	0.020237020868256975
TRISOMY 8Q	0.000545554	0.020237020868256975
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000545554	0.020237020868256975
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.000545554	0.020237020868256975
OROFACIODIGITAL SYNDROME VI	0.000545554	0.020237020868256975
XQ27.3Q28 DUPLICATION SYNDROME	0.000545554	0.020237020868256975
AUSTRALIA ANTIGEN	0.000545554	0.020237020868256975
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.000545554	0.020237020868256975
DISTAL TRISOMY 18Q	0.000545554	0.020237020868256975
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.000545554	0.020237020868256975
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.000545554	0.020237020868256975
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.000545554	0.020237020868256975
ELSAHY-WATERS SYNDROME; ESWS	0.000545554	0.020237020868256975
TRISOMY 17P	0.000545554	0.020237020868256975
16P13.11 MICRODUPLICATION SYNDROME	0.000545554	0.020237020868256975
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.000545554	0.020237020868256975
ATHYREOSIS	0.000545554	0.020237020868256975
8Q22.1 MICRODELETION SYNDROME	0.000545554	0.020237020868256975
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.000545554	0.020237020868256975
ALG6-CDG	0.000545554	0.020237020868256975
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000545554	0.020237020868256975
N SYNDROME	0.000545554	0.020237020868256975
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000545554	0.020237020868256975
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.000545554	0.020237020868256975
BRESEK SYNDROME	0.000545554	0.020237020868256975
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.000545554	0.020237020868256975
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.000545554	0.020237020868256975
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000545554	0.020237020868256975
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000545554	0.020237020868256975
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000545554	0.020237020868256975
HEREDITARY OROTIC ACIDURIA	0.000545554	0.020237020868256975
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.000545554	0.020237020868256975
3MC SYNDROME 2	0.000545554	0.020237020868256975
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000545554	0.020237020868256975
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.000545554	0.020237020868256975
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.000545554	0.020237020868256975
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.020237020868256975
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.000545554	0.020237020868256975
ROTHMUND-THOMSON SYNDROME	0.000545554	0.020237020868256975
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.020237020868256975
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.000545554	0.020237020868256975
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.000545554	0.020237020868256975
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.000545554	0.020237020868256975
DISTAL MONOSOMY 9P	0.000545554	0.020237020868256975
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000545554	0.020237020868256975
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.000545554	0.020237020868256975
WEAVER SYNDROME	0.000545554	0.020237020868256975
THAUVIN-ROBINET-FAIVRE SYNDROME	0.000545554	0.020237020868256975
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.000545554	0.020237020868256975
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.000545554	0.020237020868256975
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000545554	0.020237020868256975
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000545554	0.020237020868256975
PSEUDOAMINOPTERIN SYNDROME	0.000545554	0.020237020868256975
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.000545554	0.020237020868256975
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.000545554	0.020237020868256975
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.020237020868256975
HOLOPROSENCEPHALY 5; HPE5	0.000545554	0.020237020868256975
FRIAS SYNDROME	0.000545554	0.020237020868256975
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000545554	0.020237020868256975
NOONAN SYNDROME 3; NS3	0.000545554	0.020237020868256975
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000545554	0.020237020868256975
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.000545554	0.020237020868256975
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.000545554	0.020237020868256975
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.000545554	0.020237020868256975
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.000545554	0.020237020868256975
HYPERTRICHOSIS CUBITI	0.000545554	0.020237020868256975
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.000545554	0.020237020868256975
MCKUSICK-KAUFMAN SYNDROME	0.000545554	0.020237020868256975
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.000545554	0.020237020868256975
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000545554	0.020237020868256975
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.000545554	0.020237020868256975
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.000545554	0.020237020868256975
SECKEL SYNDROME 8; SCKL8	0.000545554	0.020237020868256975
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.020237020868256975
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.000545554	0.020237020868256975
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.020237020868256975
17Q21.31 MICRODUPLICATION SYNDROME	0.000545554	0.020237020868256975
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000545554	0.020237020868256975
CREE MENTAL RETARDATION SYNDROME	0.000545554	0.020237020868256975
ATELOSTEOGENESIS TYPE III	0.000545554	0.020237020868256975
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000545554	0.020237020868256975
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.000545554	0.020237020868256975
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.000545554	0.020237020868256975
BARDET-BIEDL SYNDROME 17; BBS17	0.000545554	0.020237020868256975
BARDET-BIEDL SYNDROME 16; BBS16	0.000545554	0.020237020868256975
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000545554	0.020237020868256975
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.020237020868256975
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.000545554	0.020237020868256975
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.000545554	0.020237020868256975
BARDET-BIEDL SYNDROME 8; BBS8	0.000545554	0.020237020868256975
BARDET-BIEDL SYNDROME 2	0.000545554	0.020237020868256975
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.000545554	0.020237020868256975
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.000545554	0.020237020868256975
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.000545554	0.020237020868256975
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.000545554	0.020237020868256975
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000545554	0.020237020868256975
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.000545554	0.020237020868256975
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.000545554	0.020237020868256975
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020237020868256975
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.000545554	0.020237020868256975
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.000545554	0.020237020868256975
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.020237020868256975
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.000545554	0.020237020868256975
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.000545554	0.020237020868256975
TRISOMY 9P	0.000545554	0.020237020868256975
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.000545554	0.020237020868256975
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.000545554	0.020237020868256975
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.000545554	0.020237020868256975
CHROMOSOME 15Q25 DELETION SYNDROME	0.000545554	0.020237020868256975
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.000545554	0.020237020868256975
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.000545554	0.020237020868256975
WARSAW BREAKAGE SYNDROME; WABS	0.000545554	0.020237020868256975
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.000545554	0.020237020868256975
CHROMOSOME 16Q22 DELETION SYNDROME	0.000545554	0.020237020868256975
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000545554	0.020237020868256975
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.000545554	0.020237020868256975
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000545554	0.020237020868256975
CHROMOSOME 4Q21 DELETION SYNDROME	0.000545554	0.020237020868256975
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.000545554	0.020237020868256975
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.000545554	0.020237020868256975
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.000545554	0.020237020868256975
CHAR SYNDROME	0.000545554	0.020237020868256975
CHROMOSOME 17P13.1 DELETION SYNDROME	0.000545554	0.020237020868256975
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.000545554	0.020237020868256975
DIAMOND-BLACKFAN ANEMIA 5	0.000545554	0.020237020868256975
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.000545554	0.020237020868256975
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.000545554	0.020237020868256975
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.000545554	0.020237020868256975
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020237020868256975
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000545554	0.020237020868256975
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020237020868256975
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.000545554	0.020237020868256975
STEEL SYNDROME; STLS	0.000545554	0.020237020868256975
TOWNES-BROCKS SYNDROME 1; TBS1	0.000545554	0.020237020868256975
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000545554	0.020237020868256975
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.000545554	0.020237020868256975
NOONAN SYNDROME 5; NS5	0.000545554	0.020237020868256975
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000545554	0.020237020868256975
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.000545554	0.020237020868256975
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.000545554	0.020237020868256975
ICF SYNDROME	0.000545554	0.020237020868256975
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.000545554	0.020237020868256975
ALAZAMI SYNDROME; ALAZS	0.000545554	0.020237020868256975
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.000545554	0.020237020868256975
8Q12 MICRODUPLICATION SYNDROME	0.000545554	0.020237020868256975
AICARDI-GOUTIERES SYNDROME 6	0.000545554	0.020237020868256975
20Q11.2 MICRODELETION SYNDROME	0.000545554	0.020237020868256975
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.000545554	0.020237020868256975
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000545554	0.020237020868256975
ADAMS-OLIVER SYNDROME 3; AOS3	0.000545554	0.020237020868256975
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000545554	0.020237020868256975
CULLER-JONES SYNDROME; CJS	0.000545554	0.020237020868256975
HYDROXYKYNURENINURIA	0.000545554	0.020237020868256975
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000545554	0.020237020868256975
AU-KLINE SYNDROME; AUKS	0.000545554	0.020237020868256975
NOONAN SYNDROME 9; NS9	0.000545554	0.020237020868256975
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.000545554	0.020237020868256975
CHROMOSOME 18P DELETION SYNDROME	0.000545554	0.020237020868256975
HOLOPROSENCEPHALY 3; HPE3	0.000545554	0.020237020868256975
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.000545554	0.020237020868256975
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.000545554	0.020237020868256975
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.000545554	0.020237020868256975
CDAGS SYNDROME	0.000545554	0.020237020868256975
3C SYNDROME	0.000545554	0.020237020868256975
HYPERTRYPTOPHANEMIA; HYPTRP	0.000545554	0.020237020868256975
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.000545554	0.020237020868256975
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.000545554	0.020237020868256975
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.000545554	0.020237020868256975
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.000545554	0.020237020868256975
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000545554	0.020237020868256975
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.000545554	0.020237020868256975
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.000545554	0.020237020868256975
HYPERMANGANESEMIA WITH DYSTONIA 2	0.000545554	0.020237020868256975
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.020237020868256975
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.000545554	0.020237020868256975
CHROMOSOME 15Q14 DELETION SYNDROME	0.000545554	0.020237020868256975
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.000545554	0.020237020868256975
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.000545554	0.020237020868256975
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000545554	0.020237020868256975
ISOLATED PLAGIOCEPHALY	0.000545554	0.020237020868256975
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.020237020868256975
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000545554	0.020237020868256975
GERODERMA OSTEODYSPLASTICA	0.000545554	0.020237020868256975
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.000545554	0.020237020868256975
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.000545554	0.020237020868256975
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020237020868256975
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000545554	0.020237020868256975
JOUBERT SYNDROME 26	0.000545554	0.020237020868256975
SECKEL SYNDROME 9; SCKL9	0.000545554	0.020237020868256975
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.000545554	0.020237020868256975
CHOPS SYNDROME; CHOPS	0.000545554	0.020237020868256975
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000545554	0.020237020868256975
BARDET-BIEDL SYNDROME 3; BBS3	0.000545554	0.020237020868256975
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.000545554	0.020237020868256975
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.000545554	0.020237020868256975
FRONTOOCULAR SYNDROME	0.000545554	0.020237020868256975
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.000545554	0.020237020868256975
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.000545554	0.020237020868256975
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.000545554	0.020237020868256975
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000545554	0.020237020868256975
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.000545554	0.020237020868256975
CEREBELLOFACIODENTAL SYNDROME	0.000545554	0.020237020868256975
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000545554	0.020237020868256975
OBESITY DUE TO SIM1 DEFICIENCY	0.000545554	0.020237020868256975
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.000545554	0.020237020868256975
NOONAN SYNDROME 2; NS2	0.000545554	0.020237020868256975
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000545554	0.020237020868256975
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.000545554	0.020237020868256975
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.000545554	0.020237020868256975
ZECHI-CEIDE SYNDROME	0.000545554	0.020237020868256975
HYPOTONIA-CYSTINURIA SYNDROME	0.000545554	0.020237020868256975
LOWRY-MACLEAN SYNDROME	0.000545554	0.020237020868256975
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.000541419	0.02008363535318378
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.000541419	0.02008363535318378
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.000541419	0.02008363535318378
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000541419	0.02008363535318378
1P36 MICRODELETION SYNDROME	0.000541419	0.02008363535318378
SANJAD-SAKATI SYNDROME	0.000541419	0.02008363535318378
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.000541419	0.02008363535318378
5Q35 MICRODUPLICATION SYNDROME	0.000541419	0.02008363535318378
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000541419	0.02008363535318378
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.000541419	0.02008363535318378
EPILEPSY-TELANGIECTASIA SYNDROME	0.000541419	0.02008363535318378
BENIGN FAMILIAL NEONATAL EPILEPSY	0.000541419	0.02008363535318378
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.000541419	0.02008363535318378
CADASIL	0.000541419	0.02008363535318378
FRAGILE X SYNDROME	0.000541419	0.02008363535318378
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.000541419	0.02008363535318378
NIPAH VIRUS DISEASE	0.000541419	0.02008363535318378
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.000541419	0.02008363535318378
POSTENCEPHALITIC PARKINSONISM	0.000541419	0.02008363535318378
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.000541419	0.02008363535318378
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.000541419	0.02008363535318378
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000541419	0.02008363535318378
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.02008363535318378
ENDOCARDIAL FIBROELASTOSIS	0.000541419	0.02008363535318378
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.000541419	0.02008363535318378
KABUKI SYNDROME	0.000541419	0.02008363535318378
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.000541419	0.02008363535318378
RING CHROMOSOME 10 SYNDROME	0.000541419	0.02008363535318378
DYSOSTEOSCLEROSIS	0.000541419	0.02008363535318378
2Q33.1 DELETION SYNDROME	0.000541419	0.02008363535318378
PARIETAL FORAMINA	0.000541419	0.02008363535318378
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.000541419	0.02008363535318378
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.000541419	0.02008363535318378
INSULINOMA	0.000541419	0.02008363535318378
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.000541419	0.02008363535318378
PINEOBLASTOMA	0.000541419	0.02008363535318378
ACROCARDIOFACIAL SYNDROME	0.000541419	0.02008363535318378
NON-FUNCTIONING PITUITARY ADENOMA	0.000541419	0.02008363535318378
TSH-SECRETING PITUITARY ADENOMA	0.000541419	0.02008363535318378
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.000541419	0.02008363535318378
PFEIFFER SYNDROME TYPE 3	0.000541419	0.02008363535318378
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.000541419	0.02008363535318378
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000541419	0.02008363535318378
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.000541419	0.02008363535318378
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.000541419	0.02008363535318378
NEUROFIBROMATOSIS, TYPE I	0.000541419	0.02008363535318378
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.000541419	0.02008363535318378
EPILEPSY, BENIGN OCCIPITAL	0.000541419	0.02008363535318378
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.000541419	0.02008363535318378
NEUROCUTANEOUS MELANOCYTOSIS	0.000541419	0.02008363535318378
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.000541419	0.02008363535318378
CONGENITAL HYDROCEPHALUS	0.000541419	0.02008363535318378
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.000541419	0.02008363535318378
ACUTE ADRENAL INSUFFICIENCY	0.000541419	0.02008363535318378
SUPRABULBAR PARESIS, CONGENITAL	0.000541419	0.02008363535318378
STURGE-WEBER SYNDROME	0.000541419	0.02008363535318378
DISTAL TRISOMY 15Q	0.000541419	0.02008363535318378
DARIER-WHITE DISEASE; DAR	0.000541419	0.02008363535318378
SECKEL SYNDROME 1; SCKL1	0.000541419	0.02008363535318378
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.000541419	0.02008363535318378
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.02008363535318378
MENTAL RETARDATION, FRA12A TYPE	0.000541419	0.02008363535318378
AICA-RIBOSIDURIA	0.000541419	0.02008363535318378
NODULAR NEURONAL HETEROTOPIA	0.000541419	0.02008363535318378
MOYAMOYA DISEASE	0.000541419	0.02008363535318378
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.000541419	0.02008363535318378
MOYNAHAN SYNDROME	0.000541419	0.02008363535318378
CENTRAL DIABETES INSIPIDUS	0.000541419	0.02008363535318378
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.000541419	0.02008363535318378
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.000541419	0.02008363535318378
EPILEPSY, READING	0.000541419	0.02008363535318378
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.000541419	0.02008363535318378
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.000541419	0.02008363535318378
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.000541419	0.02008363535318378
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.000541419	0.02008363535318378
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.000541419	0.02008363535318378
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.000541419	0.02008363535318378
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.000541419	0.02008363535318378
EDINBURGH MALFORMATION SYNDROME	0.000541419	0.02008363535318378
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.000541419	0.02008363535318378
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.000541419	0.02008363535318378
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000541419	0.02008363535318378
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.000541419	0.02008363535318378
HARROD SYNDROME	0.000541419	0.02008363535318378
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.000541419	0.02008363535318378
DERMOTRICHIC SYNDROME	0.000541419	0.02008363535318378
KNOBLOCH SYNDROME	0.000541419	0.02008363535318378
BRANCHIOOCULOFACIAL SYNDROME	0.000541419	0.02008363535318378
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.000541419	0.02008363535318378
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.000541419	0.02008363535318378
HYPOMAGNESEMIA 2, RENAL	0.000541419	0.02008363535318378
HADDAD SYNDROME	0.000541419	0.02008363535318378
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.000541419	0.02008363535318378
FAMILIAL BENIGN COPPER DEFICIENCY	0.000541419	0.02008363535318378
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000541419	0.02008363535318378
CRISPONI SYNDROME	0.000541419	0.02008363535318378
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.000541419	0.02008363535318378
SNEDDON SYNDROME	0.000541419	0.02008363535318378
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000541419	0.02008363535318378
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.000541419	0.02008363535318378
MOMO SYNDROME	0.000541419	0.02008363535318378
ROSAÏ-DORFMAN DISEASE	0.000541419	0.02008363535318378
DISTAL MONOSOMY 3P	0.000541419	0.02008363535318378
CYSTATHIONINURIA	0.000541419	0.02008363535318378
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000541419	0.02008363535318378
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000541419	0.02008363535318378
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.000541419	0.02008363535318378
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.000541419	0.02008363535318378
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.000541419	0.02008363535318378
RENIER-GABREELS-JASPER SYNDROME	0.000541419	0.02008363535318378
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.000541419	0.02008363535318378
COPPER DEFICIENCY, FAMILIAL BENIGN	0.000541419	0.02008363535318378
CROUZON SYNDROME	0.000541419	0.02008363535318378
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.000541419	0.02008363535318378
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.000541419	0.02008363535318378
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.000541419	0.02008363535318378
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.000541419	0.02008363535318378
NOONAN SYNDROME 7; NS7	0.000541419	0.02008363535318378
JERVELL AND LANGE-NIELSEN SYNDROME	0.000541419	0.02008363535318378
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.000541419	0.02008363535318378
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000541419	0.02008363535318378
WORSTER-DROUGHT SYNDROME	0.000541419	0.02008363535318378
AYME-GRIPP SYNDROME; AYGRP	0.000541419	0.02008363535318378
CHIME SYNDROME	0.000541419	0.02008363535318378
GURRIERI SYNDROME	0.000541419	0.02008363535318378
POTOCKI-SHAFFER SYNDROME	0.000541419	0.02008363535318378
INFANTILE NEUROAXONAL DYSTROPHY	0.000541419	0.02008363535318378
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.000541419	0.02008363535318378
GALACTOSIALIDOSIS	0.000541419	0.02008363535318378
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.000541419	0.02008363535318378
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000541419	0.02008363535318378
PALLISTER-KILLIAN SYNDROME	0.000541419	0.02008363535318378
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000541419	0.02008363535318378
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.000541419	0.02008363535318378
ONDINE SYNDROME	0.000541419	0.02008363535318378
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.000541419	0.02008363535318378
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.000541419	0.02008363535318378
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000541419	0.02008363535318378
NEVUS COMEDONICUS SYNDROME	0.000541419	0.02008363535318378
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.000541419	0.02008363535318378
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000541419	0.02008363535318378
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.000541419	0.02008363535318378
ADIPOSIS DOLOROSA	0.000541419	0.02008363535318378
CRANIOSYNOSTOSIS 2	0.000541419	0.02008363535318378
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.000541419	0.02008363535318378
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.000541419	0.02008363535318378
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.000541419	0.02008363535318378
FAMILIAL THROMBOCYTOSIS	0.000541419	0.02008363535318378
MENKES DISEASE	0.000541419	0.02008363535318378
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.000541419	0.02008363535318378
TAKAYASU ARTERITIS	0.000541419	0.02008363535318378
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.000541419	0.02008363535318378
COFFIN-LOWRY SYNDROME; CLS	0.000541419	0.02008363535318378
RABIES	0.000541419	0.02008363535318378
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.000541419	0.02008363535318378
TETRASOMY 18P	0.000541419	0.02008363535318378
HHHH SYNDROME	0.000541419	0.02008363535318378
HYPOPARATHYROIDISM, X-LINKED	0.000541419	0.02008363535318378
INCONTINENTIA PIGMENTI; IP	0.000541419	0.02008363535318378
SUDDEN CARDIAC FAILURE, INFANTILE	0.000541419	0.02008363535318378
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000541419	0.02008363535318378
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.000541419	0.02008363535318378
RENPENNING SYNDROME 1; RENS1	0.000541419	0.02008363535318378
MENTAL RETARDATION, X-LINKED 1	0.000541419	0.02008363535318378
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.000541419	0.02008363535318378
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000541419	0.02008363535318378
PORPHYRIA	0.000541419	0.02008363535318378
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000541419	0.02008363535318378
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.000541419	0.02008363535318378
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.000541419	0.02008363535318378
MICROPHTHALMIA, SYNDROMIC 1	0.000541419	0.02008363535318378
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.000541419	0.02008363535318378
311450 PALLISTER W SYNDROME;;W SYNDROME	0.000541419	0.02008363535318378
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000541419	0.02008363535318378
LARGE CONGENITAL MELANOCYTIC NEVUS	0.000541419	0.02008363535318378
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000541419	0.02008363535318378
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.000541419	0.02008363535318378
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.000541419	0.02008363535318378
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.000541419	0.02008363535318378
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.000541419	0.02008363535318378
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.000541419	0.02008363535318378
HYPOPHOSPHATASIA	0.000541419	0.02008363535318378
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.000541419	0.02008363535318378
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000541419	0.02008363535318378
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000541419	0.02008363535318378
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.000541419	0.02008363535318378
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.000541419	0.02008363535318378
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000541419	0.02008363535318378
AUTISM, SUSCEPTIBILITY TO, 18	0.000541419	0.02008363535318378
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.000541419	0.02008363535318378
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000541419	0.02008363535318378
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.000541419	0.02008363535318378
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.000541419	0.02008363535318378
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000541419	0.02008363535318378
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000541419	0.02008363535318378
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.000541419	0.02008363535318378
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000541419	0.02008363535318378
MECKEL SYNDROME, TYPE 10; MKS10	0.000541419	0.02008363535318378
PERRAULT SYNDROME 3	0.000541419	0.02008363535318378
PAROXYSMAL EXTREME PAIN DISORDER	0.000541419	0.02008363535318378
ACQUIRED METHEMOGLOBINEMIA	0.000541419	0.02008363535318378
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000541419	0.02008363535318378
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000541419	0.02008363535318378
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000541419	0.02008363535318378
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.000541419	0.02008363535318378
X-LINKED CENTRONUCLEAR MYOPATHY	0.000541419	0.02008363535318378
CENTRONUCLEAR MYOPATHY	0.000541419	0.02008363535318378
MUSCLE-EYE-BRAIN DISEASE	0.000541419	0.02008363535318378
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.000541419	0.02008363535318378
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000541419	0.02008363535318378
IMMUNODEFICIENCY 37; IMD37	0.000541419	0.02008363535318378
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.000541419	0.02008363535318378
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.000541419	0.02008363535318378
ADAMS-OLIVER SYNDROME 5; AOS5	0.000541419	0.02008363535318378
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.000541419	0.02008363535318378
ALZHEIMER DISEASE 3; AD	0.000541419	0.02008363535318378
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.000541419	0.02008363535318378
PACHYGYRIA, FRONTOTEMPORAL	0.000541419	0.02008363535318378
LIPOID PROTEINOSIS	0.000541419	0.02008363535318378
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.02008363535318378
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000541419	0.02008363535318378
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.000541419	0.02008363535318378
GYRATE ATROPHY OF CHOROID AND RETINA	0.000541419	0.02008363535318378
HYPERPROLINEMIA TYPE 1	0.000541419	0.02008363535318378
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.000541419	0.02008363535318378
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000541419	0.02008363535318378
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.000541419	0.02008363535318378
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000541419	0.02008363535318378
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000541419	0.02008363535318378
ZLOTOGORA-OGUR SYNDROME	0.000541419	0.02008363535318378
MENTAL RETARDATION, X-LINKED 100	0.000541419	0.02008363535318378
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000541419	0.02008363535318378
RENPENNING SYNDROME	0.000541419	0.02008363535318378
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.000541419	0.02008363535318378
ROMANO-WARD SYNDROME	0.000541419	0.02008363535318378
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.000541419	0.02008363535318378
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.000541419	0.02008363535318378
PHAKOMATOSIS PIGMENTOVASCULARIS	0.000541419	0.02008363535318378
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.000541419	0.02008363535318378
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.02008363535318378
ABETA AMYLOIDOSIS, DUTCH TYPE	0.000541419	0.02008363535318378
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.000541419	0.02008363535318378
PORENCEPHALY	0.000541419	0.02008363535318378
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.000541419	0.02008363535318378
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.02008363535318378
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.000541419	0.02008363535318378
PROLACTINOMA	0.000541419	0.02008363535318378
PHENYLKETONURIA	0.000541419	0.02008363535318378
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.000541419	0.02008363535318378
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.000541419	0.02008363535318378
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000541419	0.02008363535318378
ADDISON DISEASE	0.000541419	0.02008363535318378
RAMON SYNDROME	0.000541419	0.02008363535318378
RETINAL DEGENERATION AND EPILEPSY	0.000541419	0.02008363535318378
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000541419	0.02008363535318378
SJOGREN-LARSSON SYNDROME; SLS	0.000541419	0.02008363535318378
RAMON SYNDROME	0.000541419	0.02008363535318378
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.000541419	0.02008363535318378
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.000541419	0.02008363535318378
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.000541419	0.02008363535318378
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.000541419	0.02008363535318378
KIFAFA SEIZURE DISORDER	0.000541419	0.02008363535318378
HYPER-BETA-ALANINEMIA	0.000541419	0.02008363535318378
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.000541419	0.02008363535318378
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000541419	0.02008363535318378
HYPERPROLINEMIA, TYPE II	0.000541419	0.02008363535318378
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.000541419	0.02008363535318378
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000541419	0.02008363535318378
HYPOPHOSPHATASIA, INFANTILE	0.000541419	0.02008363535318378
HYPOPHOSPHATASIA, CHILDHOOD	0.000541419	0.02008363535318378
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000541419	0.02008363535318378
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.000541419	0.02008363535318378
KEUTEL SYNDROME; KTLS	0.000541419	0.02008363535318378
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.000541419	0.02008363535318378
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.000541419	0.02008363535318378
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.000541419	0.02008363535318378
NASU-HAKOLA DISEASE	0.000541419	0.02008363535318378
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.000541419	0.02008363535318378
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.000541419	0.02008363535318378
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000541419	0.02008363535318378
PROGRESSIVE HEMIFACIAL ATROPHY	0.000541419	0.02008363535318378
BETA-MANNOSIDOSIS	0.000541419	0.02008363535318378
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000541419	0.02008363535318378
OHDO SYNDROME	0.000541419	0.02008363535318378
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.02008363535318378
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000541419	0.02008363535318378
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.000541419	0.02008363535318378
FILIPPI SYNDROME; FLPIS	0.000541419	0.02008363535318378
ENCEPHALITIS LETHARGICA	0.000541419	0.02008363535318378
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.000541419	0.02008363535318378
ALG9-CDG	0.000541419	0.02008363535318378
ATKIN-FLAITZ SYNDROME	0.000541419	0.02008363535318378
ALG2-CDG	0.000541419	0.02008363535318378
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.000541419	0.02008363535318378
MPDU1-CDG	0.000541419	0.02008363535318378
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000541419	0.02008363535318378
L-2-HYDROXYGLUTARIC ACIDURIA	0.000541419	0.02008363535318378
MENTAL RETARDATION, X-LINKED 82	0.000541419	0.02008363535318378
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000541419	0.02008363535318378
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.000541419	0.02008363535318378
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.000541419	0.02008363535318378
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.000541419	0.02008363535318378
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000541419	0.02008363535318378
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000541419	0.02008363535318378
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.000541419	0.02008363535318378
CLARK-BARAITSER SYNDROME	0.000541419	0.02008363535318378
FRAGILE X MENTAL RETARDATION SYNDROME	0.000541419	0.02008363535318378
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.000541419	0.02008363535318378
HEREDITARY COPROPORPHYRIA	0.000541419	0.02008363535318378
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000541419	0.02008363535318378
LUJO HEMORRHAGIC FEVER	0.000541419	0.02008363535318378
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.000541419	0.02008363535318378
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000541419	0.02008363535318378
STURGE-WEBER SYNDROME	0.000541419	0.02008363535318378
MOGS-CDG	0.000541419	0.02008363535318378
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000541419	0.02008363535318378
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.000541419	0.02008363535318378
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.000541419	0.02008363535318378
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.000541419	0.02008363535318378
TAY-SACHS DISEASE; TSD	0.000541419	0.02008363535318378
SCRUB TYPHUS	0.000541419	0.02008363535318378
X-LINKED INTELLECTUAL DISABILITY-SEIZURES-PSORIASIS SYNDROME	0.000541419	0.02008363535318378
THREONINEMIA	0.000541419	0.02008363535318378
ISOLATED SPINA BIFIDA	0.000541419	0.02008363535318378
SNEDDON SYNDROME	0.000541419	0.02008363535318378
SJÖGREN-LARSSON SYNDROME	0.000541419	0.02008363535318378
BENIGN FAMILIAL INFANTILE EPILEPSY	0.000541419	0.02008363535318378
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.000541419	0.02008363535318378
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.000541419	0.02008363535318378
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.000541419	0.02008363535318378
ECTODERMAL DYSPLASIA SYNDROME	0.000541419	0.02008363535318378
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.000541419	0.02008363535318378
ZUNICH NEUROECTODERMAL SYNDROME	0.000541419	0.02008363535318378
MENTAL RETARDATION, X-LINKED 14	0.000541419	0.02008363535318378
MENTAL RETARDATION, X-LINKED 21	0.000541419	0.02008363535318378
ATYPICAL RETT SYNDROME	0.000541419	0.02008363535318378
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.000541419	0.02008363535318378
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.000541419	0.02008363535318378
PORPHYRIA VARIEGATA	0.000541419	0.02008363535318378
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.000541419	0.02008363535318378
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000541419	0.02008363535318378
SAETHRE-CHOTZEN SYNDROME	0.000541419	0.02008363535318378
WOLF-HIRSCHHORN SYNDROME	0.000541419	0.02008363535318378
